Section 56

EurekaMag Full Text Articles Chapter 55,590


Sakurai, T. 2013: Risks for impaired daily life function in the elderly with type 2 diabetes in Japan. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 50(1): 60-64
Juhn, Y.J. 2014: Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?. Journal of Allergy and Clinical Immunology 134(2): 247-257; Quiz: 258-259
Pagano, L.; Caira, M. 2012: Risks for infection in patients with myelodysplasia and acute leukemia. Current Opinion in Infectious Diseases 25(6): 612-618
Akintoye, S.O.; Hersh, E.V. 2012: Risks for jaw osteonecrosis drastically increases after 2 years of bisphosphonate therapy. journal of evidence-based dental practice 12(3 Suppl): 251-253
Ramsetty, S.K.; Stuart, L.L.; Blake, R.T.; Parsons, C.H.; Salgado, C.D. 2010: Risks for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection. HIV Medicine 11(6): 389-394
Martín-Loeches, I.; Diaz, E.; Vallés, J. 2014: Risks for multidrug-resistant pathogens in the ICU. Current Opinion in Critical Care 20(5): 516-524
Edlund, M.J.; Martin, B.C.; Fan, M.-Y.; Devries, A.; Braden, J.B.; Sullivan, M.D. 2010: Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug and Alcohol Dependence 112(1-2): 90-98
Maio, G. 2014: Risks for patient safety in the DRG era. Zeitschrift für Evidenz Fortbildung und Qualitat Im Gesundheitswesen 108(1): 32-34
Kolås, T.; Øian, P.ål.; Skjeldestad, F.E. 2010: Risks for peroperative excessive blood loss in cesarean delivery. Acta Obstetricia et Gynecologica Scandinavica 89(5): 658-663
Sullivan, M.D.; Edlund, M.J.; Fan, M.-Y.; DeVries, A.; Braden, J.B.; Martin, B.C. 2010: Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP Study. Pain 150(2): 332-339
Kidanto, H.L.; Mogren, I.; Lindmark, G.; Massawe, S.; Nystrom, L. 2009: Risks for preterm delivery and low birth weight are independently increased by severity of maternal anaemia. South African Medical Journal 99(2): 98-102
Forslund, T.; Wettermark, B.ör.; Wändell, P.; von Euler, M.; Hasselström, J.; Hjemdahl, P. 2014: Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region. European Journal of Clinical Pharmacology 70(12): 1477-1485
Finnström, O.; Nygren, K-G. 2013: Risks for the children in surrogacy. Important to follow the outcome of in vitro fertilization. Lakartidningen 110(25-26): 1201
Suarthana, E.; Heederik, D.; Ghezzo, H.; Malo, J-L.; Kennedy, S.M.; Gautrin, D. 2009: Risks for the development of outcomes related to occupational allergies: an application of the asthma-specific job exposure matrix compared with self-reports and investigator scores on job-training-related exposure. Occupational and Environmental Medicine 66(4): 256-263
Gilman, S.E.; Dupuy, J.M.; Perlis, R.H. 2012: Risks for the transition from major depressive disorder to bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 73(6): 829-836
Walsh, L.; Shore, R.; Auvinen, A.; Jung, T.; Wakeford, R. 2014: Risks from CT scans--what do recent studies tell us?. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection 34(1): E1-E5
Simkó, M.; Mattsson, M-Olof. 2010: Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review. Particle and Fibre Toxicology 7: 42
Mangurian, C.; Fuentes-Afflick, E.; Newcomer, J.W. 2010: Risks from antipsychotic medications in children and adolescents. JAMA 303(8): 729; author reply 730
Uneyama, C. 2013: Risks from hazardous chemicals in food. Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan 54(2): 83-88
Drew, P.J. 2009: Risks from heavy metal music. 'Mosh pit' breast?. Bmj 338: B42
Mobbs, S.F.; Muirhead, C.R.; Harrison, J.D. 2011: Risks from ionising radiation: an HPA viewpoint paper for Safegrounds. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection 31(3): 289-307
Jeggo, P.A. 2009: Risks from low dose/dose rate radiation: what an understanding of DNA damage response mechanisms can tell us. Health Physics 97(5): 416-425
Pierce, D.A.; Preston, D.L. 1996: Risks from low doses of radiation. Science 272(5262): 632b-633b
Loomis, D. 2011: Risks from nuclear accidents are still uncertain. Occupational and Environmental Medicine 68(6): 387
Wu, C.; Zhang, A.; Liu, W. 2013: Risks from sediments contaminated with organochlorine pesticides in Hangzhou, China. Chemosphere 90(9): 2341-2346
Thaczuk, D. 2007: Risks higher in GTi at higher CD4 threshold. Iapac Monthly 13(2): 39-40
Nathan, R.; Rautenbach, P. 2013: Risks identified in implementation of District Clinical Specialist Teams. South African Medical Journal 103(3): 144-146
Habich, S. 2012: Risks in atrial fibrillation and simultaneous renal failure. Deutsche Medizinische Wochenschrift 137(38): 1840
Lee, J.W. 2009: Risks in biomarker analysis resulting in unfit data use in clinical drug development. Biomarkers in Medicine 3(2): 103-107
Graham, I.M.; Cooney, M.-T. 2014: Risks in estimating risk. European Heart Journal 35(9): 537-539
Parmegiani, L.; Cognigni, G.Estela.; Filicori, M. 2010: Risks in injecting hyaluronic acid non-bound spermatozoa. Reproductive biomedicine online 20(3): 437-8; author reply 439
Wolters, H.H.; Vowinkel, T. 2012: Risks in life after living kidney donation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 27(8): 3021-3023
Nau, J.-Y. 2008: Risks in organ removal after cardiac arrest (2). Revue Medicale Suisse 4(155): 1120
Nau, J.-Y. 2008: Risks in organ removal after cardiac arrest (I). Revue Medicale Suisse 4(154): 1068
Murat, I.; Humblot, A.; Girault, L. 2009: Risks in paediatric anaesthesia. Annales Francaises d'Anesthesie et de Reanimation 28(7-8): 666-670
Jöhr, M. 2014: Risks in pediatric anesthesia. Causes and prevention of complications. Der Anaesthesist 63(7): 546-547
Wagner, U. 2010: Risks in the application of medical devices: human factors in the medical environment. Quality Management in Health Care 19(4): 304-311
Hawkes, N. 2014: Risks in the balance: the statins row. Bmj 349: G5007
Fleiner, J.; Schulze, D. 2007: Risks in the digital transmission of sensitive patient data. International Journal of Computerized Dentistry 10(4): 339-351
Manrique-Rodríguez, S.; Sánchez-Galindo, A.C.; López-Herce, J.ús.; Calleja-Hernández, M.Án.; Iglesias-Peinado, I.; Carrillo-Álvarez, A.; Sáez, M.ía.S.; Fernández-Llamazares, C.M. 2014: Risks in the implementation and use of smart pumps in a pediatric intensive care unit: application of the failure mode and effects analysis. International Journal of Technology Assessment in Health Care 30(2): 210-217
Ruan, J.; Xue, M.; Xu, Z. 2012: Risks in the physical recovery system of waste refrigerator cabinets and the controlling measure. Environmental Science and Technology 46(24): 13386-13392
Narvaez, R.; Moors, K.; Miller, R.; Ramirez, M. 2007: Risks in using nonrigorous spanish translations of asthma questionnaires. Chest 131(4): 1271-1272
Case, B.G. 2013: Risks interpreting odds. Journal of the American Academy of Child and Adolescent Psychiatry 52(3): 319
Dewannieux, M.; Ribet, D.; Heidmann, T. 2010: Risks linked to endogenous retroviruses for vaccine production: a general overview. Biologicals: Journal of the International Association of Biological Standardization 38(3): 366-370
Kiselev, A.V.; Gabidova, A.E.; Galynkin, V.A.; Aĭrapetian, K.V. 2010: Risks occurring during the use of raw medicinal plant material and its based phytopreparations. Gigiena i Sanitariia 6: 78-80
Chen, H.-F.; Liu, M.-D.; Chen, P.; Chen, L.-H.; Chang, Y.-H.; Wen, P.-C.; Li, C.-Y. 2013: Risks of Breast and Endometrial Cancer in Women with Diabetes: a Population-Based Cohort Study. Plos one 8(6): E67420
Schumaker, B. 2013: Risks of Brucella abortus spillover in the Greater Yellowstone area. Revue Scientifique et Technique 32(1): 71-77
Fletcher, C.M.; Jones, F.A. 1945: Risks of Gastroscopy with Flexible Gastroscope. British Medical Journal 2(4421): 421-422
Anonymous 1963: Risks of Gemoral Puncture. British Medical Journal 2(5352): 267
Cohrssen, A.; Schiller, R. 2008: Risks of H. pylori "test-and-treat" strategy in dyspepsia. American Family Physician 77(2): 146
Ha, C.Y. 2014: Risks of Infection among the Older Inflammatory Bowel Disease Patients. Current Treatment Options in Gastroenterology 12(3): 283-291
Baglietto, L.; Lindor, N.M.; Dowty, J.G.; White, D.M.; Wagner, A.; Gomez Garcia, E.B.; Vriends, A.H.J.T.; Cartwright, N.R.; Barnetson, R.A.; Farrington, S.M.; Tenesa, A.; Hampel, H.; Buchanan, D.; Arnold, S.; Young, J.; Walsh, M.D.; Jass, J.; Macrae, F.; Antill, Y.; Winship, I.M.; Giles, G.G.; Goldblatt, J.; Parry, S.; Suthers, G.; Leggett, B.; Butz, M.; Aronson, M.; Poynter, J.N.; Baron, J.A.; Le Marchand, L.; Haile, R.; Gallinger, S.; Hopper, J.L.; Potter, J.; de la Chapelle, A.; Vasen, H.F.; Dunlop, M.G.; Thibodeau, S.N.; Jenkins, M.A. 2010: Risks of Lynch syndrome cancers for MSH6 mutation carriers. Journal of the National Cancer Institute 102(3): 193-201
Peres, J. 2013: Risks of PSA screening now better understood. Journal of the National Cancer Institute 105(21): 1590-1592
Anonymous 1947: Risks of Radioactive Isotopes. British Medical Journal 2(4532): 778-779
Wiener, R.S.; Wiener, D.C.; Gould, M.K. 2013: Risks of Transthoracic Needle Biopsy: how High?. Clinical Pulmonary Medicine 20(1): 29-35
Samaras, A.T.; Bennett, C.L. 2008: Risks of Venous Thromboembolism and Mortality Associated with Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia. American Journal of Hematology/Oncology 7(8): 327-332
Dong, X.S.; Ringen, K.; Welch, L.; Dement, J. 2014: Risks of a lifetime in construction part I: traumatic injuries. American Journal of Industrial Medicine 57(9): 973-983
Ringen, K.; Dement, J.; Welch, L.; Dong, X.S.; Bingham, E.; Quinn, P.S. 2014: Risks of a lifetime in construction. Part II: Chronic occupational diseases. American Journal of Industrial Medicine 57(11): 1235-1245
Kmietowicz, Z. 2012: Risks of acupuncture range from stray needles to pneumothorax, finds study. Bmj 345: E6060
Williams, T.; Reeves, B.C.; Foss, A.J.E.; Fell, G. 2012: Risks of adverse events with therapies for age-related macular degeneration: a response. Archives of Ophthalmology 130(1): 124-5; Author Reply 125-6
Bodén, R.; Lundgren, M.; Brandt, L.; Reutfors, J.; Andersen, M.; Kieler, H. 2012: Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. Bmj 345: E7085
Brosens, I.; Brosens, J.J.; Fusi, L.; Al-Sabbagh, M.; Kuroda, K.; Benagiano, G. 2012: Risks of adverse pregnancy outcome in endometriosis. Fertility and Sterility 98(1): 30-35
Greenfield, T.K.; Ye, Y.; Bond, J.; Kerr, W.C.; Nayak, M.B.; Kaskutas, L.A.; Anton, R.F.; Litten, R.Z.; Kranzler, H.R. 2014: Risks of alcohol use disorders related to drinking patterns in the U.S. general population. Journal of Studies on Alcohol and Drugs 75(2): 319-327
Pascal, R.; Liang, W.; Gilmore, W.; Chikritzhs, T. 2013: Risks of alcohol-attributable hospitalisation and death in Australia over time: Evidence of divergence by region, age and sex. Australasian Medical Journal 6(3): 134-151
Weldy, D.L. 2010: Risks of alcoholic energy drinks for youth. Journal of the American Board of Family Medicine: Jabfm 23(4): 555-558
Chesney, E.; Goodwin, G.M.; Fazel, S. 2014: Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry: Official Journal of the World Psychiatric Association 13(2): 153-160
Lay, P.Chase.; Bass, R.; Hughes, L.F.; Lin, S.Y. 2008: Risks of allergy vial contamination: comparison of mixing in-office versus under ventilation hood. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 139(3): 364-366
Gibbs, N.M. 2012: Risks of anaesthesia and surgery in elderly patients. Anaesthesia and Intensive Care 40(1): 14-16
Metzner, J.; Domino, K.B. 2010: Risks of anesthesia or sedation outside the operating room: the role of the anesthesia care provider. Current Opinion in Anaesthesiology 23(4): 523-531
Stärk, K.D.C. 2010: Risks of animal-derived food in a global market--are we ready for the challenges?. Veterinary Journal 184(2): 121-123
Anderson, G.; Aldamluji, N. 2011: Risks of aspiration in pregnant women undergoing non-obstetric procedures: intubate or not?. British Journal of Hospital Medicine 72(4): 238
Mayor, S. 2012: Risks of aspirin outweigh benefits in people without cardiovascular disease, shows analysis. Bmj 344: E241
Farsalinos, K.E.; Voudris, V.; Le Houezec, J. 2015: Risks of attempting to regulate nicotine flux in electronic cigarettes. Nicotine and Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco 17(2): 163-164
Cappelle, J.; Zhao, D.; Gilbert, M.; Nelson, M.I.; Newman, S.H.; Takekawa, J.Y.; Gaidet, N.; Prosser, D.J.; Liu, Y.; Li, P.; Shu, Y.; Xiao, X. 2014: Risks of avian influenza transmission in areas of intensive free-ranging duck production with wild waterfowl. Ecohealth 11(1): 109-119
Bazzini, G.; Capodaglio, E.; Panigazzi, M.; Prestifilippo, E.; Vercesi, C. 2010: Risks of awkward posture. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 32(3): 215-222
Aziz, A.; McIntyre, L.; Khazen, R. 1985: Risks of baby walkers and options for prevention. Canadian Family Physician Medecin de Famille Canadien 31: 2147-2150
Schoeffler, P.; Dualé, C.; Walder, B. 2011: Risks of being an anaesthesiologist. European Journal of Anaesthesiology 28(11): 756-757
McGlynn, K.A.; Gridley, G.; Mellemkjaer, L.; Brinton, L.A.; Anderson, K.C.; Caporaso, N.E.; Landgren, O.; Olsen, J.H. 2008: Risks of cancer among a cohort of 23,935 men and women with osteoporosis. International Journal of Cancer 122(8): 1879-1884
Yakymenko, I.; Sidorik, E. 2010: Risks of carcinogenesis from electromagnetic radiation of mobile telephony devices. Experimental Oncology 32(2): 54-60
Chou, H.-W.; Wang, J.-L.; Chang, C.-H.; Lai, C.-L.; Lai, M.-S.; Chan, K.A. 2015: Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60(4): 566-577
Toms, D.A. 2011: Risks of cardiac imaging. Cmaj: Canadian Medical Association Journal 183(16): 1885; Author Reply 1885
Du, X.; Ninomiya, T.; de Galan, B.; Abadir, E.; Chalmers, J.; Pillai, A.; Woodward, M.; Cooper, M.; Harrap, S.; Hamet, P.; Poulter, N.; Lip, G.Y.H.; Patel, A. 2009: Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. European Heart Journal 30(9): 1128-1135
Nohara, T.; Terao, H.; Tobe, K.; Musashi, M.; Nagao, K. 2009: Risks of chest X-ray examination for students. Acta Medica Okayama 63(1): 43-47
Linkson, L.; Rees, P.J. 2008: Risks of chest drain insertion. International Journal of Clinical Practice 62(10): 1467-1468
Thompson, J.A.; Carozza, S.E.; Bissett, W.T.; Zhu, L. 2010: Risks of childhood cancer among Texas watersheds, based on mothers' living locations at the time of birth. Journal of Water and Health 8(1): 139-146
Moseeva, M.B.; Azizova, T.V.; Grigoryeva, E.S.; Haylock, R. 2014: Risks of circulatory diseases among Mayak PA workers with radiation doses estimated using the improved Mayak Worker Dosimetry System 2008. Radiation and Environmental Biophysics 53(2): 469-477
Strauss, R.G. 2008: Risks of clinically significant thrombocytopenia and/or lymphocytopenia in donors after multiple plateletpheresis collections. Transfusion 48(7): 1274-1278
Kurdal, A.T.; Iskesen, I. 2010: Risks of combination technique. Interactive Cardiovascular and Thoracic Surgery 11(6): 777-778
Moore, A.A.; Whiteman, E.J.; Ward, K.T. 2007: Risks of combined alcohol/medication use in older adults. American Journal of Geriatric PharmacoTherapy 5(1): 64-74
Roblin, X.; Phelip, J.Marc. 2008: Risks of combining immunosuppressive and biological treatments in inflammatory bowel disease. Archives of Internal Medicine 168(6): 667; Author Reply 667-668
Fenoy, A.J.; Simpson, R.K. 2014: Risks of common complications in deep brain stimulation surgery: management and avoidance. Journal of Neurosurgery 120(1): 132-139
Elkin, K.; Spittal, M.J.; Studdert, D.M. 2012: Risks of complaints and adverse disciplinary findings against international medical graduates in Victoria and Western Australia. Medical Journal of Australia 197(8): 448-452
Rothschild, J.M.; Keohane, C.A.; Rogers, S.; Gardner, R.; Lipsitz, S.R.; Salzberg, C.A.; Yu, T.; Yoon, C.S.; Williams, D.H.; Wien, M.F.; Czeisler, C.A.; Bates, D.W.; Landrigan, C.P. 2009: Risks of complications by attending physicians after performing nighttime procedures. JAMA 302(14): 1565-1572
Coukell, A. 2014: Risks of compounded drugs. JAMA Internal Medicine 174(4): 613-614
Kumar, B.; Borgohain, B.; Balasubramanian, S.; Sathyanarayana, V.; Muthusamy, M. 2014: Risks of concomitant trauma to the knee in lower limb long bone shaft fractures: A retrospective analysis from a prospective study population. Advanced Biomedical Research 3: 49
Davis, R.L.; Eastman, D.; McPhillips, H.; Raebel, M.A.; Andrade, S.E.; Smith, D.; Yood, M.Ulcickas.; Dublin, S.; Platt, R. 2011: Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiology and Drug Safety 20(2): 138-145
Brewer, G.J. 2010: Risks of copper and iron toxicity during aging in humans. Chemical Research in Toxicology 23(2): 319-326
Li, S.; Noble, J.; Lloyd, J.C. 2012: Risks of cosmetic iris implantation. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 47(6): E50-E51
Antunes, J.ão.; Gouveia, C.; Brito, M.J.ão. 2010: Risks of cyclosporine therapy in paediatric age. Acta Medica Portuguesa 23(5): 915-920
Charytan, D.M.; Li, S.; Liu, J.; Herzog, C.A. 2012: Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation 126(11 Suppl 1: S164-S169
Lin, C.-C.; Li, C.-I.; Liu, C.-S.; Lin, W.-Y.; Lin, C.-H.; Lai, M.-M.; Lee, Y.-D.; Chen, C.-C.; Yang, C.-W.; Li, T.-C. 2014: Risks of decreased renal function and increased albuminuria for glycemic status and metabolic syndrome components: Taichung Community Health study. Biomed Research International 2014: 841497
Keller, D.L. 2013: Risks of deep brain stimulation for Parkinson disease. American Family Physician 87(12): 822
De Jongh, A.; Broers, D.L.M. 2009: Risks of dental fear reduction treatments. Nederlands Tijdschrift Voor Tandheelkunde 116(6): 324-329
Maksimov, S.A.; Skripchenko, A.E.; Artamonova, G.V. 2012: Risks of development of arterial hypertension in occupational groups of Western Siberia: comparison with national representative data. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2012(12): 54 56-9
Lin, C.-C.; Chen, C.-C.; Chen, F.-N.; Li, C.-I.; Liu, C.-S.; Lin, W.-Y.; Yang, S.-Y.; Lee, C.-C.; Li, T.-C. 2013: Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose. American Journal of Medicine 126(11): 1017.E1
Roberts, J.A.F. 1948: Risks of dicoumarol therapy. British Medical Journal 1(4561): 1107
Riboldi, B.ár.P.; Vinhas, Ál.M.; Moreira, J.úl.D. 2014: Risks of dietary acrylamide exposure: a systematic review. Food Chemistry 157: 310-322
Barratt, C.L.; Cook, I.D. 1990: Risks of donor insemination. International Journal of Risk and Safety in Medicine 1(2): 113-115
Schmitt, M.W.; Fox, E.J.; Salk, J.J. 2014: Risks of double-counting in deep sequencing. Proceedings of the National Academy of Sciences of the United States of America 111(16): E1560
Shaikh, M.A. 2014: Risks of drowning and safety concerns at the beaches of Karachi--perspective from lifeguards. JPMA. Journal of the Pakistan Medical Association 64(5): 576-578
Peixoto, J.Sereno.; Salci, M.Aparecida.; Radovanovic, C.Aparecida.Trindade.; Salci, T.Pereira.; Torres, M.Morbin.; Carreira, Lígia. 2012: Risks of drug-nutrient interaction for the elderly in long-term care institutions. Revista Gaucha de Enfermagem 33(3): 156-164
Lim, S.; Seligson, A.Levanon.; Parvez, F.M.; Luther, C.W.; Mavinkurve, M.P.; Binswanger, I.A.; Kerker, B.D. 2012: Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001-2005. American journal of epidemiology 175(6): 519-526
Catalá-López, F.án.; Macías Saint-Gerons, D.; de la Fuente Honrubia, C.és.; Martín-Serrano, G. 2014: Risks of dual blockade of the renin-angiotensin system compared with monotherapy: a systematic review and cumulative meta-analysis of randomized trials and observational studies. Revista Espanola de Salud Publica 88(1): 37-65
Coura, J.é R.; Junqueira, A.C. 2012: Risks of endemicity, morbidity and perspectives regarding the control of Chagas disease in the Amazon Region. Memorias do Instituto Oswaldo Cruz 107(2): 145-154
Fournier, Aès.; Dossus, L.; Mesrine, S.; Vilier, A.; Boutron-Ruault, M-Christine.; Clavel-Chapelon, Fçoise.; Chabbert-Buffet, N. 2014: Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008. American journal of epidemiology 180(5): 508-517
Bigard, A.-X. 2010: Risks of energy drinks in youths. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 17(11): 1625-1631
Howland, J.; Rohsenow, D.J. 2013: Risks of energy drinks mixed with alcohol. JAMA 309(3): 245-246
Moulder, J.E. 2012: Risks of exposure to ionizing and millimeter-wave radiation from airport whole-body scanners. Radiation Research 177(6): 723-726
Wang, T.-N.; Lin, M.-C.; Wu, C.-C.; Leung, S.-Y.; Huang, M.-S.; Chuang, H.-Y.; Lee, C.-H.; Wu, D.-C.; Ho, P.-S.; Ko, A.M.-S.; Chang, P.-Y.; Ko, Y.-C. 2010: Risks of exposure to occupational asthmogens in atopic and nonatopic asthma: a case-control study in Taiwan. American Journal of Respiratory and Critical Care Medicine 182(11): 1369-1376
Anonymous 2008: Risks of extended-spectrum beta-lactamases. Drug and Therapeutics Bulletin 46(3): 21-24
Susheel Kumar, T.K.; Sinha, P.; Moulick, A.; Jonas, R.A. 2010: Risks of extracorporeal membrane oxygenation in patients with coronary artery anomalies. World Journal for Pediatric and Congenital Heart Surgery 1(2): 249-253
Hockley, N.; Gibbons, J.M.; Edwards-Jones, G. 2009: Risks of extreme heat and unpredictability. Science 324(5924): 177-9; Author Reply 177-9
Messieha, Z. 2009: Risks of general anesthesia for the special needs dental patient. Special Care in Dentistry: Official Publication of the American Association of Hospital Dentists the Academy of Dentistry for the Handicapped and the American Society for Geriatric Dentistry 29(1): 21-25; Quiz: 67-68
Nerenberg, K.A.; Johnson, J.A.; Leung, B.; Savu, A.; Ryan, E.A.; Chik, C.L.; Kaul, P. 2013: Risks of gestational diabetes and preeclampsia over the last decade in a cohort of Alberta women. Journal of Obstetrics and Gynaecology Canada: Jogc 35(11): 986-994
Hutton, B.; Joseph, L.; Fergusson, D.; Mazer, C.D.; Shapiro, S.; Tinmouth, A. 2012: Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. Bmj 345: E5798
Cutter, D.J.; Darby, S.C.; Yusuf, S.W. 2011: Risks of heart disease after radiotherapy. Texas Heart Institute Journal 38(3): 257-258
Berséus, O.; Boman, K.; Nessen, S.C.; Westerberg, L.A. 2013: Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion 53(Suppl 1): 114s-123s
Yun, H.; Xie, F.; Delzell, E.; Chen, L.; Levitan, E.B.; Lewis, J.D.; Saag, K.G.; Beukelman, T.; Winthrop, K.; Baddley, J.W.; Curtis, J.R. 2015: Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care and Research 67(5): 731-736
Rolison, J.J.; Hewson, P.J.; Hellier, E.; Hurst, L. 2013: Risks of high-powered motorcycles among younger adults. American Journal of Public Health 103(3): 568-571
Quigg, M.; Yen, C.-P.; Chatman, M.; Quigg, A.H.; McNeill, I.T.; Macneill, I.T.; Przybylowski, C.J.; Yan, G.; Sheehan, J.P. 2012: Risks of history of diabetes mellitus, hypertension, and other factors related to radiation-induced changes following Gamma Knife surgery for cerebral arteriovenous malformations. Journal of Neurosurgery 117 Suppl: 144-149
Säfholm, M.; Ribbenstedt, A.; Fick, J.; Berg, C. 2014: Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 369(1656)
Haynes, G.R. 2014: Risks of hydroxyethyl starch 130/0.4 in cardiac surgery. Journal of Pharmacy Practice 27(1): 17-18
Janota, I. 1983: Risks of hypertension. Journal of the Royal Society of Medicine 76(11): 983
Burt, R.K.; Abinun, M.; Farge-Bancel, D.; Fassas, A.; Hiepe, F.; Havrdová, E.; Ikehara, S.; Loh, Y.; Marmont du Haut Champ, A.; Voltarelli, J.úl.C.; Snowden, J.; Slavin, S. 2010: Risks of immune system treatments. Science 328(5980): 825-826
Meador, K.J.; Loring, D.W. 2013: Risks of in utero exposure to valproate. JAMA 309(16): 1730-1731
Samukawa, M.; Hirano, M.; Sakamoto, H.; Kitada, M.; Kusunoki, S.; Nakamura, Y. 2011: Risks of inappropriate secretion of antidiuretic hormone in multiple system atrophy. Movement Disorders: Official Journal of the Movement Disorder Society 26(14): 2572-2573
Grenkova, T.A.; Sel'kova, E.P. 2010: Risks of infectious disease transmission during endoscopy. Eksperimental'naia i Klinicheskaia Gastroenterologiia 10: 59-63
Curkovic, I.; Egbring, M.; Kullak-Ublick, G.A. 2013: Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylates. Digestive Diseases 31(3-4): 368-373
Jolly, C.M.; Bayard, B.; Vodouhe, S. 2009: Risks of ingestion of aflatoxin-contaminated groundnuts in Benin: scale measurements, beliefs, and socioeconomic factors. Risk Analysis: An Official Publication of the Society for Risk Analysis 29(10): 1395-1409
Suzuki, T.; Nomura, K.; Watanabe, K. 2011: Risks of intermittent antipsychotic treatment in schizophrenia. Journal of Clinical Psychiatry 72(1): 114; Author Reply 114-5
Xian, Y.; Liang, L.; Smith, E.E.; Schwamm, L.H.; Reeves, M.J.; Olson, D.M.; Hernandez, A.F.; Fonarow, G.C.; Peterson, E.D. 2012: Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA 307(24): 2600-2608
Xiaowu, H.; Xiufeng, J.; Xiaoping, Z.; Bin, H.; Laixing, W.; Yiqun, C.; Jinchuan, L.; Aiguo, J.; Jianmin, L. 2010: Risks of intracranial hemorrhage in patients with Parkinson's disease receiving deep brain stimulation and ablation. Parkinsonism and Related Disorders 16(2): 96-100
Bolier, A.R.; Jebbink, J.M.; van der Post, J.A.M.; Oude Elferink, R.P.J.; Beuers, U. 2014: Risks of intrahepatic cholestasis of pregnancy. Nederlands Tijdschrift Voor Geneeskunde 158: A7713
Khan, S.; Sewell, W.A.C. 2007: Risks of intravenous immunoglobulin in sepsis affect trial design. Annals of Internal Medicine 147(11): 813; Author Reply 813-4
Giraud, P.; Henni, M.; Cosset, J.-M. 2009: Risks of irradiation in hepatogastroenterology. Presse Medicale 38(11): 1680-1689
Chagnon, M.; Kreutzweiser, D.; Mitchell, E.A.D.; Morrissey, C.A.; Noome, D.A.; Van der Sluijs, J.P. 2015: Risks of large-scale use of systemic insecticides to ecosystem functioning and services. Environmental Science and Pollution Research International 22(1): 119-134
Engel, C.; Loeffler, M.; Steinke, V.; Rahner, N.; Holinski-Feder, E.; Dietmaier, W.; Schackert, H.K.; Goergens, H.; von Knebel Doeberitz, M.; Goecke, T.O.; Schmiegel, W.; Buettner, R.; Moeslein, G.; Letteboer, T.G.W.; Gómez García, E.; Hes, F.J.; Hoogerbrugge, N.; Menko, F.H.; van Os, T.A.M.; Sijmons, R.H.; Wagner, A.; Kluijt, I.; Propping, P.; Vasen, H.F.A. 2012: Risks of less common cancers in proven mutation carriers with lynch syndrome. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(35): 4409-4415
Belghiti, J. 2007: Risks of liver resection. Bulletin de l'Academie Nationale de Medecine 191(8): 1641-1646
Santos, L.; Macário, F.; Alves, R.; Mota, A.; Campos, M. 2010: Risks of living donor nephrectomy. Transplantation Proceedings 42(5): 1484-1486
Drazen, J.M.; O'Byrne, P.M. 2009: Risks of long-acting beta-agonists in achieving asthma control. New England Journal of Medicine 360(16): 1671-1672
Anonymous 2006: Risks of lucrative light bundles. "Blunders in laser medicine". MMW Fortschritte der Medizin 148(44): 16
Suttajit, S.; Kittirattanapaiboon, P.; Junsirimongkol, B.; Likhitsathian, S.; Srisurapanont, M. 2012: Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: findings from the 2008 Thai National Mental Health survey. Addictive Behaviors 37(12): 1395-1399
Von Buchwald, C.; Bradley, P.J. 2007: Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Current Opinion in Otolaryngology and Head and Neck Surgery 15(2): 95-98
Benyi, E.; Kieler, H.; Linder, M.; Ritzén, M.; Carlstedt-Duke, J.; Tuvemo, T.; Westphal, O.; Sävendahl, L. 2014: Risks of malignant and non-malignant tumours in tall women treated with high-dose oestrogen during adolescence. Hormone Research in Paediatrics 82(2): 89-96
Spatari, G.; Carta, A.; L'abbate, N.; Lorusso, A.; Draicchio, F. 2010: Risks of manual movement of patients. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 32(3): 208-214
Graveling, A.J.; Frier, B.M. 2010: Risks of marathon running and hypoglycaemia in Type 1 diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 27(5): 585-588
Oğüş, E.; Tekindal, M.A.; Ceylan, Y.; Demirel, M.; Emecioğlu, N.şe.; Ercan, I.çi.; Eroğlu, D.; Haner, S.ç 2013: Risks of metabolic syndrome in students of the faculty of health sciences. Balkan Medical Journal 30(3): 296-300
Stassen, L.P.S.; Bemelman, W.A.; Meijerink, J. 2010: Risks of minimally invasive surgery underestimated: a report of the Dutch Health Care Inspectorate. Surgical Endoscopy 24(3): 495-498
Solinger, A.B.; Rothman, S.I. 2013: Risks of mortality associated with common laboratory tests: a novel, simple and meaningful way to set decision limits from data available in the Electronic Medical Record. Clinical Chemistry and Laboratory Medicine 51(9): 1803-1813
Curtis, L.H.; Hammill, B.G.; Schulman, K.A.; Cousins, S.W. 2010: Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Archives of Ophthalmology 128(10): 1273-1279
Halfwerk, W.; Dixon, M.M.; Ottens, K.J.; Taylor, R.C.; Ryan, M.J.; Page, R.A.; Jones, P.L. 2014: Risks of multimodal signaling: bat predators attend to dynamic motion in frog sexual displays. Journal of Experimental Biology 217(Part 17): 3038-3044
Chang, J.-H.; Wu, J.-D.; Chen, C.-Y.; Sumd, S.-B.; Yin, H.-I.; Hsu, D.-J. 2014: Risks of musculoskeletal disorders among betel quid preparers in Taiwan. American Journal of Industrial Medicine 57(4): 476-485
Stamatis, G. 2008: Risks of neoadjuvant chemotherapy and radiation therapy. Thoracic Surgery Clinics 18(1): 71-80
Fairbrother, A.; Purdy, J.; Anderson, T.; Fell, R. 2014: Risks of neonicotinoid insecticides to honeybees. Environmental Toxicology and Chemistry 33(4): 719-731
Zeng, G.; Chen, M.; Zeng, Z. 2013: Risks of neonicotinoid pesticides. Science 340(6139): 1403
Gentile, S. 2014: Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions. Cns Spectrums 19(4): 305-315
Persson, I.; Granath, F.; Askling, J.; Ludvigsson, J.F.; Olsson, T.; Feltelius, N. 2014: Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. Journal of Internal Medicine 275(2): 172-190
Wu, M.-Y.; Wu, Y.-L.; Hsu, Y.-H.; Lin, Y.-F.; Fan, Y.-C.; Lin, Y.-C.; Chang, S.-J. 2012: Risks of nocturia in patients with chronic kidney disease--do the metabolic syndrome and its components matter?. Journal of Urology 188(6): 2269-2273
Le, T.N.; Wallen, J. 2009: Risks of non-familial violent physical and emotional victimization in four Asian ethnic groups. Journal of Immigrant and Minority Health 11(3): 174-187
Scolan, V.; Herry, C.; Carreta, M.; Stahl, C.; Barret, L.; Romanet, J.P.; Paysant, F. 2012: Risks of non-lethal weapon use: case studies of three French victims of stinger grenades. Forensic Science International 223(1-3): E18-E21
Messika, J.; Sztrymf, B.; Bertrand, F.; Billard-Pomares, T.; Barnaud, G.; Branger, C.; Dreyfuss, D.; Ricard, J.-D. 2014: Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger and more severely affected patients. Journal of Critical Care 29(5): 733-738
Jonasson, J.M.; Ye, W.; Sparén, P.är.; Apelqvist, J.; Nyrén, O.; Brismar, K. 2008: Risks of nontraumatic lower-extremity amputations in patients with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care 31(8): 1536-1540
Hurlimann, T.; Menuz, V.; Graham, J.; Robitaille, J.; Vohl, M.-C.; Godard, B. 2014: Risks of nutrigenomics and nutrigenetics? what the scientists say. Genes and Nutrition 9(1): 370
Anonymous 1898: Complaints against Hospitals. Hospital 24(622): 364
Lovett, K.M.; Liang, B.A.; Mackey, T.K. 2012: Risks of online direct-to-consumer tumor markers for cancer screening. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(13): 1411-1414
Jain, S.H.; Maxson, E.R. 2011: Risks of online forums for premedical and medical students. Academic medicine: journal of the Association of American Medical Colleges 86(2): 152
Hassall, E.; Lobe, T.E. 2007: Risks of oral sodium phosphate for pre-colonoscopy bowel preparation in children. Diseases of the Colon and Rectum 50(7): 1099
Wexner, S.D.; Rosen, L.; Baron, T.H. 2007: Risks of oral sodium phosphate for pre-colonoscopy bowel preparation in children: response to Drs. Hassall and Lobe. Surgical Endoscopy 21(6): 1040-1041
Hassall, E.; Lobe, T.E. 2007: Risks of oral sodium phosphate for precolonoscopy bowel preparation in children. Gastrointestinal Endoscopy 65(7): 1102-4; Author Reply 1104-5
Van Beek, H. 2009: Risks of orthodontic treatment. Nederlands Tijdschrift Voor Tandheelkunde 116(6): 306-310
Rozenberg, S.; Carly, B.; Liebens, F.; Antoine, C. 2009: Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment. Maturitas 64(1): 1-3
Pirkola, J.; Pouta, A.; Bloigu, A.; Hartikainen, A.-L.; Laitinen, J.; Järvelin, M.-R.; Vääräsmäki, M. 2010: Risks of overweight and abdominal obesity at age 16 years associated with prenatal exposures to maternal prepregnancy overweight and gestational diabetes mellitus. Diabetes Care 33(5): 1115-1121
Mousavi, S.Mohsen.; Brandt, A.; Sundquist, J.; Hemminki, K. 2011: Risks of papillary and follicular thyroid cancer among immigrants to Sweden. International journal of cancer 129(9): 2248-2255
Matsui, Y.; Oikawa, S.; Ando, K. 2013: Risks of pedestrian serious injuries and fatalities associated with impact velocities of cars in car-versus-pedestrian accidents in Japan. Stapp Car Crash Journal 57: 201-217
O'Byrne, P.M.; Pedersen, S.; Carlsson, L.-G.ör.; Radner, F.; Thorén, A.; Peterson, S.; Ernst, P.; Suissa, S. 2011: Risks of pneumonia in patients with asthma taking inhaled corticosteroids. American Journal of Respiratory and Critical Care Medicine 183(5): 589-595
Obermueller, T.; Schaeffner, M.; Gerhardt, J.; Meyer, B.; Ringel, F.; Krieg, S.M. 2014: Risks of postoperative paresis in motor eloquently and non-eloquently located brain metastases. Bmc Cancer 14: 21
Briese, V.; Voigt, M.; Wisser, J.; Borchardt, U.; Straube, S. 2011: Risks of pregnancy and birth in obese primiparous women: an analysis of German perinatal statistics. Archives of Gynecology and Obstetrics 283(2): 249-253
Lawter, J. 2010: Risks of prescribing/selling herbal supplements. Michigan Medicine 109(3): 9
Annes, J.P.; Giovanni, M.A.; Murray, M.F. 2010: Risks of presymptomatic direct-to-consumer genetic testing. New England Journal of Medicine 363(12): 1100-1101
Kiringoda, R.; Thurm, A.E.; Hirschtritt, M.E.; Koziol, D.; Wesley, R.; Swedo, S.E.; O'Grady, N.P.; Quezado, Z.M.N. 2010: Risks of propofol sedation/anesthesia for imaging studies in pediatric research: eight years of experience in a clinical research center. Archives of Pediatrics and Adolescent Medicine 164(6): 554-560
Zhang, Z.-F.; Wang, T.; Liu, L.-H.; Guo, H.-Q. 2014: Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysis. Plos one 9(3): E90135
Talley, N.J. 2009: Risks of proton-pump inhibitors: what every doctor should know. Medical Journal of Australia 190(3): 109-110
Grill, J.; Dhermain, F.; Habrand, J.-L. 2009: Risks of radiation therapy in patients with neurofibromatosis. International Journal of Radiation Oncology Biology Physics 75(2): 632
McOliver, C.C.; Lemerman, H.B.; Silbergeld, E.K.; Moore, R.D.; Graczyk, T.K. 2009: Risks of recreational exposure to waterborne pathogens among persons with HIV/AIDS in Baltimore, Maryland. American Journal of Public Health 99(6): 1116-1122
Premgamone, A.; Maskasem, S.; Thamrongwarangoon, A.; Ussavaphark, W. 2010: Risks of repeated visits for uninvestigated dyspepsia in three community hospitals of Khon Kaen, Thailand. Journal of the Medical Association of Thailand 93(Suppl 3): S30-S37
Gobba, F.; Bacis, M.; Capodaglio, E.; De Michieli, P.; Larese, F.; Occhionero, V. 2010: Risks of repetitive movements in health personnel. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 32(3): 223-226
Li, X.; Sundquist, J.; Sundquist, K. 2009: Risks of rheumatic diseases in first- and second-generation immigrants in Sweden: a nationwide followup study. Arthritis and Rheumatism 60(6): 1588-1596
Starr, C.; Whipple, C. 1980: Risks of risk decisions. Science 208(4448): 1114-1119
Pasricha, S.; Shet, A.; Sachdev, H.P.S.; Shet, A.S. 2009: Risks of routine iron and folic acid supplementation for young children. Indian Pediatrics 46(10): 857-866
Reiser, S.; Wuertz, S.; Schroeder, J.P.; Kloas, W.; Hanel, R. 2011: Risks of seawater ozonation in recirculation aquaculture--effects of oxidative stress on animal welfare of juvenile turbot (Psetta maxima, L.). Aquatic Toxicology 105(3-4): 508-517
Mennuti, M.T. 2008: Risks of second-trimester amniocentesis: why all the fuss 30 years later?. Obstetrics and Gynecology 111(3): 586-588
Ruiz, M.E. 2010: Risks of self-medication practices. Current Drug Safety 5(4): 315-323
Breivik, H.; Norum, H. 2013: Risks of serious complications after neuraxial blocks: apparent decrease due to guidelines for safe practice?. Acta Anaesthesiologica Scandinavica 57(5): 541-544
Dulai, P.S.; Thompson, K.D.; Blunt, H.B.; Dubinsky, M.C.; Siegel, C.A. 2014: Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 12(9): 1443-1451; Quiz E88-89
Bailey, E.J.; Maclennan, C.; Morris, P.S.; Kruske, S.G.; Brown, N.; Chang, A.B. 2009: Risks of severity and readmission of Indigenous and non-Indigenous children hospitalised for bronchiolitis. Journal of Paediatrics and Child Health 45(10): 593-597
Su, Y.; Yan, X.; Pu, Y.; Xiao, F.; Wang, D.; Yang, M. 2013: Risks of single-walled carbon nanotubes acting as contaminants-carriers: potential release of phenanthrene in Japanese medaka (Oryzias latipes). Environmental Science and Technology 47(9): 4704-4710
Li, X.; Sundquist, K.; Sundquist, J. 2012: Risks of small-for-gestational-age births in immigrants: a nationwide epidemiological study in Sweden. Scandinavian Journal of Public Health 40(7): 634-640
Stewart, L.; McInnes, G.T.; Murray, L.; Sloan, B.; Walters, M.R.; Morton, R.; Padmanabhan, S.; Reid, J.L.; Morrison, D.S. 2009: Risks of socioeconomic deprivation on mortality in hypertensive patients. Journal of Hypertension 27(4): 730-735
Kazmin, A.; Garcia-Bournissen, F.; Koren, G. 2007: Risks of statin use during pregnancy: a systematic review. Journal of Obstetrics and Gynaecology Canada: Jogc 29(11): 906-908
Leijonhufvud, A.; Lundholm, C.; Cnattingius, S.; Granath, F.; Andolf, E.; Altman, D. 2011: Risks of stress urinary incontinence and pelvic organ prolapse surgery in relation to mode of childbirth. American Journal of Obstetrics and Gynecology 204(1): 70.E1-70.E7
Perone, N. 2011: Risks of stress urinary incontinence and pelvic organ prolapse surgery in relation to mode of delivery. American Journal of Obstetrics and Gynecology 205(5): E9
Gallagher, A.M.; Setakis, E.; Plumb, J.M.; Clemens, A.; van Staa, T.-P. 2011: Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thrombosis and Haemostasis 106(5): 968-977
Chung, T.-T.; Lin, C.-Y.; Huang, W.-Y.; Lin, C.-L.; Sung, F.-C.; Kao, C.-H. 2013: Risks of subsequent epilepsy among patients with hypertensive encephalopathy: a nationwide population-based study. Epilepsy and Behavior: E&b 29(2): 374-378
Daratha, K.B.; Short, R.A.; Corbett, C.F.; Ring, M.E.; Alicic, R.; Choka, R.; Tuttle, K.R. 2012: Risks of subsequent hospitalization and death in patients with kidney disease. Clinical Journal of the American Society of Nephrology: Cjasn 7(3): 409-416
Hurtado, A.; Barandika, J.ús.F.; Oporto, B.; Minguijón, E.; Povedano, I.és.; García-Pérez, A.L. 2015: Risks of suffering tick-borne diseases in sheep translocated to a tick infested area: a laboratory approach for the investigation of an outbreak. Ticks and Tick-Borne Diseases 6(1): 31-37
Hamed, S.A.; Elserogy, Y.B.; Abdou, M.A.; Abdellah, M.M. 2012: Risks of suicidality in adult patients with epilepsy. World Journal of Psychiatry 2(2): 33-42
Rahme, E.; Dasgupta, K.; Turecki, G.; Nedjar, H.; Galbaud du Fort, G. 2008: Risks of suicide and poisoning among elderly patients prescribed selective serotonin reuptake inhibitors: a retrospective cohort study. Journal of Clinical Psychiatry 69(3): 349-357
Pyregov, A.V. 2007: Risks of surgery and anesthesia and optimization of anesthesiological maintenance of abdominal delivery. Anesteziologiia i Reanimatologiia 6: 30-34
Laidley, J.W.S. 1948: Risks of surgery in the aged. Medical Journal of Australia 1(5): 136-138
Osterberg, E.C.; Bernie, A.M.; Ramasamy, R. 2014: Risks of testosterone replacement therapy in men. Indian Journal of Urology: Iju: Journal of the Urological Society of India 30(1): 2-7
Ramasamy, R.; Dupree, J.M.; Kovac, J.R.; Lipshultz, L.I. 2014: Risks of testosterone therapy in elderly men. F1000research 3: 11
Cavallo, M. 2011: Conflicting duties over confidentiality in Argentina and Peru. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 112(2): 159-162
Casali, P.G. 2014: Risks of the new EU Data Protection Regulation: an ESMO position paper endorsed by the European oncology community. Annals of oncology: official journal of the European Society for Medical Oncology 25(8): 1458-1461
Tepetes, K. 2008: Risks of the radiofrequency-assisted liver resection. Journal of Surgical Oncology 97(2): 193; Author Reply 194-5
Anisimov, S.V. 2012: Risks of the xenogenic origin in stem cells applications. Tsitologiia 54(4): 289-297
Olesen, J.B.; Lip, G.Y.H.; Lindhardsen, J.; Lane, D.A.; Ahlehoff, O.; Hansen, M.L.; Raunsø, J.; Tolstrup, J.S.; Hansen, P.R.; Gislason, G.H.; Torp-Pedersen, C. 2011: Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study. Thrombosis and Haemostasis 106(4): 739-749
Sheehy, A.M.; Coursin, D.B.; Keegan, M.T. 2009: Risks of tight glycemic control during adult cardiac surgery. Annals of thoracic surgery 88(4): 1384-5; author reply 1385-6
Hibbert, K.; Ogunseitan, O.A. 2014: Risks of toxic ash from artisanal mining of discarded cellphones. Journal of Hazardous Materials 278: 1-7
Squires, J.E. 2011: Risks of transfusion. Southern Medical Journal 104(11): 762-769
Aguiar, T.D.'áv.d.F.; Costa, E.C.; Rolim, B.N.; Romijn, P.C.; Morais, N.él.B.d.; Teixeira, M.F.át.d.S. 2011: Risks of transmitting rabies virus from captive domiciliary common marmoset (Callithrix jacchus) to human beings, in the metropolitan region of Fortaleza, state of Ceará, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 44(3): 356-363
Powell, B.; Ford, C. 2010: Risks of travel, benefits of a specialist consult. Cleveland Clinic Journal of Medicine 77(4): 246-254
Rodhain, F.ço.; Moutou, F.ço. 2009: Risks of tropical diseases becoming established in Europe. Bulletin de l'Academie Nationale de Medecine 193(8): 1835-1846
Li, Y.-p.; Shao, Y.-h.; Tian, H.; Fang, F.-s.; Sun, B.-r.; Xiao, J.; Pei, Y.; Yan, S.-t.; Han, X.-f.; Li, C.-x. 2012: Risks of type 2 diabetes mellitus and impaired glucose regulation among elderly patients with essential hypertension: a 10-years cohort study. Zhonghua Yi Xue Za Zhi 92(2): 102-105
Piroth, M.D. 2013: Risks of unfavorable cosmetic and toxicity after percutaneous accelerated partial breast irradiation (APBI). Interim analysis from the Canadian RAPID trial. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 189(12): 1054-1055
Chan, J.; Natekar, A.; Einarson, A.; Koren, G. 2014: Risks of untreated depression in pregnancy. Canadian Family Physician Medecin de Famille Canadien 60(3): 242-243
Robinson, G.E.; Einarson, A. 2013: Risks of untreated depression outweigh any risks of SSRIs. Human Reproduction 28(4): 1145-1146
Guardiola, F.A.; Cuesta, A.; Meseguer, J.é; Esteban, M.A. 2012: Risks of using antifouling biocides in aquaculture. International Journal of Molecular Sciences 13(2): 1541-1560
Hedberg, Y.; Herting, G.; Wallinder, I.O. 2011: Risks of using membrane filtration for trace metal analysis and assessing the dissolved metal fraction of aqueous media--a study on zinc, copper and nickel. Environmental Pollution 159(5): 1144-1150
Volk, M.L. 2011: Risks of using ursodeoxycholic acid to treat primary sclerosing cholangitis. Gastroenterology 141(6): 2267-2268
Lewcock, G.A. 1913: Complaints and the Saturday Fund. Hospital 53(1388): 521
Allan, G.M.; Koppula, S. 2012: Risks of venous thromboembolism with various hormonal contraceptives. Canadian Family Physician Medecin de Famille Canadien 58(10): 1097
Carús, L. 2010: Risks of visiting snow destinations: an analysis of skiers' views. Accident; Analysis and Prevention 42(2): 667-671
Anonymous 2012: Risks of vitamin supplements. Most don't help, may cause harm. Mayo Clinic Health Letter 30(3): 4-5
Manjunath, A.; Srirangam, S.J. 2010: Risks of working time directive. Shorter shifts and more frequent handover. Bmj 341: C4858
Mancini, N.; Burioni, R.; Sanguinetti, M.; Clementi, M. 2013: Risks of "blind" automated identification systems in medical microbiology. Journal of Clinical Microbiology 51(11): 3911
Tefft, B.C. 2008: Risks older drivers pose to themselves and to other road users. Journal of Safety Research 39(6): 577-582
Wang, Q.; Xu, C.; Xu, D.; Liu, C.; Chen, Y. 2014: Risks on asthma among city children in China:a nationwide case-control study. Zhonghua Liu Xing Bing Xue Za Zhi 35(3): 237-241
Tseng, M.-C.M.; Lin, Y.-P.; Hu, F.-C.; Cheng, T.-J. 2013: Risks perception of electromagnetic fields in Taiwan: the influence of psychopathology and the degree of sensitivity to electromagnetic fields. Risk Analysis: An Official Publication of the Society for Risk Analysis 33(11): 2002-2012
Hui, D.S.C.; Hall, S.; Chan, M.T.C.; Joynt, G.M.; Chow, B.; Sung, J.J.Y. 2009: Risks posed by the use of oxygen therapy and non-invasive positive pressure ventilation: a pilot study. Hong Kong Medical Journal 15 Suppl. 8: 4-7
Zhang, L.; Jiang, G.-p.; Chen, G. 2012: Risks related to disability on children aged 0-4 in China: analysis on the supporting effects from family. Zhonghua Liu Xing Bing Xue Za Zhi 33(2): 160-163
Grove, C.; Graw, M. 2014: Risks related to intramuscular and subcutaneous injections. MMW Fortschritte der Medizin 156(2): 40-43
Sharkey, J.E.; Van Leuven, K.; Radovich, P. 2012: Risks related to patient bed safety. Journal of Nursing Care Quality 27(4): 346-351
Keller, D.L. 2010: Risks related to the use of finasteride (propecia) in pregnant women. American Family Physician 82(2): 102; Author Reply 102
Bège, T.; Berdah, S.-V.; Moutardier, V.; Brunet, C. 2009: Risks related to tobacco use in general and intestinal surgery. Journal de Chirurgie 146(6): 532-536
Mouilhade, F.; Oger, P.; Roussignol, X.; Boisrenoult, P.; Sfez, J.; Duparc, F. 2011: Risks relating to posterior 2-portal arthroscopic subtalar arthrodesis and articular surfaces abrasion quality achievable with these approaches: a cadaver study. Orthopaedics and Traumatology Surgery and Research: Otsr 97(4): 396-400
Evans, M. 2010: Risks remain. Analysts outlook uncertain for hospital borrowers. Modern Healthcare 40(10): 12-13
Gurgel, A.d.M.; Medeiros, A.C.L.V.; Alves, P.C.êa.; Silva, J.é M.d.; Gurgel, I.ê G.D.; Augusto, L.G.d.S. 2009: Risks scenarios frameworks in the context of an oil refinery installation at Pernambuco State. Ciencia and Saude Coletiva 14(6): 2027-2038
Werb, D.; Kerr, T.; Li, K.; Montaner, J.; Wood, E. 2008: Risks surrounding drug trade involvement among street-involved youth. American Journal of Drug and Alcohol Abuse 34(6): 810-820
Lynch, J.D.; Arroyo, S.B. 2009: Risks to Colombian amphibian fauna from cultivation of coca (Erythroxylum coca): a geographical analysis. Journal of Toxicology and Environmental Health. Part a 72(15-16): 974-985
Hone, C. 2013: Risks to Ireland from incidents at Sellafield. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection 33(1): 247-249
Giddings, J.M.; Williams, W.M.; Solomon, K.R.; Giesy, J.P. 2014: Risks to aquatic organisms from use of chlorpyrifos in the United States. Reviews of Environmental Contamination and Toxicology 231: 119-162
Williams, V.L.; Cunningham, A.B.; Kemp, A.C.; Bruyns, R.K. 2014: Risks to birds traded for African traditional medicine: a quantitative assessment. Plos one 9(8): E105397
Hepple, S.; Watkins, G.; Crawshaw, T.; Harwood, D.; Ellis-Iversen, J.; Clark, J.; Pollock, A.; Brough, T. 2010: Risks to cattle transported long distances in late pregnancy. Veterinary Record 167(20): 796
Cox, T.; Lowrie, K.; Kane, S.M. 2013: Risks to children and young adults. Risk Analysis: An Official Publication of the Society for Risk Analysis 33(9): 1565-1567
Thompson, J.; Rehn, M.; Lossius, H.Morten.; Lockey, D. 2014: Risks to emergency medical responders at terrorist incidents: a narrative review of the medical literature. Critical Care 18(5): 521
Jones, S.Everett.; Anderson, K.; Lowry, R.; Conner, H. 2011: Risks to health among American Indian/Alaska Native high school students in the United States. Preventing chronic disease 8(4): A76
Mayo, D.; Spanos, A. 2008: Risks to health and risks to science: the need for a responsible "bioevidential" scrutiny. Human and Experimental Toxicology 27(8): 621-625
Miranda, E.J.é P.d.; Stancato, K.át. 2008: Risks to health of intensive care unity nursing staff: proposal of integral approach of health. Revista Brasileira de Terapia Intensiva 20(1): 68-76
Sugiura, S.-i.; Asano, M.; Kinoshita, K.; Tanimura, M.; Nabeshima, T. 2011: Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 17(1): 14-19
Cameron, G.R. 1945: Risks to man and animals from the use of 2,2-bis (p-chlorphenyl), l,l,l,-trichlorethane (DDT) with a note on the toxicology of y-benzene hexachloride (666, gammexane). British Medical Bulletin 3(9-10): 233-235
Meredith, R.; Wessels, B.; Knox, S. 2008: Risks to normal tissues from radionuclide therapy. Seminars in Nuclear Medicine 38(5): 347-357
Bhandari, A.; Sandlow, J.I.; Brannigan, R.E. 2011: Risks to offspring associated with advanced paternal age. Journal of Andrology 32(2): 121-122
Qureshi, N.; Raeburn, S. 2011: Risks to offspring of consanguineous marriage: we need straight, not crooked thinking. Journal of the Royal College of Physicians of Edinburgh 41(3): 194-195
Irnich, W. 2010: Risks to pacemaker patients undergoing magnetic resonance imaging examinations. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 12(7): 918-920
Carling, C.L.L.; Kirkehei, I.; Dalsbø, T.K.; Paulsen, E. 2013: Risks to patient safety associated with implementation of electronic applications for medication management in ambulatory care--a systematic review. Bmc Medical Informatics and Decision Making 13: 133
Bombard, Y.; Offit, K.; Robson, M.E. 2012: Risks to relatives in genomic research: a duty to warn?. American Journal of Bioethics: Ajob 12(10): 12-14
Newcombe, H.B. 1968: Risks to siblings of stillborn children. Canadian Medical Association Journal 98(4): 189-193
Powers, A.M. 2015: Risks to the Americas associated with the continued expansion of chikungunya virus. Journal of General Virology 96(Pt 1): 1-5
Tennant, J.N.; Rungprai, C.; Pizzimenti, M.A.; Goetz, J.; Phisitkul, P.; Femino, J.; Amendola, A. 2014: Risks to the blood supply of the talus with four methods of total ankle arthroplasty: a cadaveric injection study. Journal of Bone and Joint Surgery. American Volume 96(5): 395-402
Martin, J.; Rieke, B.; Neppach, K.; Hillebrandt, D.; Küpper, T. 2012: Risks to young volunteers in international social projects. Annals of Occupational Hygiene 56(2): 242-252
Saguil, A.; Farnel, E. 2008: Risks unavoidable and worth taking. Cmaj: Canadian Medical Association Journal 178(12): 1533
Schuler, A. 2007: Risks versus benefits of long-term proton pump inhibitor therapy in the elderly. Geriatric Nursing 28(4): 225-229
Johnson, K.P. 2010: Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis. Therapeutics and Clinical Risk Management 6: 153-172
Tillberg, A.; Järvholm, B.; Berglund, A. 2008: Risks with dental materials. Dental Materials: Official Publication of the Academy of Dental Materials 24(7): 940-943
Atwal, A.; McIntyre, A.; Wiggett, C. 2012: Risks with older adults in acute care settings: UK occupational therapists' and physiotherapists' perceptions of risks associated with discharge and professional practice. Scandinavian Journal of Caring Sciences 26(2): 381-393
Franklin, K.A.; Haglund, B.; Axelsson, S.; Holmlund, T.ör.; Rosén, M. 2009: Risks with surgical interventions for obstructive sleep apnea in adults. a registry-based study in Sweden. Lakartidningen 106(14): 1012-1014
Zetterström, R. 2010: Risks with violent police actions. Lakartidningen 107(3): 121
Beougher, S.C.; Chakravarty, D.; Garcia, C.C.; Darbes, L.A.; Neilands, T.B.; Hoff, C.C. 2012: Risks worth taking: safety agreements among discordant gay couples. Aids Care 24(9): 1071-1077
Dir, A.L.; Cyders, M.A. 2015: Risks, Risk Factors, and Outcomes Associated with Phone and Internet Sexting Among University Students in the United States. Archives of Sexual Behavior 44(6): 1675-1684
Lang, E.; Thomas, R.; Davis, R.; Colon, I.; Allaf, M.; Hanano, A.; Kagen, A.; Sethi, E.; Emery, K.; Rudman, E.; Myers, L. 2009: Risks, advantages, and complications of intercostal vs subcostal approach for percutaneous nephrolithotripsy. Urology 74(4): 751-755
Thakkar, M.; Davis, D.C. 2006: Risks, barriers, and benefits of EHR systems: a comparative study based on size of hospital. Perspectives in Health Information Management 3: 5
Coutelle, C.; Ashcroft, R. 2012: Risks, benefits and ethical, legal, and societal considerations for translation of prenatal gene therapy to human application. Methods in Molecular Biology 891: 371-387
Phrasisombath, K.; Faxelid, E.; Sychareun, V.; Thomsen, S. 2012: Risks, benefits and survival strategies-views from female sex workers in Savannakhet, Laos. Bmc Public Health 12: 1004
Ganz, P.A.; Land, S.R. 2008: Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer. Menopause 15(4 Suppl): 797-803
Lubowitz, J.H.; Verma, N.N.; Tokish, J.M.; Goradia, V.K.; McNeil, J.W.; Provencher, M.T. 2014: Risks, benefits, and evidence-based recommendations for improving anterior cruciate ligament outcomes. Instructional Course Lectures 63: 369-382
Ried, L.D.; Huston, S.A.; Kucukarslan, S.N.; Sogol, E.M.; Schafermeyer, K.W.; Sansgiry, S.S. 2011: Risks, benefits, and issues in creating a behind-the-counter category of medications. Journal of the American Pharmacists Association: Japha 51(1): 26-39
Hens, K.; Nys, H.; Cassiman, J.-J.; Dierickx, K. 2011: Risks, benefits, solidarity: a framework for the participation of children in genetic biobank research. Journal of Pediatrics 158(5): 842-848
Glina, S.; Wroclawski, E.R.; Chaves, O.H.T. 2006: Risks, contraindications, abuse and monitoring risks of testosterone replacement therapy (TRT). International Braz J Urol: Official Journal of the Brazilian Society of Urology 32(Suppl 1): 31-34
Boiko, O.; Sheaff, R.; Child, S.; Gericke, C.A. 2014: Risks, dangers and competing clinical decisions on venous thromboembolism prophylaxis in hospital care. Sociology of Health and Illness 36(6): 932-947
Gudin, J.A.; Mogali, S.; Jones, J.D.; Comer, S.D. 2013: Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgraduate Medicine 125(4): 115-130
Boivin, Rémi. 2014: Risks, prices, and positions: A social network analysis of illegal drug trafficking in the world-economy. International Journal on Drug Policy 25(2): 235-243
Lo, C.-f. 2009: Risks, scientific uncertainty and the approach of applying precautionary principle. Medicine and Law 28(2): 283-300
Wang, I-Kuan.; Muo, C-Hsin.; Chang, Y-Chih.; Liang, C-Chia.; Lin, S-Yi.; Chang, C-Tzung.; Yen, T-Hai.; Chuang, F-Rong.; Chen, P-Chun.; Huang, C-Ching.; Sung, F-Chang. 2012: Risks, subtypes, and hospitalization costs of stroke among patients with systemic lupus erythematosus: a retrospective cohort study in Taiwan. Journal of Rheumatology 39(8): 1611-1618
Possover, M.; Lemos, N. 2011: Risks, symptoms, and management of pelvic nerve damage secondary to surgery for pelvic organ prolapse: a report of 95 cases. International Urogynecology Journal 22(12): 1485-1490
Breteler, J.Klein.; Oudhoff, J.P.; Munster, J.M.; Aarnoudse, J.G.; van Steenbergen, J.E.; Beaujean, Dée.J.M.A. 2011: Risks, trust and knowledge: determinants of pregnant women's decisions regarding participation in a future Q fever screening and treatment program during a large epidemic in The Netherlands. Prenatal Diagnosis 31(8): 814-820
Lyerly, A.D.; Mitchell, L.M.; Armstrong, E.M.; Harris, L.H.; Kukla, R.; Kuppermann, M.; Little, M.O. 2007: Risks, values, and decision making surrounding pregnancy. Obstetrics and Gynecology 109(4): 979-984
Einarson, A. 2009: Risks/safety of psychotropic medication use during pregnancy--Motherisk Update 2008. Canadian Journal of Clinical Pharmacology 16(1): E58-E65
Anonymous 1983: Risks: How to get more science in assessments. Environmental Science and Technology 17(5): 199a-200a
Racz, S.J.; McMahon, R.J.; Luthar, S.S. 2011: Risky Behavior in Affluent Youth: Examining the Co-occurrence and Consequences of Multiple Problem Behaviors. Journal of Child and Family Studies 20(1): 120-128
Jadhav, A.; Bhattacharjee, P.; Raghavendra, T.; Blanchard, J.; Moses, S.; Isac, S.; Halli, S.S. 2013: Risky Behaviors among HIV-Positive Female Sex Workers in Northern Karnataka, India. Aids Research and Treatment 2013: 878151
De Wilde, B.; Bechara, A.; Sabbe, B.; Hulstijn, W.; Dom, G. 2013: Risky Decision-Making but not Delay Discounting Improves during Inpatient Treatment of Polysubstance Dependent Alcoholics. Frontiers in Psychiatry 4: 91
Ayala, G. 1999: Risky Sex? Gay Men and HIV Prevention. Journal of Health Psychology 4(3): 436-439
Tura, G.; Alemseged, F.; Dejene, S. 2012: Risky Sexual Behavior and Predisposing Factors among Students of Jimma University, Ethiopia. Ethiopian Journal of Health Sciences 22(3): 170-180
Sanders, B.; Lankenau, S.E.; Jackson-Bloom, J. 2009: Risky Sexual Behaviors among a Sample of Gang-identified Youth in Los Angeles. Journal of Equity in Health 2(1): 61-71
Scott, M.E.; Wildsmith, E.; Welti, K.; Ryan, S.; Schelar, E.; Steward-Streng, N.R. 2011: Risky adolescent sexual behaviors and reproductive health in young adulthood. Perspectives on Sexual and Reproductive Health 43(2): 110-118
Marchand, A.; Charbonneau, M. 2009: Risky alcohol consumption among working Canadians: variations among different occupations and economic sectors. Canadian Journal of Public Health 100(4): 285-290
Obradors-Rial, N.úr.; Ariza, C.; Muntaner, C. 2014: Risky alcohol consumption and associated factors in adolescents aged 15 to 16 years in Central Catalonia (Spain): differences between rural and urban areas. Gaceta Sanitaria 28(5): 381-385
Bühler, K.-M.; Huertas, E.; Echeverry-Alzate, V.íc.; Giné, E.; Moltó, E.; Montoliu, L.; López-Moreno, J.A. 2014: Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures. Molecular Genetics and Genomics: Mgg 289(3): 279-289
Andersson, A.M.; Bendtsen, P.; Spak, F. 2010: Risky alcohol drinking. Unclear concept that needs a clear definition. Lakartidningen 107(19-20): 1304-1306
Zaller, N.; Huang, W.; He, H.; Dong, Y.; Song, D.; Zhang, H.; Operario, D. 2014: Risky alcohol use among migrant women in entertainment venues in China. Alcohol and Alcoholism 49(3): 321-326
Mota, N.; Alvarez-Gil, R.; Corral, M.; Rodríguez Holguín, S.; Parada, Mía.; Crego, A.; Caamaño-Isorna, F.; Cadaveira, F. 2010: Risky alcohol use and heavy episodic drinking among Spanish University students: a two-year follow-up. Gaceta Sanitaria 24(5): 372-377
Tsui, J.I.; Cheng, D.M.; Libman, H.; Bridden, C.; Saitz, R.; Samet, J.H. 2013: Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C. Journal of Studies on Alcohol and Drugs 74(2): 266-270
Van der Zwaluw, C.S.; Kuntsche, E.; Engels, R.C.M.E. 2011: Risky alcohol use in adolescence: the role of genetics (DRD2, SLC6A4) and coping motives. Alcoholism Clinical and Experimental Research 35(4): 756-764
Chitty, K.M.; Kaur, M.; Lagopoulos, J.; Hickie, I.B.; Hermens, D.F. 2014: Risky alcohol use predicts temporal mismatch negativity impairments in young people with bipolar disorder. Biological Psychology 99: 60-68
Ybrandt, H. 2010: Risky alcohol use, peer and family relationships and legal involvement in adolescents with antisocial problems. Journal of Drug Education 40(3): 245-264
Constantinou, E.; Panayiotou, G.; Konstantinou, N.; Loutsiou-Ladd, A.; Kapardis, A. 2011: Risky and aggressive driving in young adults: Personality matters. Accident; Analysis and Prevention 43(4): 1323-1331
Harvey, P. 2012: Risky anticoagulants: meds have the potential to turn minor trauma into a major disaster. Jems: a Journal of Emergency Medical Services 37(8): 30-31
Waylen, A.E.; McKenna, F.P. 2008: Risky attitudes towards road use in pre-drivers. Accident; Analysis and Prevention 40(3): 905-911
Ruiseñor-Escudero, H.; Wirtz, A.L.; Berry, M.; Mfochive-Njindan, I.; Paikan, F.; Yousufi, H.A.; Yadav, R.S.; Burnham, G.; Vu, A. 2014: Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan. Drug and Alcohol Dependence 143: 127-133
Groen, Y.; Gaastra, G.F.; Lewis-Evans, B.; Tucha, O. 2013: Risky behavior in gambling tasks in individuals with ADHD--a systematic literature review. Plos one 8(9): E74909
Ahern, N.R. 2009: Risky behavior of adolescent college students. Journal of psychosocial nursing and mental health services 47(4): 21-25
Strazza, L.; Azevedo, R.S.; Carvalho, Háclito.B. 2007: Risky behavior regarding drug use and HIV infection: an Internet questionnaire coupled with short education texts for Portuguese speakers. Revista da Sociedade Brasileira de Medicina Tropical 40(4): 400-404
Orlowske, L.L.; Luyben, P.D. 2009: Risky behavior: cell phone use while driving. Journal of Prevention and Intervention in the Community 37(3): 221-229
Danielson, C.K.; Macdonald, A.; Amstadter, A.B.; Hanson, R.; de Arellano, M.A.; Saunders, B.E.; Kilpatrick, D.G. 2010: Risky behaviors and depression in conjunction with--or in the absence of--lifetime history of PTSD among sexually abused adolescents. Child Maltreatment 15(1): 101-107
Glass, N.E.; Frangos, S.G.; Simon, R.J.; Bholat, O.S.; Todd, S.R.; Wilson, C.; Jacko, S.; Slaughter, D.; Foltin, G.; Levine, D.A. 2014: Risky behaviors associated with pediatric pedestrians and bicyclists struck by motor vehicles. Pediatric Emergency Care 30(6): 409-412
Chen, C-H.; Ko, W-C.; Lee, H-C.; Hsu, K-L.; Ko, N-Y. 2008: Risky behaviors for HIV infection among male incarcerated injection drug users in Taiwan: a case-control study. Aids Care 20(10): 1251-1257
Hair, E.C.; Park, M.J.; Ling, T.J.; Moore, K.A. 2009: Risky behaviors in late adolescence: co-occurrence, predictors, and consequences. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 45(3): 253-261
Malhotra, N.; Yang, J. 2011: Risky behaviour and HIV prevalence among Zambian men. Journal of Biosocial Science 43(2): 155-165
Linsley, P.; Mannion, R. 2009: Risky behaviour and patient safety: a critical culturist perspective. Journal of Health Organization and Management 23(5): 494-504
Geldenhuys, H.; Sorsdahl, K.; Kafaar, F.; Hatherill, M.; Hanekom, W.A.; Stein, D.J.; Mahomed, H. 2011: Risky behaviour and psychosocial correlates in adolescents - is there a link with tuberculosis?. African Journal of Psychiatry 14(5): 383-387
Pimenta, D.; Democratis, J. 2013: Risky behaviour: a rare complication of an uncommon disease in a returning traveller. BMJ Case Reports
Mhalu, A.; Leyna, G.H.; Mmbaga, E.J. 2013: Risky behaviours among young people living with HIV attending care and treatment clinics in Dar Es Salaam, Tanzania: implications for prevention with a positive approach. Journal of the International Aids Society 16: 17342
Asnani, M.R.; Bhatt, K.; Younger, N.; McFarlane, S.; Francis, D.; Gordon-Strachan, G.; Reid, M.E. 2014: Risky behaviours of Jamaican adolescents with sickle cell disease. Hematology 19(7): 373-379
Blesch, G. 2008: Risky board business. Virgin Islands case may offer lessons for what happens under trustees' watch. Modern Healthcare 38(44): 17
Pentecost, M.J. 2007: Risky business. Journal of the American College of Radiology: Jacr 4(6): 350-352
Petsko, G.A. 2012: Risky business. Genome Biology 12(6): 119
Passut, J. 2014: Risky business. Biomedical Instrumentation and Technology 48(3): 154
Workman, A. 2014: Risky business - a consideration of risk and dental disease. Primary Dental Journal 3(3): 78-80
Schohl, J. 2010: Risky business for dialysis services. Nephrology News and Issues 24(6): 36-39
Lonial, S. 2009: Risky business in myeloma. Blood 114(3): 496-497
Kralik, D. 2008: Risky business!. Journal of Advanced Nursing 61(3): 243
Bromley, H.R. 2008: Risky business--health care finance and the VA. Physician Executive 34(3): 42
Ferreira, A.O.; Marinho, R.T. 2014: Risky business-the real life of the unresolved HCV therapy. Gastroenterology 147(5): 1185-1186
Rubin, M. 2012: Risky business. An ambulance crash threatens a career--even without fault. Ems World 41(7): 78
Miller, S.L.; Brodsky, S.L. 2011: Risky business: Addressing the consequences of predicting violence. Journal of the American Academy of Psychiatry and the Law 39(3): 396-401
Rimmer, A. 2018: Complaints made to the GMC. Bmj 361: K2650
Bersamin, M.M.; Zamboanga, B.L.; Schwartz, S.J.; Donnellan, M.Brent.; Hudson, M.; Weisskirch, R.S.; Kim, S.Yeong.; Agocha, V.Bede.; Whitbourne, S.Krauss.; Caraway, S.Jean. 2014: Risky business: Is there an association between casual sex and mental health among emerging adults?. Journal of Sex Research 51(1): 43-51
Ekmark, E.McGarr. 2009: Risky business: Preventing skin breakdown in children with spina bifida. Journal of Pediatric Rehabilitation Medicine 2(1): 37-50
De Crespigny, L.; Douglas, T.; Wilkinson, D.; Savulescu, J. 2009: Risky business: applying risk/benefit analysis consistently in entertainment ultrasound. Ultrasound in Obstetrics and Gynecology: the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 34(6): 613-615
Melanson, M.A.; Geckle, L.S.; Davidson, B.A. 2012: Risky business: challenges and successes in military radiation risk communication. U.S. Army Medical Department Journal 2012: 82-87
Akpogheneta, O. 2011: Risky business: children at work. Lancet 378(9789): 390
O'Neill, M.; Kobayashi, S. 2009: Risky business: disambiguating ambiguity-related responses in the brain. Journal of Neurophysiology 102(2): 645-647
Spencer, E.E.; Crowther, M.S.; Dickman, C.R. 2014: Risky business: do native rodents use habitat and odor cues to manage predation risk in Australian deserts?. Plos one 9(2): E90566
Martyn, C. 2014: Risky business: doctors' understanding of statistics. Bmj 349: G5619
Stream, C.; Myers, N. 2010: Risky business: effectiveness of state market-based health programs. Journal of Health Politics Policy and Law 35(1): 29-48
Deroko, J. 2009: Risky business: ending the employer-employee relationship. Journal of the Medical Association of Georgia 98(1): 59
Moore, D.L.; Ste-Marie, M. 2009: Risky business: failure to prevent and failure to communicate. Healthcarepapers 9(3): 44-50; Discussion 60-2
Millay, T.A.; Satyanarayana, V.A.; O'Leary, C.C.; Crecelius, R.; Cottler, L.B. 2009: Risky business: focus-group analysis of sexual behaviors, drug use and victimization among incarcerated women in St. Louis. Journal of Urban Health: Bulletin of the new York Academy of Medicine 86(5): 810-817
Peltier, B.; Weinstein, P.; Fredekind, R. 2007: Risky business: influencing people to change. Journal of the California Dental Association 35(11): 794-798
Davis, E.M. 2008: Risky business: medical discourse, breast cancer, and narrative. Qualitative Health Research 18(1): 65-76
Turgeon, N.; Schnier, K.; Kaplan, B. 2013: Risky business: models of risk in transplant. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 13(5): 1121-1122
McComas, K.A.; Besley, J.C.; Yang, Z. 2008: Risky business: perceived behavior of local scientists and community support for their research. Risk Analysis: An Official Publication of the Society for Risk Analysis 28(6): 1539-1552
Xu, E.R.; Kralik, J.D. 2014: Risky business: rhesus monkeys exhibit persistent preferences for risky options. Frontiers in Psychology 5: 258
Vuletich, M. 2013: Risky business: risk management is about more than reducing malpractice costs--it's about improving care. Mgma Connexion 13(8): 18-22
Kaufman, D.J.; Bollinger, J.M.; Dvoskin, R.L.; Scott, J.A. 2012: Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. Journal of Genetic Counseling 21(3): 413-422
Morgan, R.A. 2013: Risky business: target choice in adoptive cell therapy. Blood 122(20): 3392-3394
Bassett, R.L.; Ginis, K.A.M. 2011: Risky business: the effects of an individualized health information intervention on health risk perceptions and leisure time physical activity among people with spinal cord injury. Disability and Health Journal 4(3): 165-176
Roubey, R.A.S. 2010: Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice. Lupus 19(4): 440-445
Baxter, K.; Krokosky, A.; Terry, S.F. 2011: Risky business: the need for hypothesis-generating research. Genetic Testing and Molecular Biomarkers 15(9): 577-578
Thun, M.J.; Hannan, L.M.; Stefanek, M. 2008: Risky business: tools to improve risk communication in a doctor's office. Journal of the National Cancer Institute 100(12): 830-831
Hunt, K.L.; Martens, P.M.; Belcher, H.M.E. 2011: Risky business: trauma exposure and rate of posttraumatic stress disorder in African American children and adolescents. Journal of traumatic stress 24(3): 365-369
Blankenship, J.C.; Miller, S.Clark. 2013: Risky business: when patient preferences seem irrational. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 82(2): 219-220
Matthews, J.B. 2012: Risky business? Collaborative databases and quality improvement. Archives of Surgery 147(7): 605-606
Devine, K. 2010: Risky business? the risks and benefits of umbilical cord blood collection. Medical Law Review 18(3): 330-362
Lyvers, M.; Jamieson, R.; Thorberg, F.Arne. 2013: Risky cannabis use is associated with alexithymia, frontal lobe dysfunction, and impulsivity in young adult cannabis users. Journal of Psychoactive Drugs 45(5): 394-403
Dastrup, E.; Lees, M.N.; Bechara, A.; Dawson, J.D.; Rizzo, M. 2010: Risky car following in abstinent users of MDMA. Accident; Analysis and Prevention 42(3): 867-873
Carifi, G. 2010: Risky cataract surgery and ophthalmic trainees. Journal of Cataract and Refractive Surgery 36(12): 2220; Author Reply 2220-1
Lagorio, C.H.; Hackenberg, T.D. 2010: Risky choice in pigeons and humans: a cross-species comparison. Journal of the Experimental Analysis of Behavior 93(1): 27-44
Lagorio, C.H.; Hackenberg, T.D. 2012: Risky choice in pigeons: preference for amount variability using a token-reinforcement system. Journal of the Experimental Analysis of Behavior 98(2): 139-154
Payne, J.W.; Braunstein, M.L. 1978: Risky choice: An examination of information acquisition behavior. Memory and Cognition 6(5): 554-561
Jahanshahi, M. 2013: Risky choices link the subthalamic nucleus with pathological gambling in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 28(12): 1617-1619
Alcántara-Hernández, R.ío.; Hernández-Méndez, A. 2018: Adrenergic signaling molecular complexes. Gaceta Medica de Mexico 154(2): 223-235
Newton, N.C.; Barrett, E.L.; Swaffield, L.; Teesson, M. 2014: Risky cognitions associated with adolescent alcohol misuse: moral disengagement, alcohol expectancies and perceived self-regulatory efficacy. Addictive Behaviors 39(1): 165-172
Meens, M.J.P.M.T.; Pfenniger, A.; Kwak, B.R. 2012: Risky communication in atherosclerosis and thrombus formation. Swiss Medical Weekly 142: W13553
O'Doherty, K.; Suthers, G.K. 2007: Risky communication: pitfalls in counseling about risk, and how to avoid them. Journal of Genetic Counseling 16(4): 409-417
Veronese, A.éa.M.ár.; de Oliveira, D.L.úc.C.êa. 2010: Risky conduct: from death games to life game. Revista Gaucha de Enfermagem 31(3): 591
Pieri, F.A.; Colombo, M.; Merhi, C.M.; Juliati, V.íc.A.; Ferreira, M.S.; Nero, M.A.ôn.; Nero, L.A. 2014: Risky consumption habits and safety of fluid milk available in retail sales outlets in Viçosa, Minas Gerais State, Brazil. Foodborne Pathogens and Disease 11(6): 490-496
Matthies, S.; Philipsen, A.; Svaldi, J. 2012: Risky decision making in adults with ADHD. Journal of Behavior Therapy and Experimental Psychiatry 43(3): 938-946
Buelow, M.T.; Suhr, J.A. 2014: Risky decision making in smoking and nonsmoking college students: examination of Iowa Gambling Task performance by deck type selections. Applied neuropsychology. Child 3(1): 38-44
Schutter, D.J.L.G.; van Bokhoven, I.; Vanderschuren, L.J.M.J.; Lochman, J.E.; Matthys, W. 2011: Risky decision making in substance dependent adolescents with a disruptive behavior disorder. Journal of Abnormal Child Psychology 39(3): 333-339
Rolison, J.J.; Hanoch, Y.; Wood, S. 2012: Risky decision making in younger and older adults: the role of learning. Psychology and Aging 27(1): 129-140
Kohno, M.; Morales, A.M.; Ghahremani, D.G.; Hellemann, G.; London, E.D. 2014: Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA Psychiatry 71(7): 812-820
Svaldi, J.; Philipsen, A.; Matthies, S. 2012: Risky decision-making in borderline personality disorder. Psychiatry Research 197(1-2): 112-118
Rogalsky, C.; Vidal, C.; Li, X.; Damasio, H. 2012: Risky decision-making in older adults without cognitive deficits: an fMRI study of VMPFC using the Iowa Gambling Task. Social Neuroscience 7(2): 178-190
Passetti, F.; Clark, L.; Davis, P.; Mehta, M.A.; White, S.; Checinski, K.; King, M.; Abou-Saleh, M. 2011: Risky decision-making predicts short-term outcome of community but not residential treatment for opiate addiction. Implications for case management. Drug and alcohol dependence 118(1): 12-18
Crowley, T.J.; Dalwani, M.S.; Mikulich-Gilbertson, S.K.; Du, Y.P.; Lejuez, C.W.; Raymond, K.M.; Banich, M.T. 2010: Risky decisions and their consequences: neural processing by boys with Antisocial Substance Disorder. Plos one 5(9): E12835
Schultz, W. 2012: Risky dopamine. Biological Psychiatry 71(3): 180-181
Sheridan, J.; Stewart, J.; Smart, R.; McCormick, R. 2012: Risky drinking among community pharmacy customers in New Zealand and their attitudes towards pharmacist screening and brief interventions. Drug and Alcohol Review 31(1): 56-63
Barczyk, A.N.; Yuma-Guerrero, P.; von Sternberg, K.; Velasquez, M.M.; Brown, J.; Maxson, T.; Lawson, K.A. 2013: Risky drinking among parents of pediatric trauma patients. Journal of Trauma and Acute Care Surgery 75(4): 676-681
Pennay, A.; Lubman, D.I.; Maclean, S. 2011: Risky drinking among young Australians - causes, effects and implications for GPs. Australian Family Physician 40(8): 584-588
Ketoja, J.; Svidkovski, A.-S.; Heinälä, P.; Seppä, K. 2013: Risky drinking and its detection among medical students. Addictive Behaviors 38(5): 2115-2118
Park, A.; Sher, K.J.; Krull, J.L. 2008: Risky drinking in college changes as fraternity/sorority affiliation changes: a person-environment perspective. Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors 22(2): 219-229
Anderson, A.E.; Hure, A.J.; Forder, P.M.; Powers, J.; Kay-Lambkin, F.J.; Loxton, D.J. 2014: Risky drinking patterns are being continued into pregnancy: a prospective cohort study. Plos one 9(1): E86171
Connor, J.; Psutka, R.; Cousins, K.; Gray, A.; Kypri, K. 2013: Risky drinking, risky sex: a national study of New Zealand university students. Alcoholism Clinical and Experimental Research 37(11): 1971-1978
Weathers, S.-P.S.; Kotagal, V.; Bohnen, N.I.; Chou, K.L. 2014: Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease. Parkinsonism and Related Disorders 20(1): 13-16
Summala, H.; Rajalin, S.; Radun, I. 2014: Risky driving and recorded driving offences: a 24-year follow-up study. Accident; Analysis and Prevention 73: 27-33
Cheng, A.S.K.; Ng, T.C.K. 2012: Risky driving and the perception of motorcycle accident causes among Chinese motorcyclists in Hong Kong. Traffic Injury Prevention 13(5): 485-492
Al Reesi, H.; Al Maniri, A.; Plankermann, K.; Al Hinai, M.; Al Adawi, S.; Davey, J.; Freeman, J. 2013: Risky driving behavior among university students and staff in the Sultanate of Oman. Accident; Analysis and Prevention 58: 1-9
Boufous, S.; Ivers, R.; Senserrick, T.; Norton, R.; Stevenson, M.; Chen, H-Yang.; Lam, L.T. 2010: Risky driving behavior and road traffic crashes among young Asian Australian drivers: findings from the DRIVE study. Traffic Injury Prevention 11(3): 222-227
Hassen, A.; Godesso, A.; Abebe, L.; Girma, E. 2011: Risky driving behaviors for road traffic accident among drivers in Mekele city, Northern Ethiopia. Bmc Research Notes 4: 535
Shams, M.; Rahimi-Movaghar, V. 2009: Risky driving behaviors in Tehran, Iran. Traffic Injury Prevention 10(1): 91-94
Mao, S-Jiong.; Huang, X-Mei. 2012: Risky driving behaviors should be screened to prevent motor vehicle crashes related spinal cord injury. World Journal of Pediatrics: Wjp 8(1): 90
Thompson, A.L.; Molina, B.S.G.; Pelham, W.; Gnagy, E.M. 2007: Risky driving in adolescents and young adults with childhood ADHD. Journal of Pediatric Psychology 32(7): 745-759
McDonald, C.C.; Sommers, M.S.; Fargo, J.D. 2014: Risky driving, mental health, and health-compromising behaviours: risk clustering in late adolescents and adults. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention 20(6): 365-372
Cruz-Sáez, S.; Pascual, A.; Salaberria, K.; Etxebarria, I.; Echeburúa, E. 2015: Risky eating behaviors and beliefs among adolescent girls. Journal of Health Psychology 20(2): 154-163
Byrd-Bredbenner, C.; Abbot, J.M.; Wheatley, V.; Schaffner, D.; Bruhn, C.; Blalock, L. 2008: Risky eating behaviors of young adults-implications for food safety education. Journal of the American Dietetic Association 108(3): 549-552
Kubota, K.; Kato, S.; Mawatari, H.; Iida, H.; Akiyama, T.; Fujita, K.; Yoneda, M.; Takahashi, H.; Inamori, M.; Abe, Y.; Kirikoshi, H.; Kobayashi, N.; Saito, S.; Nakajima, A. 2010: Risky endoscopic ultrasonography-guided fine-needle aspiration for asymptomatic retroperitoneal tumors. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society 22(2): 144-146
Matsushita, M.; Mori, S.; Tahashi, Y.; Okazaki, K. 2009: Risky endoscopy for acute aortic dissection with hematemesis. Endoscopy 41(12): 1100; Author Reply 1100
Wang, Y.; Liu, L.; Yang, J.; Chen, J.; Zhao, Y.; Wu, Z.; Che, G.; He, J.; Qin, J.; Zhou, Q. 2000: Risky factors of post-operative respiratory failure in patients with lung cancer. Zhongguo Fei Ai Za Zhi 3(1): 41-43
Zikmund-Fisher, B.J.; Fagerlin, A.; Ubel, P.A. 2010: Risky feelings: why a 6% risk of cancer does not always feel like 6%. Patient Education and Counseling 81 Suppl: S87-S93
Anderson Steeves, E.; Silbergeld, E.; Summers, A.; Chen, L.; Gittelsohn, J. 2012: Risky food safety behaviors are associated with higher BMI and lower healthy eating self-efficacy and intentions among African American churchgoers in Baltimore [corrected. PloS one 7(12): e52122
Chung, E.K.; Nurmohamed, L.; Mathew, L.; Elo, I.T.; Coyne, J.C.; Culhane, J.F. 2010: Risky health behaviors among mothers-to-be: the impact of adverse childhood experiences. Academic Pediatrics 10(4): 245-251
Lazarus, L.; Chettiar, J.; Deering, K.; Nabess, R.; Shannon, K. 2011: Risky health environments: women sex workers' struggles to find safe, secure and non-exploitative housing in Canada's poorest postal code. Social Science and Medicine 73(11): 1600-1607
Pieri, E.; Levitt, M. 2008: Risky individuals and the politics of genetic research into aggressiveness and violence. Bioethics 22(9): 509-518
Wilkins, L.; Bissell, P.; Meier, P.S. 2010: Risky injecting practices associated with snowballing: a qualitative study. Drug and Alcohol Review 29(3): 256-262
Garanin, S.G.; Epatko, I.V.; Istomin, R.I.; L'vov, L.V.; Malyutin, A.A.; Serov, R.V.; Sukharev, S.A. 2011: Risky intensity peaks resulting from nonlinear holographic imaging. Applied Optics 50(21): 3733-3741
Burgess Dowdell, E. 2011: Risky internet behaviors of middle-school students: communication with online strangers and offline contact. Computers Informatics Nursing: Cin 29(6): 352-359
Dowdell, E.B.; Bradley, P.K. 2010: Risky internet behaviors: a case study of online and offline stalking. Journal of School Nursing: the Official Publication of the National Association of School Nurses 26(6): 436-442
Legge, M.; Fitzgerald, R. 2007: Risky knowledges: the sociocultural impacts of personal genetics in a knowledge-driven economy. New Zealand Medical Journal 120(1262): U2736
Glick, M. 2007: Risky liaisons: what is the relationship between oral conditions and nonoral diseases?. Journal of the American Dental Association 138(8): 1056,1058,1060
Vézina, J.; Hébert, M.; Poulin, F.ço.; Lavoie, F.; Vitaro, F.; Tremblay, R.E. 2011: Risky lifestyle as a mediator of the relationship between deviant peer affiliation and dating violence victimization among adolescent girls. Journal of Youth and Adolescence 40(7): 814-824
Moriwaki, Y.; Tahara, Y.; Iwashita, M.; Kosuge, T.; Suzuki, N. 2014: Risky locations for out-of-hospital cardiopulmonary arrest in a typical urban city. Journal of Emergencies Trauma and Shock 7(4): 285-294
Pridmore, S. 2011: Risky management. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists 19(3): 272
Rhoades, E.; Jernigan, D.H. 2013: Risky messages in alcohol advertising, 2003-2007: results from content analysis. Journal of adolescent health: official publication of the Society for Adolescent Medicine 52(1): 116-121
Berger, S.E.; Baria, A.T.; Baliki, M.N.; Mansour, A.; Herrmann, K.M.; Torbey, S.; Huang, L.; Parks, E.L.; Schnizter, T.J.; Apkarian, A.V. 2014: Risky monetary behavior in chronic back pain is associated with altered modular connectivity of the nucleus accumbens. Bmc Research Notes 7: 739
Vogel, I.; van de Looij-Jansen, P.M.; Mieloo, C.L.; Burdorf, A.; de Waart, F. 2014: Risky music listening, permanent tinnitus and depression, anxiety, thoughts about suicide and adverse general health. Plos one 9(6): E98912
Harder, A.T.; Knorth, E.J.; Kalverboer, M.E. 2015: Risky or Needy? Dynamic Risk Factors and Delinquent Behavior of Adolescents in Secure Residential Youth Care. International journal of offender therapy and comparative criminology 59(10): 1047-1065
Cohen, M.R. 2008: Risky pen pals: insulin device contamination. Nursing 38(7): 17
Anonymous 2008: Risky pills: supplements to avoid. Consumer Reports 73(1): 46-47
Brussoni, M.; Olsen, L.L.; Pike, I.; Sleet, D.A. 2012: Risky play and children's safety: balancing priorities for optimal child development. International Journal of Environmental Research and Public Health 9(9): 3134-3148
Tchernev, T. 2008: Risky pregnancy with inherited or acquired thrombophilia. Akusherstvo i Ginekologiia 47(Suppl 3): 16-18
Brown, N.I.; Josey, L.B. 2011: Risky radiology: not so black and white. Medical Journal of Australia 194(8): 428-429
McGuinness, T.M.; Newell, D. 2012: Risky recreation: synthetic cannabinoids have dangerous effects. Journal of Psychosocial Nursing and Mental Health Services 50(8): 16-18
Cohen, M.R. 2008: Risky recycling. Nursing 38(10): 24
Leukefeld, C.; Havens, J.; Tindall, M.Staton.; Oser, C.B.; Mooney, J.; Hall, M.T.; Knudsen, H.K. 2012: Risky relationships: targeting HIV prevention for women offenders. Aids Education and Prevention: Official Publication of the International Society for Aids Education 24(4): 339-349
Bates, M.E.; Keisler, J.M.; Jones, E.; Linkov, I. 2013: Risky removal: developing a holistic understanding of the risks of redeveloping sites contaminated with unexploded ordnance. Environmental Science and Technology 47(9): 3955-3956
Falco, A.; Piccirelli, A.; Girardi, D.; Dal Corso, L.; De Carlo, N.A. 2013: Risky riding behavior on two wheels: the role of cognitive, social, and personality variables among young adolescents. Journal of Safety Research 46: 47-57
Halfwerk, W.; Jones, P.L.; Taylor, R.C.; Ryan, M.J.; Page, R.A. 2014: Risky ripples allow bats and frogs to eavesdrop on a multisensory sexual display. Science 343(6169): 413-416
Borders, T.F.; Stewart, K.E.; Wright, P.B.; Leukefeld, C.; Falck, R.S.; Carlson, R.G.; Booth, B.M. 2013: Risky sex in rural America: longitudinal changes in a community-based cohort of methamphetamine and cocaine users. American Journal on Addictions 22(6): 535-542
Grov, C. 2010: Risky sex- and drug-seeking in a probability sample of men-for-men online bulletin board postings. Aids and Behavior 14(6): 1387-1392
Nguyen, H.V.; Koo, K.H.; Davis, K.Cue.; Otto, J.M.; Hendershot, C.S.; Schacht, R.L.; George, W.H.; Heiman, J.R.; Norris, J. 2012: Risky sex: interactions among ethnicity, sexual sensation seeking, sexual inhibition, and sexual excitation. Archives of Sexual Behavior 41(5): 1231-1239
Huggins, S.Perrigue.; Rooney, M.E.; Chronis-Tuscano, A. 2015: Risky sexual behavior among college students With ADHD: is the mother-child relationship protective?. Journal of attention disorders 19(3): 240-250
Hall, J.H.; Fals-Stewart, W.; Fincham, F.D. 2008: Risky sexual behavior among married alcoholic men. Journal of Family Psychology: Jfp: Journal of the Division of Family Psychology of the American Psychological Association 22(2): 287-292
Juma, M.; Alaii, J.; Bartholomew, L.K.; Askew, I.; Van den Borne, B. 2013: Risky sexual behavior among orphan and non-orphan adolescents in Nyanza Province, Western Kenya. Aids and Behavior 17(3): 951-960
Hariri, A.G.; Karadag, F.; Gokalp, P.; Essizoglu, A. 2011: Risky sexual behavior among patients in Turkey with bipolar disorder, schizophrenia, and heroin addiction. Journal of Sexual Medicine 8(8): 2284-2291
Ahmadian, M.; Hamsan, H.H.; Abdullah, H.; Samah, A.A.; Noor, A.M. 2014: Risky sexual behavior among rural female adolescents in Malaysia: a limited role of protective factors. Global Journal of Health Science 6(3): 165-174
Smith, S.James. 2015: Risky sexual behavior among young adult Latinas: are acculturation and religiosity protective?. Journal of Sex Research 52(1): 43-54
El-Bassel, N.; Wingood, G.; Wyatt, G.E.; Jemmott, J.B.; Pequegnat, W.; Landis, J.Richard.; Bellamy, S.; Gilbert, L.; Remien, R.H.; Witte, S.; Wu, E.; DiClemente, R.; Myers, H.; Jemmott, L.Sweet.; Metzger, D.; Ballard, S.; Brown, T.; Greene, Q.; Helker, C.; Robinson, N.; Allen-Taylor, L.; Appleby, D.; Crowley, E.; Ankoma, A.; Ashton, D.; Goddard, D.A.; Daniel, T.; Henderson, T.; Rivkin, I.; Green, C.M.; Brently, J.; Cheraquit, R.D.; Gray, D.; Hakim, L.; Sarfo, B.; Saunders, K.; Simmons, D.; Wilson, K.; Braxton, N.D.; Camp, C.; Conner, A.; Gibson, J.; Harmo 2010: Risky sexual behavior and correlates of STD prevalence among African American HIV serodiscordant couples. AIDS and behavior 14(5): 1023-1031
Klosky, J.L.; Foster, R.H.; Li, Z.; Peasant, C.; Howell, C.R.; Mertens, A.C.; Robison, L.L.; Ness, K.K. 2014: Risky sexual behavior in adolescent survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Health Psychology: Official Journal of the Division of Health Psychology American Psychological Association 33(8): 868-877
Wayment, H.A.; Aronson, B. 2002: Risky sexual behavior in american white college women: the role of sex guilt and sexual abuse. Journal of health psychology 7(6): 723-733
Robinson, B.Bean.E.; Scheltema, K.; Cherry, T. 2005: Risky sexual behavior in low-income African American women: the impact of sexual health variables. Journal of sex research 42(3): 224-237
Morales-Mesa, S.A.; Arboleda-Álvarez, O.L.; Segura-Cardona, A.M. 2014: Risky sexual behavior regarding HIV in a college population. Revista de Salud Publica 16(1): 27-39
Russell, M.; Chen, M.-J.; Nochajski, T.H.; Testa, M.; Zimmerman, S.J.; Hughes, P.S. 2009: Risky sexual behavior, bleeding caused by intimate partner violence, and hepatitis C virus infection in patients of a sexually transmitted disease clinic. American Journal of Public Health 99(Suppl 1): S173-S179
Leech, T.G.J.; Dias, J.J. 2012: Risky sexual behavior: a race-specific social consequence of obesity. Journal of Youth and Adolescence 41(1): 41-52
Weiss, U.Keller.; Tillman, K.Harker. 2009: Risky sexual behaviors among Hispanic young adults in South Florida: nativity, age at immigration and gender differences. Perspectives on Sexual and Reproductive Health 41(4): 202-209
Fentahun, N.; Mamo, A. 2014: Risky sexual behaviors and associated factors among male and female students in Jimma Zone preparatory schools, South West Ethiopia: comparative study. Ethiopian Journal of Health Sciences 24(1): 59-68
Cavazos-Rehg, P.A.; Spitznagel, E.L.; Schootman, M.; Strickland, J.R.; Afful, S.E.; Cottler, L.B.; Bierut, L.J. 2009: Risky sexual behaviors and sexually transmitted diseases: a comparison study of cocaine-dependent individuals in treatment versus a community-matched sample. Aids Patient Care and Stds 23(9): 727-734
Lam, C.B.; Lefkowitz, E.S. 2013: Risky sexual behaviors in emerging adults: longitudinal changes and within-person variations. Archives of Sexual Behavior 42(4): 523-532
Trejos-Castillo, E.; Vazsonyi, A.T. 2009: Risky sexual behaviors in first and second generation Hispanic immigrant youth. Journal of youth and adolescence 38(5): 719-731
Shehadeh, N.; McCoy, H.Virginia. 2014: Risky sexual behaviors: The role of ethnic identity in HIV risk in migrant workers. Journal of the Association of Nurses in AIDS Care: JANAC 25(4): 330-340
Dimbuene, Z.T.; Defo, B.K. 2011: Risky sexual behaviour among unmarried young people in Cameroon: another look at family environment. Journal of Biosocial Science 43(2): 129-153
Calafat, A.; Juan, M.; Becoña, E.; Mantecón, A.; Ramón, A. 2009: Risky sexual behaviour and drug use in recreational nightlife context. a gender perspective. Psicothema 21(2): 227-233
Elam, G.; Macdonald, N.; Hickson, F.C.I.; Imrie, J.; Power, R.; McGarrigle, C.A.; Fenton, K.A.; Gilbart, V.L.; Ward, H.; Evans, B.G.; Williams, I.; Johnson, M.; Barton, S.; Peters, B.; Taylor, C.; Lacey, C.; Williams, D.; Sukthankar, A.; Porter, K.; Baster, K.; Manifold, C. 2008: Risky sexual behaviour in context: qualitative results from an investigation into risk factors for seroconversion among gay men who test for HIV. Sexually Transmitted Infections 84(6): 473-477
Kouznetsov, L.; Kuznetsov, A.V.; Zippel, S.A. 2008: Risky sexual behaviour, taboo of HIV/AIDS and HIV-prevention topics: interviews with HIV-positive immigrants from the former Soviet Union. International Journal of Std and Aids 19(1): 71-72
Nwankwo, B.O.; Nwoke, E.A. 2009: Risky sexual behaviours among adolescents in Owerri Municipal: predictors of unmet family health needs. African Journal of Reproductive Health 13(1): 135-145
Gondim, R.ér.C.; Kerr, L.R.F.S.; Werneck, G.L.; Macena, R.H.M.; Pontes, M.K.; Kendall, C. 2009: Risky sexual practices among men who have sex with men in Northeast Brazil: results from four sequential surveys. Cadernos de Saude Publica 25(6): 1390-1398
Dessie, Y.; Gerbaba, M.; Bedru, A.; Davey, G. 2011: Risky sexual practices and related factors among ART attendees in Addis Ababa Public Hospitals, Ethiopia: a cross-sectional study. Bmc Public Health 11: 422
Laurent, H.K.; Ablow, J.C.; Measelle, J. 2011: Risky shifts: how the timing and course of mothers' depressive symptoms across the perinatal period shape their own and infant's stress response profiles. Development and Psychopathology 23(2): 521-538
Gual, A. 2011: Risky single drinking occasions or acute alcohol intoxications?. Addiction 106(6): 1048-1049; Discussion: 1050-1051
Dupuis, M.; Baggio, S.ép.; Henchoz, Y.; Deline, S.ép.; N'Goran, A.; Studer, J.; Bäehler, C.; Mohler-Kuo, M.; Gmel, G. 2014: Risky single occasion drinking frequency and alcohol-related consequences: can abstinence during early adulthood lead to alcohol problems?. Swiss Medical Weekly 144: W14017
Dawson, D.A. 2011: Risky single-occasion drinking. Addiction 106(9): 1709-1710
Gmel, G.; Kuntsche, E.; Rehm, J.ür. 2011: Risky single-occasion drinking: bingeing is not bingeing. Addiction 106(6): 1037-1045
Rachidi, S.; Awada, S.; Al-Hajje, A.; Bawab, W.; Zein, S.; Saleh, N.; Salameh, P. 2013: Risky substance exposure during pregnancy: a pilot study from Lebanese mothers. Drug Healthcare and Patient Safety 5: 123-131
Wall, U.; Andrén, L. 2009: Risky to combine clopidogrel with proton pump inhibitor?. Lakartidningen 106(52): 3523-3524
Stepińska, J. 2009: Risky treatment must be justified. Kardiologia Polska 67(12): 1342-1343
Cruce, G.; Nordström, L.G.; Ojehagen, A. 2007: Risky use and misuse of alcohol, drugs and cigarettes detected by screening questionnaires in a clinical psychosis unit. Nordic Journal of Psychiatry 61(2): 92-99
Cruce, G.; Ojehagen, A. 2007: Risky use of alcohol, drugs and cigarettes in a psychosis unit: a 1 1/2 year follow-up of stability and changes after initial screening. Bmc Psychiatry 7: 31
Gungor, D.E.; Paul, I.M.; Birch, L.L.; Bartok, C.J. 2010: Risky vs rapid growth in infancy: refining pediatric screening for childhood overweight. Archives of Pediatrics and Adolescent Medicine 164(12): 1091-1097
Rhea, S. 2010: Risky-drugs list in the spotlight. Healthcare groups, drugmakers push for changes to improve safety. Modern Healthcare 40(32): 14
Jasović-Gasić, M.; Marić, N. 2004: Risperidon vs. other antipsychotics in schizophrenia: the assessment of patients' attitudes. Psychiatria Danubina 16(3): 127-131
Germann, D.; Kurylo, N.; Han, F. 2012: Risperidone. Profiles of Drug Substances Excipients and Related Methodology 37: 313-361
Kumar, P.N.; Andrade, C. 2001: Risperidone - induced tardive dyskinesia : case report and review of literature. Indian Journal of Psychiatry 43(1): 78-80
Gadow, K.D.; Arnold, L.E.; Molina, B.S.G.; Findling, R.L.; Bukstein, O.G.; Brown, N.V.; McNamara, N.K.; Rundberg-Rivera, E.V.; Li, X.; Kipp, H.L.; Schneider, J.; Farmer, C.A.; Baker, J.L.; Sprafkin, J.; Rice, R.R.; Bangalore, S.S.; Butter, E.M.; Buchan-Page, K.A.; Hurt, E.A.; Austin, A.B.; Grondhuis, S.N.; Aman, M.G. 2014: Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. Journal of the American Academy of Child and Adolescent Psychiatry 53(9): 948-959.E1
Brahm, N.C.; Fast, G.A.; Brown, R.C. 2007: Risperidone and Dysphagia in a developmentally disabled woman. Primary Care Companion to the Journal of Clinical Psychiatry 9(4): 315-316
Kato, O.; Ota, N. 2009: Risperidone and Lithium for personality and behavioral changes with Wilson's Disease. Primary Care Companion to the Journal of Clinical Psychiatry 11(6): 368
Ranjbar, F.; Akbarzadeh, F.; Ahmadi, N.M.; Abbasnejhad, M. 2012: Risperidone and corrected QT-interval prolongation in surface electrocardiogram. Pakistan Journal of Biological Sciences: Pjbs 15(10): 496-500
Anonymous 2009: Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol. Prescrire international 18(104): 248
Cop, E.; Oner, P.; Oner, O. 2011: Risperidone and double incontinence in a child with autism. Journal of Child and Adolescent Psychopharmacology 21(6): 647-648
Keilhoff, G.; Grecksch, G.; Bernstein, H.-G.; Roskoden, T.; Becker, A. 2010: Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. European Archives of Psychiatry and Clinical Neuroscience 260(2): 151-162
Grenier, E.; Ryan, M.; Ko, E.; Fajardo, K.; John, V. 2011: Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report. Journal of Nervous and Mental Disease 199(12): 987-988
Singh, G.Pal. 2004: Risperidone and olanzapine induced tardive dyskinesia : a critical review of reported cases. Indian Journal of Psychiatry 46(4): 319-323
van Haaren, F. 2010: Risperidone and parent training in pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry 49(4): 406-7; author reply 407-8
Sainani, A.; Cabral, S. 2009: Risperidone and pituitary adenomas. Australian and New Zealand Journal of Psychiatry 43(2): 177
Gallerani, M.; Imberti, D.; Mari, E.; Marra, A.; Manfredini, R. 2012: Risperidone and pulmonary embolism: a harmful association? Case series and review of the literature. Acta Neuropsychiatrica 24(6): 361-368
Wang, T.-Y.; Tsai, S.-J. 2014: Risperidone and quetiapine-related arthralgia. Journal of Clinical Psychopharmacology 34(2): 271-272
Amodeo, D.A.; Jones, J.H.; Sweeney, J.A.; Ragozzino, M.E. 2014: Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice. Autism Research: Official Journal of the International Society for Autism Research 7(5): 555-567
Duff, K.; Beglinger, L.J.; O'Rourke, M.E.; Nopoulos, P.; Paulson, H.L.; Paulsen, J.S. 2008: Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington's disease. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 20(1): 1-3
Bowskill, S.V.J.; Handley, S.A.; Fisher, D.S.; Flanagan, R.J.; Patel, M.X. 2012: Risperidone and total 9-hydroxyrisperidone in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2002-2010. Therapeutic drug monitoring 34(3): 349-355
Dervaux, A.; Levasseur, M. 2008: Risperidone and valproate for mania following stroke. Journal of Neuropsychiatry and Clinical Neurosciences 20(2): 247
Scahill, L.; Koenig, K.; Carroll, D.H.; Pachler, M. 2007: Risperidone approved for the treatment of serious behavioral problems in children with autism. Journal of Child and Adolescent Psychiatric Nursing: Official Publication of the Association of Child and Adolescent Psychiatric Nurses Inc 20(3): 188-190
Omranifard, V.; Najafi, M.; Sharbafchi, M.R.; Emami, P.; Maracy, M. 2013: Risperidone as a treatment for childhood habitual behavior. Journal of Research in Pharmacy Practice 2(1): 29-33
Parashar, A.; Varma, A.; Sharp, B. 2007: Risperidone as galactagogue?. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 23(2): 143
Ramamourthy, P.; Kumaran, A.; Kattimani, S. 2013: Risperidone associated paralytic ileus in schizophrenia. Indian Journal of Psychological Medicine 35(1): 87-88
Gadit, A. 2011: Risperidone associated tardive dyskinesia--a less common phenomenon. BMJ Case Reports
Su, Y.-A.; Si, T.-M.; Zhou, D.-F.; Guo, C.-M.; Wang, X.-D.; Yang, Y.; Shu, L.; Liang, J.-H. 2007: Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors. European Journal of Pharmacology 564(1-3): 123-130
Yamaguchi, I.; Hamada, K.; Yoshida, M.; Isayama, H.; Kanazashi, S.; Takeuchi, K. 2009: Risperidone attenuates local and systemic inflammatory responses to ameliorate diet-induced severe necrotic pancreatitis in mice: it may provide a new therapy for acute pancreatitis. Journal of Pharmacology and Experimental Therapeutics 328(1): 256-262
Agarwal, V. 1999: Risperidone augmentation of clozapine. Indian Journal of Psychiatry 41(1): 86
Yun, H.W.; Lee, B.D. 2012: Risperidone augmentation with amisulpride: the blue-tongue sign. Psychiatry and Clinical Neurosciences 66(5): 464-465
Berk S Brook F Nur, M. 2000: Risperidone compared to haloperidol in cannabis-induced psychotic disorder: A double blind randomized controlled trial. International Journal of Psychiatry in Clinical Practice 4(2): 139-142
Hussain, A.; Belderbos, S. 2008: Risperidone depot in the treatment of psychosis associated with multiple sclerosis -- a case report. Journal of Psychopharmacology 22(8): 925-926
Li, C.; Xia, J.; Wang, J. 2009: Risperidone dose for schizophrenia. Cochrane Database of Systematic Reviews 4: Cd007474
Song, S.-W.; Sun, Y.; Su, B.-L.; Liu, C.; Yang, C.; Godfraind, T.; Su, D.-F. 2012: Risperidone enhances the vulnerability to stroke in hypertensive rats. Cns Neuroscience and Therapeutics 18(4): 343-349
Jainer, A.Kumar.; Mahmood, A. 2009: Risperidone for adolescent schizophrenia. British journal of psychiatry: the journal of mental science 194(6): 568-9; author reply 569
Thomson, A.; Maltezos, S.; Paliokosta, E.; Xenitidis, K. 2009: Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities. Cochrane Database of Systematic Reviews 2: Cd007011
Wancata, J. 2000: Risperidone for non-cognitive symptoms of dementia. International Journal of Psychiatry in Clinical Practice 4(3): 249-251
Hoekstra, P.J. 2014: Risperidone for non-psychotic disorders in paediatric patients: which child is to benefit?. Developmental Medicine and Child Neurology 56(10): 919-920
Detweiler, M.B.; Khachiyants, N.; Detweiler, J.G.; Ali, R.; Kim, K.Y. 2011: Risperidone for post-traumatic combat nightmares: a report of four cases. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 26(12): 920-928
Haas, M.; Delbello, M.P.; Pandina, G.; Kushner, S.; Van Hove, I.; Augustyns, I.; Quiroz, J.; Kusumakar, V. 2009: Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Bipolar Disorders 11(7): 687-700
Fear, C.F.; Libretto, S.E. 2002: Risperidone for the treatment of delusional disorder. International Journal of Psychiatry in Clinical Practice 6(2): 113-116
Duggal, H.S.; Niazmie, H.S. 1999: Risperidone in Indian patients with schizophrenia. Indian Journal of Psychiatry 41(3): 265-267
Hrdlicka, M.; Dudova, I. 2007: Risperidone in adolescent schizophrenic psychoses: A retrospective study. International Journal of Psychiatry in Clinical Practice 11(4): 273-278
Seto, K.; Dumontet, J.; Ensom, M.H.H. 2011: Risperidone in schizophrenia: is there a role for therapeutic drug monitoring?. Therapeutic Drug Monitoring 33(3): 275-283
Canitano, R.; Scandurra, V. 2008: Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatric Disease and Treatment 4(4): 723-730
Cruz-Jentoft, A.J.; Burón, Jé-Antonio.; Diago, Jús.I.; Gallego, R. 2005: Risperidone in the treatment of behavioural and psychological symptoms of dementia in patients diagnosed with vascular or mixed-type dementia. International Journal of Psychiatry in Clinical Practice 9(1): 45-51
Sajatovic, M.; Subramoniam, M.; Fuller, M.A. 2006: Risperidone in the treatment of bipolar mania. Neuropsychiatric Disease and Treatment 2(2): 127-138
Nishimura, K.; Omori, M.; Sato, E.; Katsumata, Y.; Gono, T.; Kawaguchi, Y.; Harigai, M.; Yamanaka, H.; Ishigooka, J. 2012: Risperidone in the treatment of corticosteroid-induced mood disorders, manic/mixed episodes, in systemic lupus erythematosus: a case series. Psychosomatics 53(3): 289-293
Woo, Y.S.; Bahk, W.-M.; Jon, D.-I.; Chung, S.-K.; Lee, S.-Y.; Ahn, Y.M.; Pae, C.-U.; Cho, H.-S.; Kim, J.-G.; Hwang, T.-Y.; Lee, H.-S.; Min, K.J.; Lee, K.-U.; Yoon, B.-H. 2010: Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea. Psychiatry and Clinical Neurosciences 64(1): 28-37
Bravo-Mehmedbasic, A. 2011: Risperidone in the treatment of schizophrenia. Medicinski Arhiv 65(6): 345-347
Kumar, P.N. 1999: Risperidone induced dystonic reaction and akathisia. Indian Journal of Psychiatry 41(1): 81-82
Yadav, D.Singh. 2010: Risperidone induced stuttering. General Hospital Psychiatry 32(5): 559.E9
Vasudevan, O.V.; Pinto, D.A.; Gopinath, P.S. 2002: Risperidone induced tardive dyskinesia - a case report. Indian Journal of Psychiatry 44(4): 384-386
Mazhar, M.N.; Resch, D.S. 2010: Risperidone induced ventricular tachycardia. Psychopharmacology Bulletin 43(3): 82-83
Ahmed, H.; Ali, H. 2011: Risperidone induced weight gain leading to benign intracranial hypertension. BMJ Case Reports
Iveli, M.ía.F.; Rebolledo, A.; Martín, P.; Enrique, N.ás.; Roldán Palomo, A.R.ío.; Rimorini, L.; Salemme, S.; Milesi, V.ón. 2010: Risperidone inhibits contractions induced by serotonin and histamine and reduces K+ currents in smooth muscle of human umbilical artery. Reproductive Sciences 17(9): 854-860
Brauner, J.M.; Hessler, S.; Groemer, T.W.; Alzheimer, C.; Huth, T. 2014: Risperidone inhibits voltage-gated sodium channels. European Journal of Pharmacology 728: 100-106
Laberge, L. 2010: Risperidone injection. Deltoid muscle or buttocks?. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 7(6): 43-44
Deslandes, P.N.; Lewis, A.; Thomas, A.; Sewell, R.D.E. 2009: Risperidone long acting injection: Findings of a 2-year retrospective follow-up study. International Journal of Psychiatry in Clinical Practice 13(4): 298-302
Bobo, W.V.; Shelton, R.C. 2010: Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder. Expert Review of Neurotherapeutics 10(11): 1637-1658
Bräunig, P.; Sacchetti, E.; Medori, R. 2008: Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study. International Journal of Psychiatry in Clinical Practice 12(1): 74-77
Napryeyenko, O.; Burba, B.; Martinez, G.; Neznanov, N.G.; Fischel, T.; Baylé, F.J.; Corrivetti, G.; Smeraldi, E.; Rabinowitz, J.; Schreiner, A. 2010: Risperidone long-acting injectable in recent-onset schizophrenia examined with clinician and patient self-report measures. Journal of Clinical Psychopharmacology 30(2): 200-202
Quiroz, J.A.; Yatham, L.N.; Palumbo, J.M.; Karcher, K.; Kushner, S.; Kusumakar, V. 2010: Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar i disorder. Biological Psychiatry 68(2): 156-162
Chue, P. 2003: Risperidone long-acting injection. Expert Review of Neurotherapeutics 3(4): 435-446
Arunpongpaisal, S.; Srisurapanont, M.; Kongsakon, R.; Kitiwattanagul, K.; Samanwongthai, U. 2010: Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia. Journal of the Medical Association of Thailand 93(3): 343-350
Johnston, T.G. 2011: Risperidone long-acting injection and Huntington's disease: case series with significant psychiatric and behavioural symptoms. International Clinical Psychopharmacology 26(2): 114-119
Fagiolini, A.; Casamassima, F.; Mostacciuolo, W.; Forgione, R.; Goracci, A.; Goldstein, B.I. 2010: Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar i disorder. Expert Opinion on PharmacoTherapy 11(10): 1727-1740
Williams, R.; Chandrasena, R.; Beauclair, L.; Luong, D.; Lam, A. 2014: Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the electronic Schizophrenia Treatment Adherence Registry in Canada. Neuropsychiatric Disease and Treatment 10: 417-425
Taylor, D.; Fischetti, C.; Sparshatt, A.; Thomas, A.; Bishara, D.; Cornelius, V. 2009: Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use. Acta Psychiatrica Scandinavica 120(2): 97-101
Taylor, D.M.; Fischetti, C.; Sparshatt, A.; Thomas, A.; Bishara, D.; Cornelius, V. 2009: Risperidone long-acting injection: a prospective 3-year analysis of its use in clinical practice. Journal of Clinical Psychiatry 70(2): 196-200
Rainer, M.K. 2008: Risperidone long-acting injection: a review of its long term safety and efficacy. Neuropsychiatric Disease and Treatment 4(5): 919-927
Taylor, D.; Cornelius, V. 2010: Risperidone long-acting injection: factors associated with changes in bed stay and hospitalisation in a 3-year naturalistic follow-up. Journal of Psychopharmacology 24(7): 995-999
Deeks, E.D. 2010: Risperidone long-acting injection: in bipolar i disorder. Drugs 70(8): 1001-1012
Thyssen, A.; Rusch, S.; Herben, V.; Quiroz, J.; Mannaert, E. 2010: Risperidone long-acting injection: pharmacokinetics following administration in deltoid versus gluteal muscle in schizophrenic patients. Journal of Clinical Pharmacology 50(9): 1011-1021
Catalán, R.; Penadés, R. 2011: Risperidone long-acting injection: safety and efficacy in elderly patients with schizophrenia. Journal of Central Nervous System Disease 3: 95-105
Saxena, A.; Grace, J.; Olympia, J.L.; Trigoboff, E.; Watson, T.; Cushman, S.; Newcomer, D. 2008: Risperidone long-acting injections: successful alternative deltoid muscle injections for refractory schizophrenia. Psychiatry 5(9): 40-42
Macfadden, W.; Bossie, C.A.; Turkoz, I.; Haskins, J.T. 2010: Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia. International Clinical Psychopharmacology 25(2): 75-82
Boaz, T.L.; Constantine, R.J.; Robst, J.; Becker, M.A.; Howe, A.M. 2011: Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population. Journal of Clinical Psychiatry 72(8): 1079-1085
Wang, C.-Y.; Xiang, Y.-T.; Cai, Z.-J.; Weng, Y.-Z.; Bo, Q.-J.; Zhao, J.-P.; Liu, T.-Q.; Wang, G.-H.; Weng, S.-M.; Zhang, H.-Y.; Chen, D.-F.; Tang, W.-K.; Ungvari, G.S.; Wang, C.-Y.; Ji, C.-J.; Xu, X.-F.; Wang, G.-H.; Meng, H.-Q.; Gao, C.-G.; Deng, W.; Ji, J.-W.; Deng, H.-H.; Li, K.-Q.; Zhang, H.-Y.; Cai, F.; Liu, T.-Q.; Fan, J.-X.; Weng, S.-M.; Wang, X.-Z.; Li, M.; Fan, H.-Y.; Wang, Y. 2010: Risperidone maintenance treatment in schizophrenia: a randomized, controlled trial. American Journal of Psychiatry 167(6): 676-685
Mannheimer, B.; Holm, J.; Koukel, L.; Bertilsson, L.; Osby, U.; Eliasson, E. 2014: Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients. European Journal of Clinical Pharmacology 70(6): 695-699
Trivedi, M.; Pinto, D.; Safeekh, A.T. 2004: Risperidone mono - therapy as prophylaxis in bipolar affective disorders. Indian Journal of Psychiatry 46(3): 273-274
Forsthoff, A.; Grunze, H.; Seemüller, F.; Stampfer, R.; Dittmann, S.; Amann, B.; Schmidt, F.; Schäfer, M.; Hermle, L.; Walden, Jörg.; Schreiner, A. 2007: Risperidone monotherapy in manic inpatients: an open label, multicentre trial. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 8(4): 256-261
Subotnik, K.L.; Nuechterlein, K.H.; Ventura, J.; Gitlin, M.J.; Marder, S.; Mintz, J.; Hellemann, G.S.; Thornton, L.A.; Singh, I.R. 2011: Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. American Journal of Psychiatry 168(3): 286-292
MacDowell, K.S.; García-Bueno, B.; Madrigal, J.é L.M.; Parellada, M.; Arango, C.; Micó, J.A.; Leza, J.C. 2013: Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation. International Journal of Neuropsychopharmacology 16(1): 121-135
Kusumi, I.; Honda, M.; Ito, K.; Uemura, K.; Kumazawa, Y.; Ishikane, T.; Niide, Y.; Koyama, T. 2011: Risperidone oral solution versus standard tablets for the acute treatment of patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35(2): 537-540
Page, C.B.; Calver, L.A.; Isbister, G.K. 2010: Risperidone overdose causes extrapyramidal effects but not cardiac toxicity. Journal of Clinical Psychopharmacology 30(4): 387-390
Copur, M.; Erdogan, A. 2011: Risperidone rechallenge for marked liver function test abnormalities in an autistic child. Recent Patents on Endocrine Metabolic and Immune Drug Discovery 5(3): 237-239
Tavano, A.; Busan, P.; Borelli, M.; Pelamatti, G. 2011: Risperidone reduces tic-like motor behaviors and linguistic dysfluencies in severe persistent developmental stuttering. Journal of Clinical Psychopharmacology 31(1): 131-134
Stojković, T.; Radonjić, N.V.; Velimirović, M.; Jevtić, G.; Popović, V.; Doknić, M.; Petronijević, N.ša.D. 2012: Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39(1): 192-199
Rodríguez-Salgado, B. 2008: Risperidone safety in pregnancy. A case report. Actas Espanolas de Psiquiatria 36(6): 366-368
Rahman, Z.; Zidan, A.S.; Khan, M.A. 2010: Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation. International Journal of Pharmaceutics 400(1-2): 49-58
Mendhekar, D.; Lohia, D. 2008: Risperidone therapy in two successive pregnancies. Journal of Neuropsychiatry and Clinical Neurosciences 20(4): 485-486
Biederman, J.; Hammerness, P.; Doyle, R.; Joshi, G.; Aleardi, M.; Mick, E. 2008: Risperidone treatment for ADHD in children and adolescents with bipolar disorder. Neuropsychiatric Disease and Treatment 4(1): 203-207
Rao, N.; Venkatasubramanian, G.; Korpade, V.; Behere, R.; Varambally, S.; Gangadhar, B. 2011: Risperidone treatment for polydipsia and hyponatremia in schizophrenia: a case report. Turk Psikiyatri Dergisi 22(2): 123-125
Sarı, B.A.ın.; Taşkıntuna, N.ün.; Yalçın, Öz. 2014: Risperidone treatment in a case of Tourette syndrome with factor V Leiden heterozygous mutation. Journal of Child and Adolescent Psychopharmacology 24(4): 235-236
Secher, A.; Husum, H.; Holst, B.; Egerod, K.L.; Mellerup, E. 2010: Risperidone treatment increases CB1 receptor binding in rat brain. Neuroendocrinology 91(2): 155-168
Keeshin, B.R.; Strawn, J.R. 2009: Risperidone treatment of an adolescent with severe posttraumatic stress disorder. Annals of PharmacoTherapy 43(7): 1374
Friedel, R.O.; Jackson, W.T.; Huston, C.S.; May, R.S.; Kirby, N.L.; Stoves, A.ée. 2008: Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study. Journal of Clinical Psychopharmacology 28(3): 345-347
Campbell, J.J.; Ngo, G. 2008: Risperidone treatment of complex hallucinations in a patient with posterior cortical atrophy. Journal of Neuropsychiatry and Clinical Neurosciences 20(3): 378-379
Suenaga, T.; Tawara, Y.; Goto, S.; Kouhata, S.; Kagaya, A.; Horiguchi, J.; Yamanaka, Y.; Yamawaki, S. 2000: Risperidone treatment of neuroleptic-induced tardive extrapyramidal symptoms. International Journal of Psychiatry in Clinical Practice 4(3): 241-243
Meighen, K.G.; Hines, L.A.; Lagges, A.M. 2007: Risperidone treatment of preschool children with thermal burns and acute stress disorder. Journal of Child and Adolescent Psychopharmacology 17(2): 223-232
Arana-Lechuga, Y.; Sanchez-Escandón, O.; de Santiago-Treviño, N.; Castillo-Montoya, C.; Terán-Pérez, G.; Velázquez-Moctezuma, J. 2008: Risperidone treatment of sleep disturbances in Tourette's syndrome. Journal of Neuropsychiatry and Clinical Neurosciences 20(3): 375-376
Etminan, M.; Heran, B.; Carleton, B.; Brophy, J.M. 2014: Risperidone use and risk for gynecomastia in men. Journal of Clinical Psychopharmacology 34(5): 656-657
Chevreuil, C.; Reymann, J.-M.; Frémaux, T.; Polard, E.; Séveno, T.; Bentué-Ferrer, D.èl. 2008: Risperidone use in child and adolescent psychiatric patients. Therapie 63(5): 359-375
Mahmoud, R.A.; Engelhart, L.M.; Janagap, C.C.; Oster, G.; Ollendorf, D. 2004: Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder : Symptoms, Quality of Life and Resource Use under Customary Clinical Care. Clinical Drug Investigation 24(5): 275-286
Fakra, E.; Salgado-Pineda, P.; Besnier, N.; Azorin, J-Michel.; Blin, O. 2009: Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 10(4 Pt 3): 719-728
Chaudhuri, B.P.; Bhagabati, D.; Medhi, D. 2000: Risperidone versus haloperidol in acute and transient psychotic disorder. Indian Journal of Psychiatry 42(3): 280-290
Miral, S.; Gencer, O.; Inal-Emiroglu, F.N.; Baykara, B.; Baykara, A.; Dirik, E. 2008: Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial. European Child and Adolescent Psychiatry 17(1): 1-8
Kim, S.-W.; Yoo, J.-A.; Lee, S.-Y.; Kim, S.-Y.; Bae, K.-Y.; Yang, S.-J.; Kim, J.-M.; Shin, I.-S.; Yoon, J.-S. 2010: Risperidone versus olanzapine for the treatment of delirium. Human Psychopharmacology 25(4): 298-302
Komossa, K.; Rummel-Kluge, C.; Schwarz, S.; Schmid, F.; Hunger, H.; Kissling, W.; Leucht, S. 2011: Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews 1: Cd006626
Rattehalli, R.D.; Jayaram, M.B.; Smith, M. 2010: Risperidone versus placebo for schizophrenia. Schizophrenia Bulletin 36(3): 448-449
Moosavi, S.M.; Ahmadi, M.; Monajemi, M.B. 2014: Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial. Global Journal of Health Science 6(6): 163-167
Kripke, C. 2010: Risperidone vs. placebo for schizophrenia. American Family Physician 81(9): 1096
Vieweg, W.Victor.R.; Hasnain, M.; Hancox, J.C.; Baranchuk, A.; Digby, Gève.C.; Kogut, C.; Crouse, E.L.Breden.; Koneru, J.N.; Deshmukh, A.; Pandurangi, A.K. 2013: Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports. Psychopharmacology 228(4): 515-524
Dhir, A.; Kulkarni, S.K. 2008: Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors. Neuroscience Letters 445(1): 83-88
Rocca, P.; Marino, F.; Montemagni, C.; Perrone, D.; Bogetto, F. 2007: Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study. Psychiatry and Clinical Neurosciences 61(6): 622-629
Gabriel, A. 2013: Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study. Neuropsychiatric Disease and Treatment 9: 485-492
Qureshi, S.Uddin.; Rubin, E. 2008: Risperidone- and aripiprazole-induced leukopenia: a case report. Primary Care Companion to the Journal of Clinical Psychiatry 10(6): 482-483
Wright, T.M.; Vandenberg, A.M. 2007: Risperidone- and quetiapine-induced cholestasis. Annals of PharmacoTherapy 41(9): 1518-1523
Milovanovic, D.R.; Janjic, V.; Zornic, N.; Dejanovic, S.D.; Jankovic, S.M. 2010: Risperidone-associated hypocalcemia. American Journal of Psychiatry 167(12): 1533-1534
Weinbrenner, A.; Peus, V.; Inta, D.; Englisch, S.; Zink, M. 2009: Risperidone-associated increase in triglyceride levels. American Journal of Psychiatry 166(1): 113-114
Lu, C.-H.; Yan, Y.-H. 2009: Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient. Diabetes Research and Clinical Practice 83(2): E66-E67
Kumazaki, H.; Watanabe, K.; Imasaka, Y.; Iwata, K.; Tomoda, A.; Mimura, M. 2014: Risperidone-associated urinary incontinence in patients with autistic disorder with mental retardation. Journal of Clinical Psychopharmacology 34(5): 624-626
Iuppa, C.A.; Diefenderfer, L.A. 2013: Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine. Annals of PharmacoTherapy 47(9): 1223-1228
Pollak, P.T.; Verjee, Z.H.; Lyon, A.W. 2011: Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics. Journal of Clinical Pharmacology 51(7): 1112-1115
Koroglu, Aşe.; Hocaoglu, C. 2012: Risperidone-induced acromegaly: a case report. Therapeutic Advances in Psychopharmacology 2(2): 85-89
Rizos, E.; Tsigkaropoulou, E.; Lambrou, P.; Kanakaki, M.; Chaniotou, A.; Alevyzakis, E.; Liappas, I. 2013: Risperidone-induced acute eosinophilic pneumonia. In Vivo 27(5): 651-653
Sico, J.J.; Patwa, H. 2011: Risperidone-induced bulbar palsy-like syndrome. Dysphagia 26(3): 340-343
Kodama, M.; Fujiwara, M. 2012: Risperidone-induced dislocation of the temporomandibular joint. Journal of Clinical Psychiatry 73(2): 176
Singh, T.; Rais, T.; Rais, A. 2007: Risperidone-induced enuresis in an adult. Psychiatry 4(1): 17-21
Hergüner, S.; Mukaddes, N.M. 2007: Risperidone-induced enuresis in two children with autistic disorder. Journal of Child and Adolescent Psychopharmacology 17(4): 527-530
Cheng, Y.-M.; Lin, W.-A.; Yang, H.-N. 2011: Risperidone-induced hiccups in a youth with down syndrome. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35(2): 641-642
Ghio, L.; Fornaro, G.; Rossi, P. 2009: Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report. Journal of Clinical Psychopharmacology 29(4): 391-392
Davidson, C.K.D.; Johnson, T.; Jansen, K. 2013: Risperidone-induced hypersexuality. British Journal of Psychiatry: the Journal of Mental Science 203(3): 233
Smith, C.; Toohey, N.; Knight, J.A.; Klein, M.T.; Teitler, M. 2011: Risperidone-induced inactivation and clozapine-induced reactivation of rat cortical astrocyte 5-hydroxytryptamine₇ receptors: evidence for in situ G protein-coupled receptor homodimer protomer cross-talk. Molecular Pharmacology 79(2): 318-325
Manfredi, G.; Solfanelli, A.; Dimitri, G.; Cuomo, I.; Sani, G.; Kotzalidis, G.D.; Girardi, P. 2013: Risperidone-induced leukopenia: a case report and brief review of literature. General Hospital Psychiatry 35(1): 102.E3-6
Kavoor, A.R.; Mitra, S.; Mondal, S.K.; Das, B. 2014: Risperidone-induced mania: An emergent complication of treatment. Journal of Pharmacology and Pharmacotherapeutics 5(4): 258-260
Venkatasubramanian, G.; Yogananda, B.H.; Gangadhar, B.N. 2000: Risperidone-induced neuroleptic malignant syndrome : a case report. Indian Journal of Psychiatry 42(1): 101-103
Johnson, D.; Philip, A.Z.; Joseph, D.J.; Varghese, R. 2007: Risperidone-induced neuroleptic malignant syndrome in neurodegenerative disease: a case report. Primary Care Companion to the Journal of Clinical Psychiatry 9(3): 237-238
Farrell, H.; Eastman, P. 2013: Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma. Bmj Supportive and Palliative Care 3(1): 4-5
Khalid, A.; Nepal, M.K. 2000: Risperidone-induced oculogyric crisis. Indian Journal of Psychiatry 42(4): 449-450
Bozkurt, H.; Ayaydın, H.; Adak, İb.; Zoroğlu, S.S. 2012: Risperidone-induced paroxysmal perceptual alteration in a child with autism. Journal of Child and Adolescent Psychopharmacology 22(6): 470-471
Afzal, K.I.; Briones, D.F.; DeVargas, C. 2007: Risperidone-induced polydipsia and polyphagia associated with galactorrhea, abdominal pain, and rapid weight gain in an adolescent Hispanic female. Cns Spectrums 12(11): 818-820
Prabhuswamy, M.; Srinath, S.; Girimaji, S.; Seshadri, S. 2007: Risperidone-induced priapism in a 12-year-old boy with schizophrenia. Journal of Child and Adolescent Psychopharmacology 17(4): 539-540
Sharma, A.; Fleisher, M.H. 2009: Risperidone-induced priapism: a case report. Primary Care Companion to the Journal of Clinical Psychiatry 11(4): 174-175
Sansare, K.; Singh, D.; Khanna, V.; Karjodkar, F.R. 2012: Risperidone-induced rabbit syndrome: an unusual movement disorder. New York State Dental Journal 78(5): 44-46
Mishra, B.; Saddichha, S.; Kumar, R.; Akhtar, S. 2007: Risperidone-induced recurrent giant urticaria. British Journal of Clinical Pharmacology 64(4): 558-559
Focosi, D.; Kast, R.E.; Maggi, F.; Ceccherini-Nelli, L.; Petrini, M. 2007: Risperidone-induced reduction in JC viruria as a surrogate marker for efficacy against progressive multifocal leukoencephalopathy and hemorrhagic cystitis. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 39(1): 63-64
Wadoo, O.; Chalhoub, N. 2009: Risperidone-induced sexual dysfunction in a prepubertal child - a case report. Journal of Psychopharmacology 23(6): 727-728
Pollice, R.; Di Giovambattista, E.; Tomassini, A.; Di Pucchio, A.; Mazza, M.; Di Michele, V.; Roncone, R.; Casacchia, M. 2007: Risperidone-induced symptomatic hyperprolactinemia in youth with schizophrenia: efficacy and tolerability of cabergoline treatment. La Clinica Terapeutica 158(2): 121-126
Duggal, H.S.; Mendhekar, D.N. 2008: Risperidone-induced tardive pharyngeal dystonia presenting with persistent Dysphagia: a case report. Primary Care Companion to the Journal of Clinical Psychiatry 10(2): 161-162
Semba, J'ichi.; Okui, S. 2009: Risperidone-induced thrombocytopenia: a case report. General Hospital Psychiatry 31(1): 97-98
Hoekstra, P.J.; Troost, P.W.; Lahuis, B.E.; Mulder, H.; Mulder, E.J.; Franke, B.; Buitelaar, J.K.; Anderson, G.M.; Scahill, L.; Minderaa, R.B. 2010: Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene. Journal of Child and Adolescent Psychopharmacology 20(6): 473-477
Manousaridis, K.; Gupta, R. 2013: Risperidone-related bilateral cystoid macular oedema. Graefe's Archive for Clinical and Experimental Ophthalmology 251(3): 1037-1038
Tobiasova, Z.; van der Lingen, K.H.B.; Scahill, L.; Leckman, J.F.; Zhang, Y.; Chae, W.; McCracken, J.T.; McDougle, C.J.; Vitiello, B.; Tierney, E.; Aman, M.G.; Arnold, L.E.; Katsovich, L.; Hoekstra, P.J.; Volkmar, F.; Bothwell, A.L.M.; Kawikova, I. 2011: Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. Journal of Child and Adolescent Psychopharmacology 21(6): 555-564
Mendhekar, D.N.; Andrade, C. 2010: Risperidone-related reversal of primary enuresis: an unusual case report. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 11(2 Pt 2): 514-515
Raj, V.; Druitt, T.; Purushothaman, S.; Dunsdon, J. 2013: Risperidone/paliperidone induced neutropenia and lymphopenia. Australian and New Zealand Journal of Psychiatry 47(3): 291-292
Madaan, V. 2009: Risperidone: a review of efficacy studies in adolescents with schizophrenia. Drugs of Today 45(1): 55-62
Scott, L.J.; Dhillon, S. 2007: Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents. Paediatric Drugs 9(5): 343-354
Generali, J.A.; Cada, D.J. 2014: Risperidone: stuttering. Hospital Pharmacy 49(3): 242-243
Hardan, A.Y.; Fung, L.K.; Amin, H. 2010: Risperidone: switching from brand name to generic. Journal of Child and Adolescent Psychopharmacology 20(5): 457-458
Reem, J.; Carney, J.; Stanley, M.; Cassidy, J. 2009: Risser sign inter-rater and intra-rater agreement: is the Risser sign reliable?. Skeletal Radiology 38(4): 371-375
Kotwicki, T. 2008: Risser sign: the value of the lateral spinal radiograph to assess the excursion of the iliac apophysis. Studies in Health Technology and Informatics 140: 44-47
Papi, M.; Maulucci, G.; De Spirito, M.; Missori, M.; Arcovito, G.; Lancellotti, S.; Di Stasio, E.; De Cristofaro, R.; Arcovito, A. 2010: Ristocetin-induced self-aggregation of von Willebrand factor. European Biophysics Journal: Ebj 39(12): 1597-1603
Cohen, R. 2014: Risus sardonicus. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 20: 79
Preti, A. 2013: Risus sardonicus: assisted suicide or ritual violent euthanasia?. Crisis 34(2): 71-81
Cai, W.; Rudolph, J.L.; Sengoku, T.; Andres, D.A. 2012: Rit GTPase regulates a p38 MAPK-dependent neuronal survival pathway. Neuroscience Letters 531(2): 125-130
Cai, W.; Carlson, S.W.; Brelsfoard, J.M.; Mannon, C.E.; Moncman, C.L.; Saatman, K.E.; Andres, D.A. 2012: Rit GTPase signaling promotes immature hippocampal neuronal survival. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(29): 9887-9897
Andres, D.A.; Shi, G-Xian.; Bruun, D.; Barnhart, C.; Lein, P.J. 2008: Rit signaling contributes to interferon-gamma-induced dendritic retraction via p38 mitogen-activated protein kinase activation. Journal of Neurochemistry 107(5): 1436-1447
Shi, G.-X.; Cai, W.; Andres, D.A. 2012: Rit-mediated stress resistance involves a p38-mitogen- and stress-activated protein kinase 1 (MSK1)-dependent cAMP response element-binding protein (CREB) activation cascade. Journal of Biological Chemistry 287(47): 39859-39868
McGirk, J.; Giacaman, R.; Khatib, R. 2009: Rita Giacaman and Rana Khatib: promoting health for Palestinians. Lancet 373(9666): 801
Strakowski, S.M. 2007: Brain structures involved in bipolar disorder: findings from structural and functional imaging. Cns Spectrums 12(6 Suppl 8: 5-8
Aloe, L.; levi-Montalcini, R. 2011: Rita Levi-Montalcini and the discovery of NGF, the first nerve cell growth factor. Archives Italiennes de Biologie 149(2): 175-181
Federico, A.; Levi-Montalcini, R. 2013: Rita Levi-Montalcini, one of the most prominent Italian personalities of the twentieth century. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 34(2): 131-133
Zeliadt, N.; Levi-Montalcini, R. 2013: Rita Levi-Montalcini: NGF, the prototypical growth factor. Proceedings of the National Academy of Sciences of the United States of America 110(13): 4873-4876
Chao, M.; Cattaneo, A.; Mobley, W.; Levi-Montalcini, R. 2013: Rita Levi-Montalcini: the story of an uncommon intellect and spirit. Neuroscience 252: 431-437
Levi-Montalcini, R.; Knight, R.A.; Nicotera, P.; Nisticó, G.; Bazan, N.; Melino, G.; Levi-Montalcini, R. 2011: Rita's 102!!. Molecular Neurobiology 43(2): 77-79
De Chambrier, A.; Scholz, T.ás.; Ash, A.; Kar, P.K. 2011: Ritacestus gen. n. (Cestoda: Proteocephalidea) and redescription of R. ritaii comb. n., a parasite of Rita rita (Siluriformes) in India. Folia Parasitologica 58(4): 279-288
Piao, C.; Zhang, W-Mei.; Li, T-Tao.; Zhang, C-Cong.; Qiu, S.; Liu, Y.; Liu, S.; Jin, M.; Jia, L-Xin.; Song, W-Chao.; Du, J. 2018: Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer. Experimental Cell Research 366(2): 127-138
Rosin, S. 1966: Ritchey Chrétien corrector system. Applied Optics 5(4): 675-676
Swartzwelder, J.C.; Seabury, J.H. 1947: Rite of Amblyomma americanum associated with possible tick paralysis. Journal of Parasitology 33(2): 22
Berry, S. 2012: Rite of P-wave passage: the art of interpreting the ECG. Jems: a Journal of Emergency Medical Services 37(1): 72
McCrary, J.W. 1967: Rite of penitence. Science 157(3784): 8
Wozniak, D.F. 2009: Rites of passage and healing efficacy: an ethnographic study of an intimate partner violence intervention. Global Public Health 4(5): 453-463
Field, C. 2010: Rites of passage in Italy. Gastronomica: the Journal of Food and Culture 10(1): 32-37
Silverman, H. 1995: Rites of revitalization. Science 268(5214): 1215-1217
Rušavý, Z.; Karbanová, J.; Bednářová, B.; Kališ, V. 2014: Ritgen maneuver and its modifications. Ceska Gynekologie 79(1): 64-67
Yogol, N.S.; Shakya, R.; Thapa, P. 2009: Ritodrine and isoxsuprine in management of preterm labor. Jnma; Journal of the Nepal Medical Association 48(176): 265-268
Sugiura, Y.; Nemoto, E.; Kadohira, I.; Kaseda, S. 2013: Ritodrine for intractable uterine pain due to extrapelvic malignant tumor metastases: a case report. Clinical Journal of Pain 29(11): E22-E25
Zhang, L.; Liu, X.; Li, J. 2014: Ritodrine-induced agranulocytosis in pregnancy. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 34(6): 533-534
Sato, Y.; Teraki, Y.; Izaki, S.; Baba, K. 2010: Ritodrine-induced erythematous papular eruption in 14 pregnant women. International Journal of Dermatology 49(12): 1450-1453
Sohn, I.-S.; Park, J.-H.; Cho, J.-M.; Kim, C.-J. 2009: Ritodrine-induced hypokalemia. Korean Circulation Journal 39(7): 295-296
Kuwabara, Y.; Sato, A.; Abe, H.; Abe, S.; Kawai, N.; Takeshita, T. 2011: Ritodrine-induced pustular eruptions distinctly resembling impetigo herpetiformis. Journal of Nippon Medical School 78(5): 329-333
Sato, A.; Asano, T.; Isono, M.; Ito, K.; Asano, T. 2014: Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth. Molecular and Clinical Oncology 2(6): 1016-1022
Sevrioukova, I.F.; Poulos, T.L. 2014: Ritonavir analogues as a probe for deciphering the cytochrome P450 3A4 inhibitory mechanism. Current Topics in Medicinal Chemistry 14(11): 1348-1355
Foley, K.; Kast, R.E.; Altschuler, E.L. 2009: Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure. Medical Hypotheses 72(2): 150-152
Kast, R.Eric. 2008: Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery. Jop: Journal of the Pancreas 9(3): 350-353
Pillai, V.C.; Venkataramanan, R.; Parise, R.A.; Christner, S.M.; Gramignoli, R.; Strom, S.C.; Rudek, M.A.; Beumer, J.H. 2013: Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer. Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(10): 1843-1851
Albert, N.E.; Kazi, S.; Santoro, J.; Dougherty, R. 2012: Ritonavir and epidural triamcinolone as a cause of iatrogenic Cushing's syndrome. American Journal of the Medical Sciences 344(1): 72-74
Xiang, J.; Wang, Y.; Su, K.; Liu, M.; Hu, P.-C.; Ma, T.; Li, J.-X.; Wei, L.; Zheng, Z.; Yang, F. 2014: Ritonavir binds to and downregulates estrogen receptors: molecular mechanism of promoting early atherosclerosis. Experimental Cell Research 327(2): 318-330
Kumar, S.; Bryant, C.S.; Chamala, S.; Qazi, A.; Seward, S.; Pal, J.; Steffes, C.P.; Weaver, D.W.; Morris, R.; Malone, J.M.; Shammas, M.A.; Prasad, M.; Batchu, R.B. 2009: Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells. Molecular Cancer 8: 26
Estévez, J.A.; Moltó, J.é; Tuneu, L.; Cedeño, S.; Antonijoan, R.M.; Mangues, M.A.; Clotet, B.; Domingo, P.; Puntes, M.; Barbanoj, M.J.; Valle, M. 2012: Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers. Journal of Antimicrobial ChemoTherapy 67(8): 2013-2019
Knox, T.A.; Oleson, L.; von Moltke, L.L.; Kaufman, R.C.; Wanke, C.A.; Greenblatt, D.J. 2008: Ritonavir greatly impairs CYP3A activity in HIV infection with chronic viral hepatitis. Journal of Acquired Immune Deficiency Syndromes 49(4): 358-368
Pou, J.; Rebollo, A.; Roglans, N.úr.; Sánchez, R.M.; Vázquez-Carrera, M.; Laguna, J.C.; Pedro-Botet, J.; Alegret, M. 2008: Ritonavir increases CD36, ABCA1 and CYP27 expression in THP-1 macrophages. Experimental Biology and Medicine 233(12): 1572-1582
Kraus, M.; Malenke, E.; Gogel, J.; Müller, H.; Rückrich, T.; Overkleeft, H.; Ovaa, H.; Koscielniak, E.; Hartmann, J.ör.T.; Driessen, C. 2008: Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis. Molecular Cancer Therapeutics 7(7): 1940-1948
Sato, A.; Asano, T.; Ito, K.; Asano, T. 2012: Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells. Urology 79(4): 966.E13
Barillari, G.; Iovane, A.é; Bacigalupo, I.; Palladino, C.; Bellino, S.; Leone, P.; Monini, P.; Ensoli, B. 2012: Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. Aids 26(8): 909-919
Anonymous 2012: Ritonavir oral solution: still graduated in ml in the EU. Prescrire International 21(131): 235
Den Boer, M.A.M.; Westerterp, M.; de Vries-van der Weij, J.; Wang, Y.; Hu, L.; Espirito Santo, S.M.S.; Kooistra, T.; Reiss, P.; Romijn, J.A.; Havekes, L.M.; Rensen, P.C.N. 2010: Ritonavir protects against the development of atherosclerosis in APOE*3-Leiden mice. Atherosclerosis 210(2): 381-387
Kraus, M.; Müller-Ide, H.; Rückrich, T.; Bader, J.ür.; Overkleeft, H.; Driessen, C. 2014: Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations. Leukemia Research 38(3): 383-392
Batchu, R.B.; Gruzdyn, O.V.; Bryant, C.S.; Qazi, A.M.; Kumar, S.; Chamala, S.; Kung, S.T.; Sanka, R.S.; Puttagunta, U.S.; Weaver, D.W.; Gruber, S.A. 2014: Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways. Pharmaceuticals 7(1): 46-57
Rockwood, N.; Mandalia, S.; Bower, M.; Gazzard, B.; Nelson, M. 2011: Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir. Aids 25(13): 1671-1673
Raffi, F.ço.; Babiker, A.G.; Richert, L.; Molina, J.-M.; George, E.C.; Antinori, A.; Arribas, J.R.; Grarup, J.; Hudson, F.; Schwimmer, C.; Saillard, J.; Wallet, C.éd.; Jansson, P.O.; Allavena, C.; Van Leeuwen, R.; Delfraissy, J.-F.ço.; Vella, S.; Chêne, G.èv.; Pozniak, A.; Dedes, N.; Chêne, G.èv.; Richert, L.; Allavena, C.; Raffi, F.ço.; Autran, B.; Antinori, A.; Bucciardini, R.; Vella, S.; Horban, A.; Arribas, J.é; Babiker, A.G.; Boffito, M.; Pillay, D.; Pozniak, A.; Franquet, X.; Schwarze, S.; Grarup, J.; Chêne, G.èv.; Fischer, A.él.; Richert, L.; Wallet, C.éd.; Raffi, F.ço.; Diallo, A.; Molina, J.-M.; Saillard, J.; Moecklinghoff, C.; Stellbrink, H.-J.ür.; Vella, S.; Van Leeuwen, R.; Gatell, J.é; Sandström, E.; Flepp, M.; 2014: Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Lancet 384(9958): 1942-1951
Nishijima, T.; Hamada, Y.; Watanabe, K.; Komatsu, H.; Kinai, E.; Tsukada, K.; Teruya, K.; Gatanaga, H.; Kikuchi, Y.; Oka, S. 2013: Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patients. Plos one 8(10): E77268
Espiau, M.ía.; Soler-Palacín, P.; Borrull, A.; Figueras, C.ó 2011: Ritonavir-boosted lopinavir monotherapy due to intolerance to nucleoside reverse transcriptase inhibitors in an HIV-infected paediatric patient. Enfermedades Infecciosas y Microbiologia Clinica 29(4): 319
Boyd, M.A.; Kumarasamy, N.; Moore, C.L.; Nwizu, C.; Losso, M.H.; Mohapi, L.; Martin, A.; Kerr, S.; Sohn, A.H.; Teppler, H.; Van de Steen, O.; Molina, J.-M.; Emery, S.; Cooper, D.A.; Belloso, W.; Boyd, M.A.; Cooper, D.A.; Elliott, J.; Emery, S.; Gazzard, B.; Gotuzzo, E.; Humphries, A.; Kamarulzaman, A.; Kedem, E.; Kumarasamy, N.; Li, P.; Lim, P.-L.; Losso, M.H.; Madero, J.S.; Mallon, P.; Mohapi, L.; Molina, J.-M.; Nwizu, C.; Phanuphak, P.; Kerr, S.; Teppler, H.; Van de Steen, O.; Woodward, C.; Wolff, M.; Abela, C.; Amin, J.; Arriaga, M.; Berthon-Jones, N.; Boyd, M.A.; Cooper, D.A.; Courtney-Vega, K.; Emery, S.; Espinosa, N.; Haskelberg, H.; Hough, S.; Martin, A.; Lee, W.; Moore, C.L.; Passadee, K.; Taylor, J.; Valdovinos, M.; Zhou, J.; Bello 2013: Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study. Lancet 381(9883): 2091-2099
Hull, M.W.; Montaner, J.S.G. 2011: Ritonavir-boosted protease inhibitors in HIV therapy. Annals of Medicine 43(5): 375-388
Shafi, T.; Choi, M.J.; Racusen, L.C.; Spacek, L.A.; Berry, C.; Atta, M.; Fine, D.M. 2011: Ritonavir-induced acute kidney injury: kidney biopsy findings and review of literature. Clinical Nephrology 75 Suppl. 1: 60-64
Deray, D.G. 1998: Ritonavir-induced acute renal failure. Clinical Drug Investigation 16(2): 175
Kuang, C.-C.; Wang, Y.; Hu, P.-C.; Gao, F.-F.; Bu, L.; Wen, X.-M.; Xiang, Q.-M.; Song, H.; Li, Q.; Wei, L.; Li, K. 2014: Ritonavir-induced hepatotoxicity and ultrastructural changes of hepatocytes. Ultrastructural Pathology 38(5): 329-334
Mencarelli, A.; Francisci, D.; Renga, B.; D'Amore, C.; Cipriani, S.; Basile, F.; Schiaroli, E.; Baldelli, F.; Fiorucci, S. 2012: Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. Antiviral therapy 17(4): 669-678
Seidahmed, M.Zein.; Alkuraya, F.S.; Shaheed, M.; Al Zahrani, M.; Al Manea, W.; Mansour, F.; Mustafa, T.; Farid, G.; Salih, M.A. 2011: Ritscher-Schinzel (cranio-cerebello-cardiac, 3C) syndrome: report of four new cases with renal involvement. American Journal of Medical Genetics. Part a 155a(6): 1393-1397
Audiger, L.; Watts, K.; Elmore, S.C.; Robinson, R.I.; Wirth, T. 2012: Ritter reactions in flow. Chemsuschem 5(2): 257-260
Lande, J.N. 1949: Ritter's disease. Journal. Iowa State Medical Society 39(5): 189
Tichenor, C.J. 1946: Ritter's disease (dermatitis exfoliativa neonatorum); report of a case. Clinical Proceedings - Children's Hospital of the District of Columbia 2(12): 295-297
Wiener, A.S. 1947: Ritter's disease in fraternal twins, with special reference to the pathogenesis. New York State Journal of Medicine 47(16): 1796
Chen, J.; Shen, T.Y. 1948: Ritter's disease; report of a case treated with vitamins and penicillin with recovery. Chinese Medical Journal 66(7): 356-358
Czifrák, K.; Gyóllai, V.; Kövér, K.E.; Somsák, L.ás.ó 2011: Ritter-type reaction of C-(1-bromo-1-deoxy-D-glycopyranosyl)formamides and its application for the synthesis of oligopeptides incorporating anomeric α-amino acids. Carbohydrate Research 346(14): 2104-2112
Schlesinger, L.B.; Kassen, M.; Mesa, V.B.; Pinizzotto, A.J. 2010: Ritual and signature in serial sexual homicide. Journal of the American Academy of Psychiatry and the Law 38(2): 239-246
Lewin, S.; Green, J. 2009: Ritual and the organisation of care in primary care clinics in Cape Town, South Africa. Social Science and Medicine 68(8): 1464-1471
Brock, G. 1990: Ritual and vulnerability. Journal of Religion and Health 29(4): 285-295
Collier, J.F. 1982: Ritual as politics. Science 215(4537): 1230-1232
Hsu, W.-S.; Ho, M.-H. 2009: Ritual behaviours of children with autism spectrum disorders in Taiwan. Journal of Intellectual and Developmental Disability 34(4): 290-295
Amir, J. 2010: Ritual circumcision and urinary tract infection in Israel. Israel Medical Association Journal: Imaj 12(5): 303-304
Poliak, D.B. 2013: Ritual circumcision in the age of germ theory amongst nineteenth-century new york immigrants. Medical history 57(4): 579-592
Schultz, A. 2013: Ritual circumcision in the global world. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 133(15): 1556
Heidari, A. 2012: Ritual circumcision is health care. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 132(5): 508-509
Solbakk, J.H.; Pedersen, R.; Alnæs, A.H. 2012: Ritual circumcision is not health care. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 132(2): 134-135
Atkin, G.K.; Butler, C.; Broadhurst, J.; Khan, A.; Nataraj, R.; Madden, N.; Haddad, M.; Clarke, S.A. 2009: Ritual circumcision: no longer a problem for health services in the British Isles. Annals of the Royal College of Surgeons of England 91(8): 693-696
Brettschneider, M. 2003: Ritual encounters of the queer kind: a political analysis of jewish lesbian ritual innovation. Journal of Lesbian Studies 7(2): 29-48
Llaurens, V.; Raymond, M.; Faurie, C. 2009: Ritual fights and male reproductive success in a human population. Journal of Evolutionary Biology 22(9): 1854-1859
Hoque, N.; Chakkarapani, E.; Liu, X.; Thoresen, M. 2010: A comparison of cooling methods used in therapeutic hypothermia for perinatal asphyxia. Pediatrics 126(1): E124-E130
Sax, W. 2014: Ritual healing and mental health in India. Transcultural Psychiatry 51(6): 829-849
Sherman, A.; Weiner, M. 2012: Ritual in the ecosystem of caregiving. Beginnings 32(2): 12-13
Lambooij, B.; Kijlstra, A. 2009: Ritual slaughter and animal welfare of ruminants and poultry: a literature review. Tijdschrift Voor Diergeneeskunde 134(23): 984-989
Straka, L.; Novomesky, F.; Krajcovic, J.; Macko, V. 2009: Ritual suicide of a Japanese girl in the Slovak Republic. Legal Medicine 11(Suppl 1): S506-S507
Carod-Artal, F.J.; Vázquez Cabrera, C.B. 2007: Ritual use of Anadenanthera seeds among South America natives. Neurologia 22(6): 410-415
Holas, B. 1951: Ritual use of funeral statuettes in the Krinjabo kingdom on the Ivory Coast. Acta Tropica 8(1): 1-17
Gruca, M.; van Andel, T.R.; Balslev, H. 2014: Ritual uses of palms in traditional medicine in sub-Saharan Africa: a review. Journal of Ethnobiology and Ethnomedicine 10: 60
Toulson, R.E. 2012: Ritual vicissitudes: the uncertainties of Singaporean suicide rites. Culture Medicine and Psychiatry 36(2): 372-390
Brisse, J.ël.; Ghoul, A.; Samoun, A. 2011: Ritual washing, another aspect of care. Soins; la Revue de Reference Infirmiere 761: 42-44
Running, A.; Tolle, L.W.; Girard, D. 2008: Ritual: the final expression of care. International Journal of Nursing Practice 14(4): 303-307
Mercier, J.L.; Lenoir, A.; Dejean, A. 1997: Ritualised versus aggressive behaviours displayed by Polyrhachis laboriosa (F. Smith) during intraspecific competition. Behavioural Processes 41(1): 39-50
Kreiss, D.S.; Coffman, C.F.; Fiacco, N.R.; Granger, J.C.; Helton, B.M.; Jackson, J.C.; Kim, L.V.; Mistry, R.S.; Mizer, T.M.; Palmer, L.V.; Vacca, J.A.; Winkler, S.S.; Zimmer, B.A. 2013: Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder. Pharmacology Biochemistry and Behavior 104: 119-124
Webb, J.R.; Toussaint, L.; Dula, C.S. 2014: Ritualistic, theistic, and existential spirituality: initial psychometric qualities of the RiTE measure of spirituality. Journal of Religion and Health 53(4): 972-985
Graves, B.M. 2010: Ritualized combat as an indicator of intrasexual selection effects on male life history evolution. American journal of human biology: the official journal of the Human Biology Council 22(1): 45-49
Dietze, S.; Winkelmann, D.; Garve, R.; Blens, T.; Fanghänel, J.; Proff, P.; Gedrange, T.; Maile, S. 2007: Ritually induced growth disturbances and deformities of the orofacial system--a contribution to cranial morphogenesis. Annals of Anatomy 189(3): 304-308
Norton, M.I.; Gino, F. 2014: Rituals alleviate grieving for loved ones, lovers, and lotteries. Journal of Experimental Psychology. General 143(1): 266-272
Thuring, J. 2009: Rituals and ethics; ritual slaughter or humane killing?. Tijdschrift Voor Diergeneeskunde 134(6): 254
Brelsford, W.V. 1949: Rituals and medicines of Chishinga ironworkers. Man; a Monthly Record of Anthropological Science 49(26-45): 27-29
Achappa, B.; Madi, D.; Babu, Y.P.R.; Mahalingam, S. 2012: Rituals can kill - a fatal case of brucine poisoning. Australasian Medical Journal 5(8): 421-423
Kozai, T. 2007: Rituals for the dissected in pre-modern Japan. Nihon Ishigaku Zasshi 53(4): 531-544
Greenway, K. 2014: Rituals in nursing: intramuscular injections. Journal of Clinical Nursing 23(23-24): 3583-3588
Bächle, B. 2007: Rituals in pediatric nursing -- possibilities and limitations. Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 26(8): 315-317
Hawkes, J. 2016: Rituals of Madness in the Practices of Place. Journal of Medical Humanities 37(1): 95-109
Feyer, I.S.S.; Monticelli, M.; Boehs, A.E.; Santos, E.K.A.D. 2013: Rituals of care performed by families in preparing for the experience of planned home birth. Revista Brasileira de Enfermagem 66(6): 879-886
Wilf, E. 2012: Rituals of creativity: tradition, modernity, and the "acoustic unconscious" in a U.S. collegiate jazz music program. American Anthropologist 114(1): 32-44
Shaw, A. 2014: Rituals of infant death: defining life and Islamic personhood. Bioethics 28(2): 84-95
Filihia, M. 1999: Rituals of sacrifice in early post-European contact Tonga and Tahiti. Journal of Pacific History 34(1): 5-23
Mercurio, M.R. 2008: Rituals of unburdening. Hastings Center Report 38(2): 8-9
Wear, D.; Varley, J.D. 2008: Rituals of verification: the role of simulation in developing and evaluating empathic communication. Patient Education and Counseling 71(2): 153-156
Mohammed, S.; Peter, E. 2009: Rituals, death and the moral practice of medical futility. Nursing Ethics 16(3): 292-302
Palese, A. 2012: Rituals, myths and fashions of nursing care: a follow-up after 30 years and new risky trends. Assistenza Infermieristica e Ricerca: Air 31(1): 14-19
Thakkar, J.; Chaudhari, S.; Sarkar, P.K. 2011: Ritucharya: Answer to the lifestyle disorders. Ayu 32(4): 466-471
Henning, J.S.; Firoz, B.F. 2011: Rituxan is not associated with Stevens Johnson Syndrome. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(6): 1463-1464
Bitzan, M.; Anselmo, M.; Carpineta, L. 2009: Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature. Pediatric Pulmonology 44(9): 922-934
Pham, T.; Fautrel, B.; Gottenberg, J.-E.; Goupille, P.; Hachulla, E.; Masson, C.; Morel, J.; Mouthon, L.; Saraux, A.; Schaeverbeke, T.; Wendling, D.; Mariette, X.; Sibilia 2008: Rituximab (MabThera) therapy and safety management. Clinical tool guide. Joint Bone Spine 75(Suppl 1): S1-99
Nemec, P. 2007: Rituximab (MabThera)--a new biological medicine in rheumatoid arthritis therapy. Vnitrni Lekarstvi 53(11): 1199-1210
Lozinski, A.; Baum, S.; Sagi, L.; Volkov, A.; Trau, H.; Barzilai, A. 2012: Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders. Harefuah 151(10): 562
Anić, B. 2007: Rituximab (Mabthera)--new approach in treatment of rheumatoid arthritis. Reumatizam 54(2): 72-73
Morović-Vergles, J. 2008: Rituximab (Mabthera)--treatment of rheumatoid arthritis patients with inadequate response to TNF inhibitors--when to change therapy?. Reumatizam 55(2): 70-72
Bouquegneau, A.; Loheac, C.; Aubert, O.; Bouatou, Y.; Viglietti, D.; Empana, J-Philippe.; Ulloa, C.; Murad, M.Hassan.; Legendre, C.; Glotz, D.; Jackson, A.M.; Zeevi, A.; Schaub, S.; Taupin, J-Luc.; Reed, E.F.; Friedewald, J.J.; Tyan, D.B.; Süsal, C.; Shapiro, R.; Woodle, E.Steve.; Hidalgo, L.G.; O'Leary, J.; Montgomery, R.A.; Kobashigawa, J.; Jouven, X.; Jabre, P.; Lefaucheur, C.; Loupy, A. 2018: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. Plos Medicine 15(5): E1002572
Xanthouli, P.; Sailer, S.; Fiehn, C. 2012: Rituximab (RTX) as an Alternative to TNF-Alpha Antagonists in Patients with Rheumatoid Arthritis and High Risk of Severe Infections: a Systematic Analysis of the Experience in one Center. Open Rheumatology Journal 6: 286-289
Selewski, D.T.; Shah, G.V.; Mody, R.J.; Rajdev, P.A.; Mukherji, S.K. 2010: Rituximab (Rituxan). AJNR. American Journal of Neuroradiology 31(7): 1178-1180
McCoy, A.N.; Kim, D.S.; Gillespie, E.F.; Atkins, S.J.; Smith, T.J.; Douglas, R.S. 2014: Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells. Journal of Clinical Endocrinology and Metabolism 99(7): E1294-E1299
Hertl, M.; Eming, R.üd.; Borradori, L. 2007: Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus?. Dermatology 214(4): 275-277
Akaishi, T.; Nakashima, I. 2014: Rituximab (anti-CD20) in neurological disorders. Brain and Nerve 66(10): 1167-1178
Berentsen, Sørn. 2018: Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease. Seminars in Hematology 55(3): 141-149
Ram, R.; Raanani, P. 2008: Rituximab -- a double-edged sword: can one treatment for thrombocytopenia also induce it?. Leukemia and Lymphoma 49(11): 2035-2036
Ahbeddou, N.; Fetohi, M.; Khanoussi, B.E.; Errihani, H. 2011: Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary. Archives of Gynecology and Obstetrics 283(5): 1173-1174
Ribeiro, E.; Cressend, T.; Duffau, P.; Grenouillet-Delacre, M.; Rouanet-Larivière, M.; Vital, A.; Longy-Boursier, M.ït.é; Mercié, P. 2009: Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare. Case Reports in Medicine 2009: 738293
Kodaira, M.; Yamamoto, K. 2013: Rituximab Improves Subclinical Temporal Dispersion of Distal Compound Muscle Action Potential in Anti-MAG/SGPG Neuropathy Associated with Waldenström Macroglobulinemia: A Case Report. Case Reports in Neurology 5(1): 34-39
Hamano, Y.; Yoshizawa, H.; Sugase, T.; Miki, T.; Ohtani, N.; Hanawa, S.; Takeshima, E.; Morishita, Y.; Saito, O.; Takemoto, F.; Muto, S.; Yumura, W.; Kusano, E. 2012: Rituximab Treatment for PR3-ANCA-Positive Membranoproliferative Glomerulonephritis Associated with Adult-Onset Periodic Fever Syndrome. Case Reports in Nephrology and Urology 2(2): 92-101
Nozaki, Y.; Mitsumori, T.; Yamamoto, T.; Kawashima, I.; Shobu, Y.; Hamanaka, S.; Nakajima, K.; Komatsu, N.; Kirito, K. 2013: Rituximab activates Syk and AKT in CD20-positive B cell lymphoma cells dependent on cell membrane cholesterol levels. Experimental Hematology 41(8): 687-696.E1
Naismith, R.T.; Piccio, L.; Lyons, J.A.; Lauber, J.; Tutlam, N.T.; Parks, B.J.; Trinkaus, K.; Song, S.K.; Cross, A.H. 2010: Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase Ii trial. Neurology 74(23): 1860-1867
Herold, M.; Haas, A.; Srock, S.; Neser, S.; Al-Ali, K.H.; Neubauer, A.; Dölken, G.; Naumann, R.; Knauf, W.; Freund, M.; Rohrberg, R.; Höffken, K.; Franke, A.; Ittel, T.; Kettner, E.; Haak, U.; Mey, U.; Klinkenstein, C.; Assmann, M.; von Grünhagen, U. 2007: Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(15): 1986-1992
Shah, N.; Rule, S. 2013: Rituximab administration in a community hospital environment. Leukemia and Lymphoma 54(7): 1532-1533
McIver, Z.; Stephens, N.; Grim, A.; Barrett, A.J. 2010: Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 16(11): 1549-1556
Glass, B.; Hasenkamp, J.; Wulf, G.; Dreger, P.; Pfreundschuh, M.; Gramatzki, M.; Silling, G.; Wilhelm, C.; Zeis, M.; Görlitz, A.; Pfeiffer, S.; Hilgers, R.; Truemper, L.; Schmitz, N. 2014: Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial. LANCET. Oncology 15(7): 757-766
Khan, A.; Scott, D. 2011: Rituximab after methotrexate failure in rheumatoid arthritis: evaluation of the SERENE trial. Expert Opinion on Biological Therapy 11(11): 1515-1518
Sano, T.; Sakai, H.; Takimoto, K.; Ohno, H. 2007: Rituximab alone was effective for the treatment of a diffuse large B-cell lymphoma associated with hemophagocytic syndrome. International Journal of Clinical Oncology 12(1): 59-62
Orsoni, J.G.; Laganà, B.; Rubino, P.; Zavota, L.; Bacciu, S.; Mora, P. 2010: Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report. Orphanet Journal of Rare Diseases 5: 18
Hachiya, Y.; Uruha, A.; Kasai-Yoshida, E.; Shimoda, K.; Satoh-Shirai, I.; Kumada, S.; Kurihara, E.; Suzuki, K.; Ohba, A.; Hamano, S.-i.; Sakuma, H. 2013: Rituximab ameliorates anti-N-methyl-D-aspartate receptor encephalitis by removal of short-lived plasmablasts. Journal of Neuroimmunology 265(1-2): 128-130
Wilde, B.; Witzke, O.; Cohen Tervaert, J.W. 2014: Rituximab and B-cell return in ANCA-associated vasculitis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 63(6): 1066
Chang, J.E.; Seo, S.; Kim, K.M.; Werndli, J.E.; Bottner, W.A.; Rodrigues, G.A.; Sanchez, F.A.; Saphner, T.J.; Longo, W.L.; Kahl, B.S. 2010: Rituximab and CHOP chemotherapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin oncology network study. Clinical Lymphoma Myeloma and Leukemia 10(5): 379-384
Crnkic Kapetanovic, M.; Saxne, T.; Jönsson, G.ör.; Truedsson, L.; Geborek, P. 2013: Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis. Arthritis Research and Therapy 15(5): R171
Crawley, L.M.; Ahn, D.K.; Winkleby, M.A. 2008: Perceived medical discrimination and cancer screening behaviors of racial and ethnic minority adults. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 17(8): 1937-1944
Gómez Centeno, T. 2009: Rituximab and abatacept in rheumatoid arthritis. Reumatologia Clinica 5(Suppl 1): 77-81
Wong, C.F. 2008: Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis: granulomatous disease more resistant than vasculitis disease?. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 14(2): 61-64
Walter, E.; Schmitt, T.; Dietrich, S.; Ho, A.; Witzens-Harig, M. 2012: Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy. Leukemia and Lymphoma 53(11): 2290-2292
Qureshi, Z.P.; Magwood, J.S.; Singh, S.; Bennett, C.L. 2013: Rituximab and biosimilars - equivalence and reciprocity. Biosimilars 3: 19-25
Sonet, A.; Bosly, A.é 2009: Rituximab and chemotherapy in diffuse large B-cell lymphoma. Expert Review of Anticancer Therapy 9(6): 719-726
Avilés, A.; Castañeda, C.; Cleto, S.; Neri, N.; Huerta-Guzmán, J.; Gonzalez, M.; Nambo, M.-J.ús. 2009: Rituximab and chemotherapy in primary gastric lymphoma. Cancer BioTherapy and Radiopharmaceuticals 24(1): 25-28
Lévy, M.ël.; Copie-Bergman, C.; Amiot, A.él.; Dupuis, J.; Le Baleur, Y.; Belhadj, K.; Hémery, F.ço.; Sobhani, I.; Delfau-Larue, M.-H.él.èn.; Leroy, K.; Haioun, C.; Delchier, J.-C. 2013: Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study. Leukemia and Lymphoma 54(5): 940-944
Rodríguez-Ferrero, M.; Ampuero, J.; Anaya, F. 2009: Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis. Transplantation Proceedings 41(6): 2406-2408
Henes, J.C.; Schedel, J.; Kanz, L.; Koetter, I. 2010: Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis. Rheumatology International 30(5): 709-712
Ogimi, C.; Tanaka, R.; Arai, T.; Kikuchi, A.; Hanada, R.; Oh-Ishi, T. 2011: Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome. Pediatric Blood and Cancer 57(4): 677-680
Kulkarni, H.S.; Kasi, P.M. 2012: Rituximab and cytokine release syndrome. Case Reports in Oncology 5(1): 134-141
Alexander, S.; Hopewell, S.; Hunter, S.; Chouksey, A. 2008: Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis. Journal of Pediatric Hematology/Oncology 30(1): 93-95
Avilés, A.; Castañeda, C.; Neri, N.; Cleto, S.; Nambo, M.J.ús. 2007: Rituximab and dose dense chemotherapy in primary breast lymphoma. Haematologica 92(8): 1147-1148
Avilés, A.; Nambo, M.J.ús.; Cleto, S.; Neri, N.; Huerta-Guzmán, J. 2009: Rituximab and dose-dense chemotherapy in primary testicular lymphoma. Clinical Lymphoma and Myeloma 9(5): 386-389
Xu, X.; Wang, C.; Wang, Y.; Zhou, L.; Bai, H. 2013: Rituximab and fludarabine or cyclophosphamide combination treatment for older waldenström macroglobulinemia patients. Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology 30(4): 422-423
Kaplan, B.; Kopyltsova, Y.; Khokhar, A.; Lam, F.; Bonagura, V. 2014: Rituximab and immune deficiency: case series and review of the literature. Journal of Allergy and Clinical Immunology. in Practice 2(5): 594-600
Collins, P.W.; Mathias, M.; Hanley, J.; Keeling, D.; Keenan, R.; Laffan, M.; Perry, D.; Liesner, R. 2009: Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort. Journal of Thrombosis and Haemostasis: Jth 7(5): 787-794
Pandey, S.; Nakagawa, M.; Rosenbaum, E.R.; Arnaoutakis, K.; Hutchins, L.F.; Makhoul, I.; Milojkovic, N.; Cottler-Fox, M. 2015: Rituximab and intermediate-purity plasma-derived factor VIIi concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor. Journal of Clinical Apheresis 30(1): 50-54
Muzaffar, J.; Katragadda, L.; Haider, S.; Javed, A.; Anaissie, E.; Usmani, S. 2012: Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature. International Journal of Hematology 95(1): 102-106
Fehr, T.; Rüsi, B.; Fischer, A.; Hopfer, H.; Wüthrich, R.P.; Gaspert, A. 2009: Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection. Transplantation 87(12): 1837-1841
Leen, W.G.; Weemaes, C.M.; Verbeek, M.M.; Willemsen, M.èl.A.; Rotteveel, J.J. 2008: Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome. Pediatric Neurology 39(3): 213-217
Bryant, A.; Moore, J. 2006: Rituximab and its potential for the treatment of rheumatoid arthritis. Therapeutics and Clinical Risk Management 2(2): 207-212
Daniel, B.S.; Murrell, D.éd.ée.F.; Joly, P. 2012: Rituximab and its use in autoimmune bullous disorders. Immunology and Allergy Clinics of North America 32(2): 331-337 Viii
Henes, J.C.; Kanz, L.; Koetter, I. 2011: Rituximab and leflunomide for Wegener's granulomatosis: a long-term follow-up. Rheumatology International 31(3): 425-426
O'Connor, M.B.; Phelan, M.J. 2012: Rituximab and lung disease. Irish Medical Journal 105(9): 314
Efthimiou, P.; Kukar, M.; Hersh, A. 2011: Rituximab and lupus interstitial lung disease: friend or foe?. International Journal of Rheumatic Diseases 14(1): E3-E4
Ekö, S.L.; van Vollenhoven, R.F. 2014: Rituximab and lupus--a promising pair?. Current Rheumatology Reports 16(9): 444
Quach, Q.Huy.; Kong, R.Li.Xian.; Kah, J.Chen.Yong. 2018: Complement Activation by PEGylated Gold Nanoparticles. Bioconjugate Chemistry 29(4): 976-981
Edey, M.M. 2011: Rituximab and memory antibody levels after desensitization. Transplant International: Official Journal of the European Society for Organ Transplantation 24(8): E67-E68
Kitsos, D.K.; Tsiodras, S.; Stamboulis, E.; Voumvourakis, K.I. 2012: Rituximab and multiple sclerosis. Clinical Neuropharmacology 35(2): 90-96
Parziale, N.; Kovacs, S.C.; Thomas, C.B.; Srinivasan, J. 2011: Rituximab and mycophenolate combination therapy in refractory dermatomyositis with multiple autoimmune disorders. Journal of Clinical Neuromuscular Disease 13(2): 63-67
Boletis, J.N.; Marinaki, S.; Skalioti, C.; Lionaki, S.S.; Iniotaki, A.; Sfikakis, P.P. 2009: Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 24(7): 2157-2160
Ahmed, M.S.; Wong, C.F. 2008: Rituximab and nephrotic syndrome: a new therapeutic hope?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(1): 11-17
Besada, E. 2012: Rituximab and neutropenia. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 132(20): 2259; Author Reply 2259
Yong, P.F.K.; Malik, R.; Arif, S.; Peakman, M.; Amiel, S.; Ibrahim, M.A.A.; Gough, A. 2009: Rituximab and omalizumab in severe, refractory insulin allergy. New England Journal of Medicine 360(10): 1045-1047
Diaz, L.A. 2007: Rituximab and pemphigus--a therapeutic advance. New England Journal of Medicine 357(6): 605-607
Carson, K.R.; Bennett, C.L. 2009: Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leukemia and Lymphoma 50(3): 323-324
Carver, J.R.; Johnson, T.; Schuster, S.J. 2010: Rituximab and statins. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 28(30): e611; author reply e612
Laszlo, D.; Andreola, G.; Rigacci, L.; Fabbri, A.; Rabascio, C.; Pinto, A.; Negri, M.; Martinelli, G. 2011: Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine as therapy in untreated and relapsed Waldenström's macroglobulinemia. Clinical Lymphoma Myeloma and Leukemia 11(1): 130-132
Laszlo, D.; Andreola, G.; Rigacci, L.; Fabbri, A.; Rabascio, C.; Mancuso, P.; Pruneri, G.; Radice, D.; Pinto, A.; Frigeri, F.; Calabrese, L.; Billio, A.; Bertolini, F.; Martinelli, G. 2010: Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase Ii multicenter study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(13): 2233-2238
Bertazzoni, P.; Rabascio, C.; Gigli, F.; Calabrese, L.; Radice, D.; Calleri, A.; Gregato, G.; Negri, M.; Liptrott, S.J.; Bassi, S.; Nassi, L.; Sammassimo, S.; Laszlo, D.; Preda, L.; Pruneri, G.; Orlando, L.; Martinelli, G. 2010: Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients. Leukemia and Lymphoma 51(8): 1485-1493
Ramasamy, K.; Gandhi, S.; Tenant-Flowers, M.; Ceesay, M.; Corderoy, S.; Marcus, R.; Schey, S. 2012: Rituximab and thalidomide combination therapy for Castleman disease. British Journal of Haematology 158(3): 421-423
Bussel, J.B.; Lee, C.S.; Seery, C.; Imahiyerobo, A.A.; Thompson, M.V.; Catellier, D.; Turenne, I.G.; Patel, V.L.; Basciano, P.A.; Elstrom, R.L.; Ghanima, W. 2014: Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration. Haematologica 99(7): 1264-1271
Raterman, H.G.; Simsek, S.; Lems, W.F.; Meesters, E.W.; Dijkmans, B.A.C.; Nurmohamed, M.T. 2009: Rituximab and thyroid function. Archives of Internal Medicine 169(11): 1073-1074
González-Vacarezza, N.ás.; Alemán, A.; González, G.; Pérez, A. 2014: Rituximab and tocilizumab for the treatment of rheumatoid arthritis. International Journal of Technology Assessment in Health Care 30(3): 282-288
Haroon, M.; Devlin, J. 2012: Rituximab as a first-line agent for the treatment of dermatomyositis. Rheumatology International 32(6): 1783-1784
Karenfort, M.; Kieseier, B.C.; Tibussek, D.; Assmann, B.; Schaper, J.; Mayatepek, E. 2009: Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis. Developmental Medicine and Child Neurology 51(2): 159-161
Siddiqi, A.Imran. 2011: Rituximab as a possible cause of posterior reversible encephalopathy syndrome. Australasian Medical Journal 4(9): 513-515
Aleem, A.; Saidu, A.; Abdulkarim, H.; Al-Diab, A.R.; Al-Sagheer, A.; Qayum, A.; Al-Momen, A.K. 2009: Rituximab as a single agent in the management of adult patients with haemophilia a and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor. Haemophilia: the Official Journal of the World Federation of Hemophilia 15(1): 210-216
Roccatello, D.; Baldovino, S.; Rossi, D.; Giachino, O.; Mansouri, M.; Naretto, C.; Di Simone, D.; Francica, S.; Cavallo, R.; Alpa, M.; Napoli, F.; Sena, L.M. 2008: Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Clinical Reviews in Allergy and Immunology 34(1): 111-117
Belkhou, A.; Younsi, R.; El Bouchti, I.; El Hassani, S. 2008: Rituximab as a treatment alternative in sarcoidosis. Joint Bone Spine 75(4): 511-512
Jasti, S.; Coyle, T.; Gentile, T.; Rosales, L.; Poiesz, B. 2008: Rituximab as an adjunct to plasma exchange in TTP: a report of 12 cases and review of literature. Journal of Clinical Apheresis 23(5): 151-156
Muñoz-Beamud, F.; Isenberg, D.A. 2013: Rituximab as an effective alternative therapy in refractory idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology 31(6): 896-903
Bachmeyer, C.; Maury, J.; Parrot, A.; Bachir, D.; Stankovic, K.; Girot, R.; Lionnet, F.ço. 2010: Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. American Journal of Hematology 85(1): 91-92
Narshi, C.B.; Haider, S.; Ford, C.M.; Isenberg, D.A.; Giles, I.P. 2010: Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus. Rheumatology 49(2): 392-394
Sautner, J.; Rintelen, B.; Leeb, B.F. 2013: Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis. Rheumatology 52(8): 1535-1537
Croxtall, J.D. 2011: Rituximab as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma: profile report. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 25(5): 329-331
Lim, M.Y.; Nielsen, B.; Lee, K.; Kasthuri, R.S.; Key, N.S.; Ma, A.D. 2014: Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia a and inhibitors. Journal of Thrombosis and Haemostasis: Jth 12(6): 897-901
Rhee, E.P.; Laliberte, K.A.; Niles, J.L. 2010: Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical Journal of the American Society of Nephrology: Cjasn 5(8): 1394-1400
Vidal, L.; Gafter-Gvili, A.; Leibovici, L.; Shpilberg, O. 2009: Rituximab as maintenance therapy for patients with follicular lymphoma. Cochrane Database of Systematic Reviews 2: Cd006552
Shabbat, S.; Aharoni, J.; Sarid, L.; Ben-Harush, M.; Kapelushnik, J. 2009: Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma. Pediatric Blood and Cancer 52(5): 664-666
Yeo, K.K.; Walter, A.W.; Miller, R.E.; Dalmau, J. 2012: Rituximab as potential therapy for paraneoplastic cerebellar degeneration in pediatric Hodgkin disease. Pediatric Blood and Cancer 58(6): 986-987
Bresin, E.; Gastoldi, S.; Daina, E.; Belotti, D.; Pogliani, E.; Perseghin, P.; Scalzulli, P.R.; Paolini, R.; Marcenò, R.; Remuzzi, G.; Galbusera, M. 2009: Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies. Thrombosis and Haemostasis 101(2): 233-238
Montoya, R.C.; Poiesz, B.J. 2012: Rituximab as prophylaxis in chronic relapsing thrombotic thrombocytopenic purpura: a case report and review of the literature. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 23(4): 338-341
Lovric, S.; Erdbruegger, U.; Kümpers, P.; Woywodt, A.; Koenecke, C.; Wedemeyer, H.; Haller, H.; Haubitz, M. 2009: Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 24(1): 179-185
Goñi Esarte, S.; Arín Letamendía, A.; Vila Costas, J.J.é; Jiménez Pérez, F.J.; Ruiz-Clavijo García, D.; Carrascosa Gil, J.; Almendral López, M.ía.L. 2013: Rituximab as rescue therapy in refractory esophageal lichen planus. Gastroenterologia y Hepatologia 36(4): 264-267
Powles, T.; Stebbing, J.; Montoto, S.; Nelson, M.; Gazzard, B.; Orkin, C.; Webb, A.; Bower, M. 2007: Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease. Blood 110(12): 4132-4133
Czaja, C.A.; Merkel, P.A.; Chan, E.D.; Lenz, L.L.; Wolf, M.L.; Alam, R.; Frankel, S.K.; Fischer, A.; Gogate, S.; Perez-Velez, C.M.; Knight, V. 2014: Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 58(6): E115-E118
Thomas, D.A. 2010: Rituximab as therapy for acute lymphoblastic leukemia. Clinical Advances in Hematology and Oncology: H&o 8(3): 168-171
Lin, H.C.; Alvarez, L.; Laroche, G.; Melin-Aldana, H.; Pfeifer, K.; Schwarz, K.; Whitington, P.F.; Alonso, E.M.; Ekong, U.D. 2013: Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 19(12): 1403-1410
Cervetti, G.; Galimberti, S.; Andreazzoli, F.; Fazzi, R.; Cecconi, N.; Caracciolo, F.; Petrini, M. 2008: Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up. British Journal of Haematology 143(2): 296-298
López Carmona, D.; Pérez de Pedro, I.án.; de Ramón, E.; Camps García, M.ía.T. 2007: Rituximab as treatment for thrombocytopenic thrombotic purpura associated with systemic lupus erythematosus. Medicina Clinica 129(20): 797-798
Weissmann-Brenner, A.; Brenner, B.; Belyaeva, I.; Lahav, M.; Rabizadeh, E. 2011: Rituximab associated neutropenia: description of three cases and an insight into the underlying pathogenesis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 17(11): Cs133-Cs137
Arulkumaran, N.; Suleman, R.; Cecconi, M.; Kiely, P.; Chua, F. 2012: Rituximab associated pneumonitis in antineutrophil cytoplasmic antibody-associated vasculitis. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 18(1): 39-41
Cerny, J.; Trneny, M.; Slavickova, A.; Pytlik, R.; Salkova, J.; Valkova, V.; Liu, Q.; Houghton, J.; Klener, P. 2009: Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders. Hematology 14(4): 187-197
Vital, E.M.; Kay, J.; Emery, P. 2013: Rituximab biosimilars. Expert Opinion on Biological Therapy 13(7): 1049-1062
Yri, O.E.; Torfoss, D.; Hungnes, O.; Tierens, A.; Waalen, K.; Nordøy, T.; Dudman, S.; Kilander, A.; Wader, K.F.; Ostenstad, B.ør.; Ekanger, R.; Meyer, P.; Kolstad, A. 2011: Rituximab blocks protective serologic response to influenza a (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood 118(26): 6769-6771
Askeland, G. 2013: Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study. Expert Review of Clinical Immunology 9(5): 402
Zinzani, P.Luigi.; Stefoni, V.; Finolezzi, E.; Brusamolino, E.; Cabras, M.Giuseppina.; Chiappella, A.; Salvi, F.; Rossi, A.; Broccoli, A.; Martelli, M. 2009: Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study. Clinical Lymphoma and Myeloma 9(5): 381-385
Saadoun, D.; Resche-Rigon, M.; Sene, D.; Perard, L.; Karras, A.; Cacoub, P. 2008: Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Annals of the Rheumatic Diseases 67(10): 1431-1436
Li, Y.; Huang, S.; Wang, X.; Zhou, D.; Huang, K.; Guo, H.; Fang, J.; Chen, C.; Liu, Q. 2010: Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma. Journal of Tropical Pediatrics 56(5): 337-341
Salles, G.; Mounier, N.; de Guibert, S.; Morschhauser, F.; Doyen, C.; Rossi, J.-F.ço.; Haioun, C.; Brice, P.; Mahé, B.éa.; Bouabdallah, R.; Audhuy, B.; Ferme, C.; Dartigeas, C.; Feugier, P.; Sebban, C.; Xerri, L.; Foussard, C. 2008: Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study. Blood 112(13): 4824-4831
Rey, J.; Coso, D.; Roger, V.; Bouayed, N.; Belmecheri, N.; Ivanov, V.; Gastaut, J.A.; Bouabdallah, R. 2009: Rituximab combined with chemotherapy for lymphoma during pregnancy. Leukemia Research 33(3): E8-E9
Heredia, M.; Canales, S.; Sáez, C.; Testillano, M. 2008: The nutritional status of patients with colorectal cancer undergoing chemotherapy. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 32(1): 35-37
Ronaghy, A.; Streilein, R.D.; Hall, R.P. 2014: Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP). Journal of Dermatological Science 74(1): 93-94
Aletaha, D.; Alasti, F.; Smolen, J.S. 2013: Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients. Annals of the Rheumatic Diseases 72(1): 7-12
Papajik, T.; Pikalova, Z.; Raida, L.; Skoumalova, I.; Vondrakova, J.; Faber, E.; Prochazka, V.; Kubova, Z.; Kucerova, L.; Pavlik, T.; Dusek, L.; Indrak, K. 2009: Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission. Biomedical Papers of the Medical Faculty of the University Palacky Olomouc Czechoslovakia 153(3): 211-214
Greenberg, B.M.; Graves, D.; Remington, G.; Hardeman, P.; Mann, M.; Karandikar, N.; Stuve, O.; Monson, N.; Frohman, E. 2012: Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success. Multiple Sclerosis 18(7): 1022-1026
Willeke, P.; Becker, H.; Schlüter, B.; Pavenstäd, H.; Mickholz, E.; Wierichs, C.; Gaubitz, M.; Schotte, H. 2012: Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis. Scandinavian Journal of Rheumatology 41(3): 242-243
Chalam, K.V.; Gupta, S.K.; Agarwal, S. 2007: Rituximab effectively reverses papilledema associated with cerebral venous sinus thrombosis in antiphospholipid antibody syndrome. European Journal of Ophthalmology 17(5): 867-870
Jimenez, A.R.T.; Vallejo, E.S.; Cruz, M.Z.; Cruz, A.C.; Miramontes, J.V.R.; Jara, B.S. 2013: Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome. Lupus 22(14): 1514-1517
Benedetti, L.; Franciotta, D.; Beronio, A.; Cadenotti, L.; Gobbi, M.; Mancardi, G.L.; Schenone, A.; Tartaglione, A. 2008: Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura. Muscle and Nerve 38(2): 1076-1077
Ansari, S.; Rostami, T.; Yousefian, S.; Kiumarsi, A.; Miri-Aliabad, G.; Ramim, T. 2014: Rituximab efficacy in the treatment of children with chronic immune thrombocytopenic purpura. Pediatric Hematology and Oncology 31(6): 555-562
Sellier-Leclerc, A.-L.; Macher, M.-A.; Loirat, C.; Guérin, V.ér.; Watier, H.é; Peuchmaur, M.; Baudouin, V.ér.; Deschênes, G. 2010: Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Pediatric Nephrology 25(6): 1109-1115
Palanichamy, A.; Jahn, S.; Nickles, D.; Derstine, M.; Abounasr, A.; Hauser, S.L.; Baranzini, S.E.; Leppert, D.; von Büdingen, H.-C. 2014: Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients. Journal of Immunology 193(2): 580-586
Kahl, B.S.; Hong, F.; Williams, M.E.; Gascoyne, R.D.; Wagner, L.I.; Krauss, J.C.; Habermann, T.M.; Swinnen, L.J.; Schuster, S.J.; Peterson, C.G.; Sborov, M.D.; Martin, S.E.; Weiss, M.; Ehmann, W.C.; Horning, S.J. 2014: Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32(28): 3096-3102
Yabu, J.M.; Ho, B.; Scandling, J.D.; Vincenti, F. 2008: Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 8(1): 222-227
Rousset-Rouvière, C.; Cailliez, M.; Garaix, F.; Bruno, D.; Laurent, D.; Tsimaratos, M. 2014: Rituximab fails where eculizumab restores renal function in C3nef-related DDD. Pediatric Nephrology 29(6): 1107-1111
Grimaldi, D.; Bartolucci, P.; Gouault-Heilmann, M.; Martin-Toutain, I.; Khellaf, M.; Godeau, B. 2008: Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)-associated acquired von Willebrand syndrome. Thrombosis and Haemostasis 99(4): 782-783
Buchler, T.; Dubash, S.; Lee, V.; Chilton, D.; Cartledge, J.; Isaacson, P.; Tedder, R.S.; Lee, S.M. 2008: Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases. Aids 22(13): 1685-1687
Teng, Y.K.O.; Tekstra, J.; Breedveld, F.C.; Lafeber, F.; Bijlsma, J.W.J.; van Laar, J.M. 2009: Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies. Annals of the Rheumatic Diseases 68(6): 1075-1077
Gu, J.'a.; Xia, Y.; Mao, J.; Fu, H.; Liu, A.'m. 2012: Rituximab followed by mycophenolate mofetil in children with IgM nephropathy. Indian Pediatrics 49(10): 831-833
Guillevin, L. 2014: Rituximab for ANCA-associated vasculitides. Clinical and Experimental Rheumatology 32(3 Suppl 82: S118-S121
Gregersen, J.W.; Chaudhry, A.; Jayne, D.R.W. 2013: Rituximab for ANCA-associated vasculitis in the setting of severe infection. Scandinavian Journal of Rheumatology 42(3): 207-210
Takemoto, C.M. 2009: Rituximab for ITP: a long-term fix?. Pediatric Blood and Cancer 52(2): 155-156
Reshef, R.; Tsai, D.E. 2008: Rituximab for PTLD of the CNS: is it a 'no-brainer'?. Onkologie 31(12): 650-651
Rüfer, A.; Brodmann, D.; Gregor, M.; Kremer Hovinga, J.A.; Lämmle, B.; Wuillemin, W.A. 2007: Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature. Swiss Medical Weekly 137(37-38): 518-524
Lunardon, L.; Payne, A.S. 2012: Rituximab for autoimmune blistering diseases: recent studies, new insights. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 147(3): 269-276
Ansari, S.; Tashvighi, M.; Darbandi, B.; Arbani, B.D.; Salimi, A.B.; Golpaygani, M. 2011: Rituximab for child with chronic relapsing autoimmune hemolytic anemia. Pediatric Hematology and Oncology 28(2): 164-166
Iijima, K. 2011: Rituximab for childhood refractory nephrotic syndrome. Pediatrics International: Official Journal of the Japan Pediatric Society 53(5): 617-621
Hodson, E.M.; Craig, J.C. 2014: Rituximab for childhood-onset nephrotic syndrome. Lancet 384(9950): 1242-1243
Iijima, K.; Sako, M.; Nozu, K.; Mori, R.; Tuchida, N.; Kamei, K.; Miura, K.; Aya, K.; Nakanishi, K.; Ohtomo, Y.; Takahashi, S.; Tanaka, R.; Kaito, H.; Nakamura, H.; Ishikura, K.; Ito, S.; Ohashi, Y.; Nozu, K.; Kaito, H.; Hashimura, Y.; Ninchoji, T.; Takahashi, S.; Saito, H.; Nakanishi, K.; Shima, Y.; Tanaka, R.; Morinaga, K.; Miura, K.; Sekine, T.; Ohtomo, Y.; Umino, D.; Aya, K.; Miyai, T.; Ishikura, K.; Hataya, H.; Hamasaki, Y.; Ito, S.; Kamei, K.; Ogura, M.; Udagawa, T.; Tsutsumi, A.; Iijima, K.; Sako, M.; Tsuchida, N.; Igarashi, T.; Honda, M.; Morita, S. 2014: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384(9950): 1273-1281
Liang, Y.; Zhang, L.; Gao, J.; Hu, D.; Ai, Y. 2012: Rituximab for children with immune thrombocytopenia: a systematic review. Plos one 7(5): E36698
Robak, T. 2012: Rituximab for chronic lymphocytic leukemia. Expert Opinion on Biological Therapy 12(4): 503-515
LeBlanc, T.; Kamal, A.; Abernethy, A. 2014: Rituximab for follicular lymphoma: watch and wait, watch and worry, or watch and live?. LANCET. Oncology 15(7): E251-E252
Gajraj, E.; Chung, H.; Longson, C.; Stevens, A. 2008: Rituximab for follicular non-Hodgkin lymphoma. LANCET. Oncology 9(4): 320-321
Rostaing, L.; Guilbeau-Frugier, Céline.; Kamar, N. 2009: Rituximab for humoral rejection after kidney transplantation: an update. Transplantation 87(8): 1261
Ruggenenti, P.; Chiurchiu, C.; Abbate, M.; Perna, A.; Cravedi, P.; Bontempelli, M.; Remuzzi, G. 2006: Rituximab for idiopathic membranous nephropathy: who can benefit?. Clinical Journal of the American Society of Nephrology: Cjasn 1(4): 738-748
Calich, A.L.; Puéchal, X.; Pugnet, G.ég.; London, J.; Terrier, B.; Charles, P.; Mouthon, L.; Guillevin, L.ïc. 2014: Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients. Journal of Autoimmunity 50: 135-141
Charles, P.; Néel, A.; Tieulié, N.; Hot, A.; Pugnet, G.; Decaux, O.; Marie, I.; Khellaf, M.; Kahn, J-Emmanuel.; Karras, A.; Ziza, J-Marc.; Deligny, C.; Tchérakian, C.; Guillevin, Lïc. 2014: Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Rheumatology 53(3): 532-539
Itty, S.; Pulido, J.S. 2009: Rituximab for intraocular lymphoma. Retina 29(2): 129-132
Gall, B.; Yee, A.; Berry, B.; Bircham, D.; Hayashi, A.; Dansereau, J.; Hart, J. 2010: Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura. Journal of Obstetrics and Gynaecology Canada: Jogc 32(12): 1167-1171
Imashuku, S.; Kudo, N.; Kubo, K.; Saigo, K.; Okuno, N.; Tohyama, K. 2012: Rituximab for managing acquired hemophilia a in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation. Journal of Blood Medicine 3: 157-161
Yamanouchi, J.; Hato, T.; Miyoshi, K.; Kobayashi, S.; Azuma, T.; Hasegawa, H.; Yasukawa, M. 2013: Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases. Japanese Journal of Clinical Hematology 54(2): 205-209
Caramazza, D.; Quintini, G.; Abbene, I.; Coco, L.L.; Malato, A.; Di Trapani, R.; Saccullo, G.; Pizzo, G.; Palazzolo, R.; Barone, R.; Mazzola, G.; Rizzo, S.; Ragonese, P.; Aridon, P.; Abbadessa, V.; Siragusa, S. 2010: Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome. Blood Transfusion 8(3): 203-210
Bruchfeld, A.; Benedek, S.; Hilderman, M.; Medin, C.; Snaedal-Jonsdottir, S.; Korkeila, M. 2014: Rituximab for minimal change disease in adults: long-term follow-up. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 29(4): 851-856
Guitard, J.ël.; Hebral, A.-L.; Fakhouri, F.; Joly, D.; Daugas, E.; Rivalan, J.; Guigonis, V.; Ducret, F.çi.; Presne, C.; Pirson, Y.; Hourmant, M.; Glachant, J.-C.; Vendrely, B.; Moranne, O.; Faguer, S.; Chauveau, D. 2014: Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 29(11): 2084-2091
Stieglbauer, K.; Topakian, R.; Schäffer, V.; Aichner, F.T. 2009: Rituximab for myasthenia gravis: three case reports and review of the literature. Journal of the Neurological Sciences 280(1-2): 120-122
Harrison, A.M.; Thalji, N.M.; Greenberg, A.J.; Tapia, C.J.; Windebank, A.J. 2014: Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation. Clinical and Translational Science 7(1): 82-86
Miserocchi, E.; Modorati, G. 2012: Rituximab for noninfectious uveitis. Developments in Ophthalmology 51: 98-109
Sinha, S.; Sarin, Y.K. 2014: Rituximab for opsoclonus myoclonus ataxia syndrome associated with neuroblastoma. Indian Journal of Pediatrics 81(2): 218-219
Peñalver, F.Javier.; Cabrera, J.Rafael. 2007: Rituximab for patients with idiopathic thrombocytopenic purpura. Annals of Internal Medicine 147(4): 281; Author Reply 281-2
Castellano, G.; Franzin, R.; Stasi, A.; Divella, C.; Sallustio, F.; Pontrelli, P.; Lucarelli, G.; Battaglia, M.; Staffieri, F.; Crovace, A.; Stallone, G.; Seelen, M.; Daha, M.R.; Grandaliano, G.; Gesualdo, L. 2018: Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling. Frontiers in Immunology 9: 1002
Le Roux-Villet, C.; Prost-Squarcioni, C.; Alexandre, M.; Caux, F.éd.ér.; Pascal, F.; Doan, S.; Brette, M.-D.; Soued, I.; Gabison, Ér.; Aucouturier, F.ço.; Letestu, R.ém.; Laroche, L.; Bachelez, H.é 2011: Rituximab for patients with refractory mucous membrane pemphigoid. Archives of Dermatology 147(7): 843-849
Huerva, V.ín.; Sanchez, M.ía.C.; Traveset, A.; Jurjo, C.; Ruiz, A.ín. 2010: Rituximab for peripheral ulcerative keratitis with wegener granulomatosis. Cornea 29(6): 708-710
Niermeijer, J.M.F.; Eurelings, M.; Lokhorst, H.L.; van der Pol, W.-L.; Franssen, H.; Wokke, J.H.J.; Notermans, N.C. 2009: Rituximab for polyneuropathy with IgM monoclonal gammopathy. Journal of Neurology Neurosurgery and Psychiatry 80(9): 1036-1039
Bayrakci, U.S.; Baskin, E.; Sakalli, H.; Karakayali, H.; Haberal, M. 2009: Rituximab for post-transplant recurrences of FSGS. Pediatric Transplantation 13(2): 240-243
Noizat-Pirenne, F.; Bachir, D.; Chadebech, P.; Michel, M.; Plonquet, A.; Lecron, J-C.; Galactéros, F.; Bierling, P. 2007: Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 92(12): e132-e135
De Boysson, H.; Arquizan, C.; Guillevin, L.; Pagnoux, C. 2013: Rituximab for primary angiitis of the central nervous system: report of 2 patients from the French COVAC cohort and review of the literature. Journal of Rheumatology 40(12): 2102-2103
Fenot, M.; Quereux, G.; Brocard, A.; Renaut, J.-J.; Dreno, B. 2010: Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type. European Journal of Dermatology: Ejd 20(6): 753-757
Lee, W.-S.; Yoo, W.-H. 2014: Rituximab for refractory adult-onset Still's disease with thrombotic microangiopathy. Rheumatology 53(9): 1717-1718
Elliott, M.A.; Heit, J.A.; Pruthi, R.K.; Gastineau, D.A.; Winters, J.L.; Hook, C.Christopher. 2009: Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. European Journal of Haematology 83(4): 365-372
Al-Busafi, S.A.; Michel, Ré.P.; Deschenes, M. 2013: Rituximab for refractory autoimmune hepatitis: a case report. Arab Journal of Gastroenterology: the Official Publication of the Pan-Arab Association of Gastroenterology 14(3): 135-138
Kari, J.A.; El-Morshedy, S.M.; El-Desoky, S.; Alshaya, H.O.; Rahim, K.A.; Edrees, B.M. 2011: Rituximab for refractory cases of childhood nephrotic syndrome. Pediatric Nephrology 26(5): 733-737
Khor, C.-G.; Chen, X.L.-F.; Lin, T.-S.; Lu, C.-H.; Hsieh, S.-C. 2014: Rituximab for refractory digital infarcts and ulcers in systemic sclerosis. Clinical Rheumatology 33(7): 1019-1020
Lower, E.E.; Baughman, R.P.; Kaufman, A.H. 2012: Rituximab for refractory granulomatous eye disease. Clinical Ophthalmology 6: 1613-1618
Ho, L.Y.; Mok, C.C.; To, C.H.; Anselm, M.; Cheung, M.Y.; Yu, K.L. 2007: Rituximab for refractory rheumatoid arthritis: a 24-week open-label prospective study. Open Rheumatology Journal 1: 1-4
He, D.; Guo, R.; Zhang, F.; Zhang, C.; Dong, S.; Zhou, H. 2013: Rituximab for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews 12: Cd009130
Cartin-Ceba, R.; Golbin, J.M.; Keogh, K.A.; Peikert, T.; Sánchez-Menéndez, M.; Ytterberg, S.R.; Fervenza, F.C.; Specks, U. 2012: Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center. Arthritis and Rheumatism 64(11): 3770-3778
Bonilla-Abadía, F.; Coronel Restrepo, N.ás.; Tobón, G.J.; Echeverri, A.és.F.; Muñoz-Buitrón, E.; Castro, A.M.; Bejarano, M.A.; Cañas, C.A. 2014: Rituximab for remission induction and maintenance in refractory systemic lupus erythematosus. Autoimmune Diseases 2014: 731806
Onal, S.; Kazokoglu, H.; Koc, A.; Yavuz, S. 2008: Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis. Ocular Immunology and Inflammation 16(5): 230-232